Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPD
NM_014704.4(CEP104):c.1879G>T (p.Glu627Ter)	CEP104	E627*	See cases|Joubert syndrome 25	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001691031	1	3746519	1	3829955	1691031	1683439		NC_000001.11:3829954:C:A
NM_003000.3(SDHB):c.260T>C (p.Leu87Ser)	SDHB	L87S	Gastrointestinal stromal tumor|Paragangliomas 4|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000178686	1	17359581	1	17033086	178686	172493	rs727504457	NC_000001.11:17033085:A:G
NM_003000.3(SDHB):c.79C>T (p.Arg27Ter)	SDHB	R27*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 4	Pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012783	1	17371377	1	17044882	12783	27822	rs74315369	NC_000001.11:17044881:G:A
NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp)	MUTYH	G382D, G396D, G276D, G393D, G369D, G368D, G383D, G253D, G379D	Familial adenomatous polyposis 2|Neoplasm of stomach|Pilomatrixoma|Hereditary cancer-predisposing syndrome|not provided|Familial colorectal cancer|Familial adenomatous polyposis 2|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|See cases|Ovarian carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005294	1	45797228	1	45331556	5294	20333	rs36053993	NC_000001.11:45331555:C:T
NM_002524.5(NRAS):c.182A>G (p.Gln61Arg)	NRAS	Q61R	Non-small cell lung carcinoma|not provided	Pathogenic(Last reviewed: Sep 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013900	1	115256529	1	114713908	13900	28939	rs11554290	NC_000001.11:114713907:T:C
NM_002524.5(NRAS):c.35G>A (p.Gly12Asp)	NRAS	G12D	Noonan syndrome and Noonan-related syndrome|not provided|RASopathy|Noonan syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039648	1	115258747	1	114716126	39648	48247	rs121913237	NC_000001.11:114716125:C:T
NM_019026.6(TMCO1):c.463C>T (p.Arg155Ter)	TMCO1	R206*, R172*, R143*	Cerebrofaciothoracic dysplasia|Autism|Bilateral cleft lip|Pulmonic stenosis|Sensorineural hearing loss disorder|Relative macrocephaly|Renal agenesis|Unilateral renal agenesis|Strabismus|Severely reduced visual acuity|Cryptorchidism|Cleft palate|Global developmental delay|Bilateral cleft lip and palate|Rib fusion|Abnormal sternum morphology|Bilateral cleft palate|Delayed speech and language development|Hemivertebrae|Scoliosis	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000598963	1	165712409	1	165743172	598963	590035	rs765379963	NC_000001.11:165743171:G:A
NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys)	RAB3GAP2	R426C	Martsolf syndrome|Warburg micro syndrome 2|Martsolf syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000100787	1	220364621	1	220191279	100787	106652	rs587777167	NC_000001.11:220191278:G:A
NM_001206744.2(TPO):c.1978C>G (p.Gln660Glu)	TPO	Q660E, Q603E, Q487E	not provided|Deficiency of iodide peroxidase	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004053	2	1497783	2	1494011	4053	19092	rs121908088	NC_000002.12:1494010:C:G
NM_001378454.1(ALMS1):c.161T>A (p.Leu54Ter)	ALMS1	L55*, L54*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000555236	2	73613157	2	73386029	555236	542228	rs755760721	NC_000002.12:73386028:T:A
NM_001378454.1(ALMS1):c.283C>T (p.Gln95Ter)	ALMS1	Q96*, Q95*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556723	2	73613279	2	73386151	556723	542151	rs750326619	NC_000002.12:73386150:C:T
NM_001378454.1(ALMS1):c.355C>T (p.Gln119Ter)	ALMS1	Q120*, Q119*	Alstrom syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550543	2	73635780	2	73408652	550543	542438	rs751804613	NC_000002.12:73408651:C:T
NM_001378454.1(ALMS1):c.427C>T (p.Gln143Ter)	ALMS1	Q144*, Q143*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551028	2	73635852	2	73408724	551028	542158	rs150825781	NC_000002.12:73408723:C:T
NM_001378454.1(ALMS1):c.709G>T (p.Glu237Ter)	ALMS1	E238*, E237*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000555777	2	73650047	2	73422919	555777	542190	rs989080548	NC_000002.12:73422918:G:T
NM_001378454.1(ALMS1):c.805C>T (p.Arg269Ter)	ALMS1	R270*, R269*	Alstrom syndrome	Pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000812221	2	73651598	2	73424470	812221	800474	rs1426009756	NC_000002.12:73424469:C:T
NM_001378454.1(ALMS1):c.857C>G (p.Ser286Ter)	ALMS1	S286*, S287*	Retinal dystrophy|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000866803	2	73651650	2	73424522	866803	856187	rs1270472063	NC_000002.12:73424521:C:G
NM_001378454.1(ALMS1):c.1051C>T (p.Arg351Ter)	ALMS1	R352*, R351*	Alstrom syndrome	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000459845	2	73651844	2	73424716	459845	451767	rs1275113273	NC_000002.12:73424715:C:T
NM_001378454.1(ALMS1):c.1625T>A (p.Leu542Ter)	ALMS1	L543*, L542*	not provided|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000808770	2	73675279	2	73448152	808770	795274	rs1347176614	NC_000002.12:73448151:T:A
NM_001378454.1(ALMS1):c.1727C>G (p.Ser576Ter)	ALMS1	S577*, S576*	Alstrom syndrome	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000801720	2	73675381	2	73448254	801720	790290	rs756389027	NC_000002.12:73448253:C:G
NM_001378454.1(ALMS1):c.2038C>T (p.Arg680Ter)	ALMS1	R680*, R681*	Alstrom syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000937720	2	73675692	2	73448565	937720	931571	rs115444326	NC_000002.12:73448564:C:T
NM_001378454.1(ALMS1):c.2326C>T (p.Gln776Ter)	ALMS1	Q777*, Q776*	Alstrom syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000801721	2	73675980	2	73448853	801721	790291	rs758195453	NC_000002.12:73448852:C:T
NM_001378454.1(ALMS1):c.2617C>T (p.Gln873Ter)	ALMS1	Q874*, Q873*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Apr 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000816972	2	73676271	2	73449144	816972	805317	rs1572932845	NC_000002.12:73449143:C:T
NM_001378454.1(ALMS1):c.2819T>A (p.Leu940Ter)	ALMS1	L941*, L940*	Cardiovascular phenotype|not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000224801	2	73676473	2	73449346	224801	226620	rs539612316	NC_000002.12:73449345:T:A
NM_001378454.1(ALMS1):c.3011C>G (p.Ser1004Ter)	ALMS1	S1005*, S1004*	Alstrom syndrome	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000861254	2	73676665	2	73449538	861254	826986	rs1359874667	NC_000002.12:73449537:C:G
NM_001378454.1(ALMS1):c.3899C>A (p.Ser1300Ter)	ALMS1	S1301*, S1300*	Alstrom syndrome|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264657	2	73677553	2	73450426	264657	248730	rs769219669	NC_000002.12:73450425:C:A
NM_001378454.1(ALMS1):c.4390C>T (p.Gln1464Ter)	ALMS1	Q1465*, Q1464*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000529397	2	73678044	2	73450917	529397	518655	rs904289501	NC_000002.12:73450916:C:T
NM_001378454.1(ALMS1):c.4743C>G (p.Tyr1581Ter)	ALMS1	Y1582*, Y1581*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000638587	2	73678397	2	73451270	638587	626367	rs1572935708	NC_000002.12:73451269:C:G
NM_001378454.1(ALMS1):c.4888C>T (p.Gln1630Ter)	ALMS1	Q1630*, Q1631*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Oct 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV001301455	2	73678542	2	73451415	1301455	1291741		NC_000002.12:73451414:C:T
NM_001378454.1(ALMS1):c.5142T>G (p.Tyr1714Ter)	ALMS1	Y1715*, Y1714*	Cardiovascular phenotype|not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212728	2	73678796	2	73451669	212728	209346	rs772136379	NC_000002.12:73451668:T:G
NM_001378454.1(ALMS1):c.5197C>T (p.Gln1733Ter)	ALMS1	Q1734*, Q1733*	Alstrom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000529398	2	73678851	2	73451724	529398	518733	rs750136202	NC_000002.12:73451723:C:T
NM_001378454.1(ALMS1):c.5452C>T (p.Arg1818Ter)	ALMS1	R1819*, R1818*	Retinal dystrophy|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000866994	2	73679106	2	73451979	866994	856193	rs749339938	NC_000002.12:73451978:C:T
NM_001378454.1(ALMS1):c.5966C>A (p.Ser1989Ter)	ALMS1	S1989*, S1990*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV001421573	2	73679620	2	73452493	1421573	1422989		NC_000002.12:73452492:C:A
NM_001378454.1(ALMS1):c.6302C>A (p.Ser2101Ter)	ALMS1	S2101*, S2102*	not provided|Inborn genetic diseases|Cardiovascular phenotype|Alstrom syndrome	Pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000871762	2	73679956	2	73452829	871762	859195	rs28730854	NC_000002.12:73452828:C:A
NM_001378454.1(ALMS1):c.6433C>T (p.Arg2145Ter)	ALMS1	R2146*, R2145*	Retinitis pigmentosa|Alstrom syndrome|Retinal dystrophy	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000210129	2	73680087	2	73452960	210129	207022	rs770558150	NC_000002.12:73452959:C:T
NM_001378454.1(ALMS1):c.6797T>A (p.Leu2266Ter)	ALMS1	L2267*, L2266*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554903	2	73680451	2	73453324	554903	542399	rs761071372	NC_000002.12:73453323:T:A
NM_001378454.1(ALMS1):c.7399G>T (p.Glu2467Ter)	ALMS1	E2467*, E2468*	Alstrom syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000858665	2	73681053	2	73453926	858665	827006	rs1198051503	NC_000002.12:73453925:G:T
NM_001378454.1(ALMS1):c.7531C>T (p.Arg2511Ter)	ALMS1	R2512*, R2511*	Alstrom syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000866836	2	73681185	2	73454058	866836	856195	rs1315351235	NC_000002.12:73454057:C:T
NM_001378454.1(ALMS1):c.7786C>T (p.Gln2596Ter)	ALMS1	Q2597*, Q2596*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000813154	2	73716872	2	73489745	813154	801343	rs1672934629	NC_000002.12:73489744:C:T
NM_001378454.1(ALMS1):c.8005C>T (p.Arg2669Ter)	ALMS1	R2670*, R2669*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000529386	2	73717091	2	73489964	529386	518587	rs549857076	NC_000002.12:73489963:C:T
NM_001378454.1(ALMS1):c.8653C>T (p.Arg2885Ter)	ALMS1	R2885*, R2886*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV001071885	2	73717739	2	73490612	1071885	1059503		NC_000002.12:73490611:C:T
NM_001378454.1(ALMS1):c.9804T>A (p.Tyr3268Ter)	ALMS1	Y3268*, Y3269*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV001452837	2	73761973	2	73534846	1452837	1431980		NC_000002.12:73534845:T:A
NM_001378454.1(ALMS1):c.10480C>T (p.Gln3494Ter)	ALMS1	Q3495*, Q3494*	not provided|Cardiovascular phenotype|Alstrom syndrome	Pathogenic(Last reviewed: Mar 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000210122	2	73799484	2	73572357	210122	207024	rs772624348	NC_000002.12:73572356:C:T
NM_001378454.1(ALMS1):c.10822C>T (p.Arg3608Ter)	ALMS1	R3609*, R3608*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488677	2	73799826	2	73572699	488677	481663	rs1192396248	NC_000002.12:73572698:C:T
NM_001378454.1(ALMS1):c.10882C>T (p.Arg3628Ter)	ALMS1	R3629*, R3628*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000434136	2	73799886	2	73572759	434136	428097	rs1473611414	NC_000002.12:73572758:C:T
NM_001378454.1(ALMS1):c.10933C>T (p.Gln3645Ter)	ALMS1	Q3646*, Q3645*	Alstrom syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000866528	2	73799937	2	73572810	866528	856200	rs1674967197	NC_000002.12:73572809:C:T
NM_001378454.1(ALMS1):c.11104C>T (p.Arg3702Ter)	ALMS1	R3702*, R3703*	Alstrom syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000971131	2	73800108	2	73572981	971131	953221	rs747747269	NC_000002.12:73572980:C:T
NM_001378454.1(ALMS1):c.11204C>A (p.Ser3735Ter)	ALMS1	S3736*, S3735*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280474	2	73800208	2	73573081	280474	264140	rs367877017	NC_000002.12:73573080:C:A
NM_001378454.1(ALMS1):c.11413C>T (p.Arg3805Ter)	ALMS1	R3805*, R3806*	Retinal dystrophy|Alstrom syndrome	Pathogenic(Last reviewed: Nov 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000865871	2	73800417	2	73573290	865871	856202	rs376091780	NC_000002.12:73573289:C:T
NM_001378454.1(ALMS1):c.11446C>T (p.Gln3816Ter)	ALMS1	Q3817*, Q3816*	not provided|Cardiovascular phenotype|Alstrom syndrome	Pathogenic(Last reviewed: Aug 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000620477	2	73800450	2	73573323	620477	611575	rs940576720	NC_000002.12:73573322:C:T
NM_001378454.1(ALMS1):c.11668+1G>T	ALMS1		Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV001522091	2	73826649	2	73599522	1522091	1344106		NC_000002.12:73599521:G:T
NM_001378454.1(ALMS1):c.11991G>A (p.Trp3997Ter)	ALMS1	W3998*, W3997*	not provided|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000489198	2	73828440	2	73601313	489198	481664	rs1553421725	NC_000002.12:73601312:G:A
NM_001378454.1(ALMS1):c.12115-1G>T	ALMS1		Alstrom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV001338514	2	73829311	2	73602184	1338514	1329522		NC_000002.12:73602183:G:T
NM_001128178.3(NPHP1):c.1588C>T (p.Arg530Ter)	NPHP1	R530*, R529*, R585*, R586*, R467*	Senior-Loken syndrome 1|Nephronophthisis 1|Joubert syndrome with renal defect|Nephronophthisis|Joubert syndrome with renal defect	Pathogenic(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV001030710	2	110889310	2	110131733	1030710	1015818	rs547352656	NC_000002.12:110131732:G:A
NM_012233.3(RAB3GAP1):c.748+1G>A	RAB3GAP1		not provided|Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000007058	2	135878489	2	135120919	7058	22097	rs587776651	NC_000002.12:135120918:G:A
NM_012233.3(RAB3GAP1):c.899+1G>A	RAB3GAP1		not provided	Pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000100769	2	135883820	2	135126250	100769	106635	rs587777152	NC_000002.12:135126249:G:A
NM_012233.3(RAB3GAP1):c.1039C>T (p.Arg347Ter)	RAB3GAP1	R347*	not provided|Warburg micro syndrome 1	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000545410	2	135887630	2	135130060	545410	535675	rs532964185	NC_000002.12:135130059:C:T
NM_012233.3(RAB3GAP1):c.1908C>G (p.Tyr636Ter)	RAB3GAP1	Y636*	Warburg micro syndrome 1|not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635325	2	135893487	2	135135917	635325	623129	rs1573585099	NC_000002.12:135135916:C:G
NM_012233.3(RAB3GAP1):c.2642T>G (p.Leu881Ter)	RAB3GAP1	L881*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000211979	2	135922199	2	135164629	211979	206843	rs797045905	NC_000002.12:135164628:T:G
NM_024753.5(TTC21B):c.2758-2A>G	TTC21B		Infantile nephronophthisis|Jeune thoracic dystrophy|Nephronophthisis|Nephronophthisis 12|Asphyxiating thoracic dystrophy 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030937	2	166756392	2	165899882	30937	39894	rs766132877	NC_000002.12:165899881:T:C
NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu)	TTC21B|TTC21B-AS1	P209L	Retinal dystrophy|Asphyxiating thoracic dystrophy 4|Nephronophthisis 12|Jeune thoracic dystrophy|Nephronophthisis|not provided|Nephronophthisis 12|Infantile nephronophthisis|See cases	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000030935	2	166797621	2	165941111	30935	39892	rs140511594	NC_000002.12:165941110:G:A
NM_001044385.3(TMEM237):c.943+1G>T	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031184	2	202492798	2	201628075	31184	40141	rs748510210	NC_000002.12:201628074:C:A
NM_001044385.3(TMEM237):c.869+1G>A	TMEM237		Joubert syndrome 14	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000183328	2	202493952	2	201629229	183328	181405	rs730882231	NC_000002.12:201629228:C:T
NM_001044385.3(TMEM237):c.52C>T (p.Arg18Ter)	TMEM237	R18*, R10*	Joubert syndrome and related disorders|Joubert syndrome 14	Pathogenic(Last reviewed: May 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031180	2	202505638	2	201640915	31180	40137	rs199469707	NC_000002.12:201640914:G:A
NM_001352754.2(ARMC9):c.1027C>T (p.Arg343Cys)	ARMC9	R343C, R310C	not provided	Pathogenic(Last reviewed: Jan 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV000427932	2	232127019	2	231262306	427932	419008	rs759799287	NC_000002.12:231262305:C:T
NM_000551.4(VHL):c.191G>C (p.Arg64Pro)	VHL	R64P	not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002226	3	10183722	3	10142038	2226	17265	rs104893826	NC_000003.12:10142037:G:C
NM_000551.4(VHL):c.194C>T (p.Ser65Leu)	VHL	S65L	Spinal hemangioblastoma|Cerebellar hemangioblastoma|Retinal capillary hemangioma|Pancreatic cysts|Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182975	3	10183725	3	10142041	182975	180112	rs5030826	NC_000003.12:10142040:C:T
NM_000551.4(VHL):c.194C>G (p.Ser65Trp)	VHL	S65W	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043597	3	10183725	3	10142041	43597	52766	rs5030826	NC_000003.12:10142040:C:G
NM_000551.4(VHL):c.208G>T (p.Glu70Ter)	VHL	E70*	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428806	3	10183739	3	10142055	428806	420438	rs5030802	NC_000003.12:10142054:G:T
NM_000551.4(VHL):c.208G>A (p.Glu70Lys)	VHL	E70K	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043598	3	10183739	3	10142055	43598	52767	rs5030802	NC_000003.12:10142054:G:A
NM_000551.4(VHL):c.214T>C (p.Ser72Pro)	VHL	S72P	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223163	3	10183745	3	10142061	223163	224894	rs869025618	NC_000003.12:10142060:T:C
NM_000551.4(VHL):c.217C>T (p.Gln73Ter)	VHL	Q73*	not provided|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223164	3	10183748	3	10142064	223164	224895	rs869025619	NC_000003.12:10142063:C:T
NM_000551.4(VHL):c.232A>G (p.Asn78Asp)	VHL	N78D	not provided|Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000625226	3	10183763	3	10142079	625226	613559	rs869025621	NC_000003.12:10142078:A:G
NM_000551.4(VHL):c.233A>C (p.Asn78Thr)	VHL	N78T	Chuvash polycythemia|Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223168	3	10183764	3	10142080	223168	224899	rs5030804	NC_000003.12:10142079:A:C
NM_000551.4(VHL):c.233A>G (p.Asn78Ser)	VHL	N78S	Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000093326	3	10183764	3	10142080	93326	99233	rs5030804	NC_000003.12:10142079:A:G
NM_000551.4(VHL):c.238A>G (p.Ser80Gly)	VHL	S80G	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186220	3	10183769	3	10142085	186220	182207	rs786202787	NC_000003.12:10142084:A:G
NM_000551.4(VHL):c.239G>T (p.Ser80Ile)	VHL	S80I	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000625229	3	10183770	3	10142086	625229	613562	rs5030805	NC_000003.12:10142085:G:T
NM_000551.4(VHL):c.242C>T (p.Pro81Leu)	VHL	P81L	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome|See cases	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000036899	3	10183773	3	10142089	36899	45560	rs193922608	NC_000003.12:10142088:C:T
NM_000551.4(VHL):c.245G>T (p.Arg82Leu)	VHL	R82L	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000526675	3	10183776	3	10142092	526675	518732	rs794726890	NC_000003.12:10142091:G:T
NM_000551.4(VHL):c.245G>C (p.Arg82Pro)	VHL	R82P	Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193118	3	10183776	3	10142092	193118	190283	rs794726890	NC_000003.12:10142091:G:C
NM_000551.4(VHL):c.250G>C (p.Val84Leu)	VHL	V84L	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229860	3	10183781	3	10142097	229860	232861	rs5030827	NC_000003.12:10142096:G:C
NM_000551.4(VHL):c.250G>T (p.Val84Leu)	VHL	V84L	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002236	3	10183781	3	10142097	2236	17275	rs5030827	NC_000003.12:10142096:G:T
NM_000551.4(VHL):c.256C>T (p.Pro86Ser)	VHL	P86S	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000178692	3	10183787	3	10142103	178692	173736	rs398123481	NC_000003.12:10142102:C:T
NM_000551.4(VHL):c.256C>G (p.Pro86Ala)	VHL	P86A	Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093327	3	10183787	3	10142103	93327	99234	rs398123481	NC_000003.12:10142102:C:G
NM_000551.4(VHL):c.257C>G (p.Pro86Arg)	VHL	P86R	Hereditary cancer-predisposing syndrome|Nonpapillary renal cell carcinoma|Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223170	3	10183788	3	10142104	223170	224901	rs730882034	NC_000003.12:10142103:C:G
NM_000551.4(VHL):c.257C>T (p.Pro86Leu)	VHL	P86L	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182977	3	10183788	3	10142104	182977	180115	rs730882034	NC_000003.12:10142103:C:T
NM_000551.4(VHL):c.262T>C (p.Trp88Arg)	VHL	W88R	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496053	3	10183793	3	10142109	496053	487013	rs1553619431	NC_000003.12:10142108:T:C
NM_000551.4(VHL):c.262T>A (p.Trp88Arg)	VHL	W88R	Chuvash polycythemia|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000456577	3	10183793	3	10142109	456577	451870	rs1553619431	NC_000003.12:10142108:T:A
NM_000551.4(VHL):c.263G>A (p.Trp88Ter)	VHL	W88*	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182978	3	10183794	3	10142110	182978	180116	rs119103277	NC_000003.12:10142109:G:A
NM_000551.4(VHL):c.264G>T (p.Trp88Cys)	VHL	W88C	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000223171	3	10183795	3	10142111	223171	224902	rs869025622	NC_000003.12:10142110:G:T
NM_000551.4(VHL):c.266T>C (p.Leu89Pro)	VHL	L89P	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182979	3	10183797	3	10142113	182979	180117	rs5030807	NC_000003.12:10142112:T:C
NM_000551.4(VHL):c.277G>A (p.Gly93Ser)	VHL	G93S	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002237	3	10183808	3	10142124	2237	17276	rs5030808	NC_000003.12:10142123:G:A
NM_000551.4(VHL):c.278G>A (p.Gly93Asp)	VHL	G93D	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496054	3	10183809	3	10142125	496054	486941	rs1553619440	NC_000003.12:10142124:G:A
NM_000551.4(VHL):c.280G>T (p.Glu94Ter)	VHL	E94*	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000584477	3	10183811	3	10142127	584477	575529	rs5030829	NC_000003.12:10142126:G:T
NM_000551.4(VHL):c.292T>C (p.Tyr98His)	VHL	Y98H	Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Apr 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002223	3	10183823	3	10142139	2223	17262	rs5030809	NC_000003.12:10142138:T:C
NM_000551.4(VHL):c.293A>C (p.Tyr98Ser)	VHL	Y98S	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000219160	3	10183824	3	10142140	219160	217068	rs864321643	NC_000003.12:10142139:A:C
NM_000551.4(VHL):c.319C>G (p.Arg107Gly)	VHL	R107G	Hereditary cancer-predisposing syndrome|Nonpapillary renal cell carcinoma|Chuvash polycythemia|Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043599	3	10183850	3	10142166	43599	52768	rs397516440	NC_000003.12:10142165:C:G
NM_000551.4(VHL):c.320G>A (p.Arg107His)	VHL	R107H	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223184	3	10183851	3	10142167	223184	224915	rs193922609	NC_000003.12:10142166:G:A
NM_000551.4(VHL):c.320G>C (p.Arg107Pro)	VHL	R107P	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000036900	3	10183851	3	10142167	36900	45561	rs193922609	NC_000003.12:10142166:G:C
NM_000551.4(VHL):c.331A>G (p.Ser111Gly)	VHL	S111G	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000633016	3	10183862	3	10142178	633016	621143	rs1559426203	NC_000003.12:10142177:A:G
NM_000551.4(VHL):c.332G>A (p.Ser111Asn)	VHL	S111N	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000223186	3	10183863	3	10142179	223186	224916	rs869025631	NC_000003.12:10142178:G:A
NM_000551.4(VHL):c.333C>G (p.Ser111Arg)	VHL	S111R	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223187	3	10183864	3	10142180	223187	224918	rs765978945	NC_000003.12:10142179:C:G
NM_000551.4(VHL):c.334T>A (p.Tyr112Asn)	VHL	Y112N	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002228	3	10183865	3	10142181	2228	17267	rs104893824	NC_000003.12:10142180:T:A
NM_000551.4(VHL):c.334T>C (p.Tyr112His)	VHL	Y112H	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002222	3	10183865	3	10142181	2222	17261	rs104893824	NC_000003.12:10142180:T:C
NM_000551.4(VHL):c.336C>G (p.Tyr112Ter)	VHL	Y112*	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633015	3	10183867	3	10142183	633015	621144	rs751232153	NC_000003.12:10142182:C:G
NM_000551.4(VHL):c.340+1G>C	VHL		Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182973	3	10183872	3	10142188	182973	180118	rs730882032	NC_000003.12:10142187:G:C
NM_000551.4(VHL):c.341-2A>G	LOC107303340|VHL		Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000223194	3	10188196	3	10146512	223194	224926	rs869025637	NC_000003.12:10146511:A:G
NM_000551.4(VHL):c.345C>A (p.His115Gln)	LOC107303340|VHL	H115Q	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496057	3	10188202	3	10146518	496057	487024	rs864622646	NC_000003.12:10146517:C:A
NM_000551.4(VHL):c.351G>T (p.Trp117Cys)	LOC107303340|VHL		Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000167827	3	10188208	3	10146524	167827	178148	rs727504215	NC_000003.12:10146523:G:T
NM_000551.4(VHL):c.353T>C (p.Leu118Pro)	LOC107303340|VHL	L118P	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428807	3	10188210	3	10146526	428807	420444	rs5030830	NC_000003.12:10146525:T:C
NM_000551.4(VHL):c.355T>C (p.Phe119Leu)	LOC107303340|VHL	F119L	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496059	3	10188212	3	10146528	496059	486985	rs1553619948	NC_000003.12:10146527:T:C
NM_000551.4(VHL):c.357C>G (p.Phe119Leu)	LOC107303340|VHL	F119L	Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000625240	3	10188214	3	10146530	625240	613572	rs1559428077	NC_000003.12:10146529:C:G
NM_000551.4(VHL):c.362A>G (p.Asp121Gly)	LOC107303340|VHL	D121G	not provided|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223200	3	10188219	3	10146535	223200	224931	rs5030832	NC_000003.12:10146534:A:G
NM_000551.4(VHL):c.388G>C (p.Val130Leu)	LOC107303340|VHL	V130L	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002229	3	10188245	3	10146561	2229	17268	rs104893830	NC_000003.12:10146560:G:C
NM_000551.4(VHL):c.394C>T (p.Gln132Ter)	LOC107303340|VHL	Q132*	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000288749	3	10188251	3	10146567	288749	272986	rs5030813	NC_000003.12:10146566:C:T
NM_000551.4(VHL):c.395A>C (p.Gln132Pro)	LOC107303340|VHL	Q132P	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000496063	3	10188252	3	10146568	496063	486953	rs1347416980	NC_000003.12:10146567:A:C
NM_000551.4(VHL):c.407T>C (p.Phe136Ser)	LOC107303340|VHL	F136S	not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496064	3	10188264	3	10146580	496064	487032	rs5030833	NC_000003.12:10146579:T:C
NM_000551.4(VHL):c.414A>G (p.Pro138=)	LOC107303340|VHL		Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223206	3	10188271	3	10146587	223206	224936	rs869025648	NC_000003.12:10146586:A:G
NM_000551.4(VHL):c.445G>T (p.Ala149Ser)	LOC107303340|VHL	A149S	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000127829	3	10188302	3	10146618	127829	133286	rs587780077	NC_000003.12:10146617:G:T
NM_000551.4(VHL):c.452T>C (p.Ile151Thr)	LOC107303340|VHL	I151T	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Neoplasm|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428803	3	10188309	3	10146625	428803	420449	rs869025655	NC_000003.12:10146624:T:C
NM_000551.4(VHL):c.460C>T (p.Pro154Ser)	LOC107303340|VHL	P154S	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000486714	3	10188317	3	10146633	486714	473461	rs1553619993	NC_000003.12:10146632:C:T
NM_000551.4(VHL):c.461C>T (p.Pro154Leu)	LOC107303340|VHL	P154L	Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000649525	3	10188318	3	10146634	649525	630724	rs1399097617	NC_000003.12:10146633:C:T
NM_000551.4(VHL):c.463+1G>T	LOC107303340|VHL		Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV001457709	3	10188321	3	10146637	1457709	1393649		NC_000003.12:10146636:G:T
NM_000551.4(VHL):c.463+1G>A	LOC107303340|VHL		not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia	Pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000526679	3	10188321	3	10146637	526679	518746	rs869025657	NC_000003.12:10146636:G:A
NM_000551.4(VHL):c.464-2A>G	LOC107303340|VHL		Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Nonpapillary renal cell carcinoma|Pheochromocytoma|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223222	3	10191469	3	10149785	223222	224950	rs5030816	NC_000003.12:10149784:A:G
NM_000551.4(VHL):c.464-1G>A	VHL|LOC107303340		Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043603	3	10191470	3	10149786	43603	52772	rs5030817	NC_000003.12:10149785:G:A
NM_000551.4(VHL):c.467A>G (p.Tyr156Cys)	LOC107303340|VHL	Y156C, Y115C	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Jun 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000043600	3	10191474	3	10149790	43600	52769	rs397516441	NC_000003.12:10149789:A:G
NM_000551.4(VHL):c.472C>G (p.Leu158Val)	LOC107303340|VHL	L158V, L117V	not provided|Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000567944	3	10191479	3	10149795	567944	559265	rs1559429613	NC_000003.12:10149794:C:G
NM_000551.4(VHL):c.473T>C (p.Leu158Pro)	LOC107303340|VHL	L158P, L117P	Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182980	3	10191480	3	10149796	182980	180119	rs121913346	NC_000003.12:10149795:T:C
NM_000551.4(VHL):c.481C>G (p.Arg161Gly)	LOC107303340|VHL	R161G, R120G	not provided|Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000618484	3	10191488	3	10149804	618484	609491	rs5030818	NC_000003.12:10149803:C:G
NM_000551.4(VHL):c.481C>T (p.Arg161Ter)	LOC107303340|VHL	R161*, R120*	not provided|Nonpapillary renal cell carcinoma|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002217	3	10191488	3	10149804	2217	17256	rs5030818	NC_000003.12:10149803:C:T
NM_000551.4(VHL):c.482G>A (p.Arg161Gln)	LOC107303340|VHL	R161Q, R120Q	not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182983	3	10191489	3	10149805	182983	180121	rs730882035	NC_000003.12:10149804:G:A
NM_000551.4(VHL):c.484T>C (p.Cys162Arg)	LOC107303340|VHL	C162R, C121R	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496067	3	10191491	3	10149807	496067	487017	rs1553620313	NC_000003.12:10149806:T:C
NM_000551.4(VHL):c.486C>G (p.Cys162Trp)	LOC107303340|VHL	C162W, C121W	not provided|Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223227	3	10191493	3	10149809	223227	224957	rs5030622	NC_000003.12:10149808:C:G
NM_000551.4(VHL):c.490C>T (p.Gln164Ter)	LOC107303340|VHL	Q164*, Q123*	Hereditary cancer-predisposing syndrome|not provided|Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223228	3	10191497	3	10149813	223228	224958	rs5030819	NC_000003.12:10149812:C:T
NM_000551.4(VHL):c.491A>G (p.Gln164Arg)	LOC107303340|VHL	Q164R, Q123R	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002238	3	10191498	3	10149814	2238	17277	rs267607170	NC_000003.12:10149813:A:G
NM_000551.4(VHL):c.492G>C (p.Gln164His)	LOC107303340|VHL	Q164H, Q123H	Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000618485	3	10191499	3	10149815	618485	609492	rs1352275281	NC_000003.12:10149814:G:C
NM_000551.4(VHL):c.496G>T (p.Val166Phe)	LOC107303340|VHL	V166F, V125F	not provided|Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002224	3	10191503	3	10149819	2224	17263	rs104893825	NC_000003.12:10149818:G:T
NM_000551.4(VHL):c.497T>C (p.Val166Ala)	LOC107303340|VHL	V166A, V125A	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043605	3	10191504	3	10149820	43605	52774	rs397516445	NC_000003.12:10149819:T:C
NM_000551.4(VHL):c.499C>G (p.Arg167Gly)	LOC107303340|VHL	R167G, R126G	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002219	3	10191506	3	10149822	2219	17258	rs5030820	NC_000003.12:10149821:C:G
NM_000551.4(VHL):c.499C>T (p.Arg167Trp)	LOC107303340|VHL	R167W, R126W	Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Nonpapillary renal cell carcinoma|Von Hippel-Lindau syndrome|Chuvash polycythemia|not provided|Nonpapillary renal cell carcinoma|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Jun 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002218	3	10191506	3	10149822	2218	17257	rs5030820	NC_000003.12:10149821:C:T
NM_000551.4(VHL):c.500G>C (p.Arg167Pro)	LOC107303340|VHL	R167P, R126P	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428799	3	10191507	3	10149823	428799	420451	rs5030821	NC_000003.12:10149822:G:C
NM_000551.4(VHL):c.509T>A (p.Val170Asp)	LOC107303340|VHL	V170D, V129D	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000625256	3	10191516	3	10149832	625256	613588	rs864321642	NC_000003.12:10149831:T:A
NM_000551.4(VHL):c.524A>G (p.Tyr175Cys)	LOC107303340|VHL	Y175C, Y134C	Von Hippel-Lindau syndrome|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036905	3	10191531	3	10149847	36905	45566	rs193922613	NC_000003.12:10149846:A:G
NM_000551.4(VHL):c.525C>G (p.Tyr175Ter)	LOC107303340|VHL	Y175*, Y134*	Chuvash polycythemia|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182974	3	10191532	3	10149848	182974	180122	rs5030835	NC_000003.12:10149847:C:G
NM_000551.4(VHL):c.533T>C (p.Leu178Pro)	LOC107303340|VHL	L178P, L137P	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428795	3	10191540	3	10149856	428795	420453	rs5030822	NC_000003.12:10149855:T:C
NM_000551.4(VHL):c.548C>A (p.Ser183Ter)	LOC107303340|VHL	S183*, S142*	Von Hippel-Lindau syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002215	3	10191555	3	10149871	2215	17254	rs5030823	NC_000003.12:10149870:C:A
NM_000551.4(VHL):c.551T>C (p.Leu184Pro)	LOC107303340|VHL	L184P, L143P	not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419447	3	10191558	3	10149874	419447	406072	rs1064793878	NC_000003.12:10149873:T:C
NM_000551.4(VHL):c.555C>G (p.Tyr185Ter)	LOC107303340|VHL	Y185*, Y144*	Hereditary cancer-predisposing syndrome|Chuvash polycythemia|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000223233	3	10191562	3	10149878	223233	224963	rs864622109	NC_000003.12:10149877:C:G
NM_000551.4(VHL):c.583C>T (p.Gln195Ter)	LOC107303340|VHL	Q195*, Q154*	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428794	3	10191590	3	10149906	428794	420456	rs5030825	NC_000003.12:10149905:C:T
NM_000551.4(VHL):c.586A>T (p.Lys196Ter)	LOC107303340|VHL	K196*, K155*	not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000196284	3	10191593	3	10149909	196284	193445	rs281860296	NC_000003.12:10149908:A:T
NM_001174150.2(ARL13B):c.131-1G>T	ARL13B		not provided|Joubert syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000285657	3	93722502	3	94003658	285657	269894	rs373604132	NC_000003.12:94003657:G:T
NM_001174150.2(ARL13B):c.599G>A (p.Arg200His)	ARL13B	R200H, R93H, R185H, R97H	not provided|Joubert syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000266096	3	93755508	3	94036664	266096	260900	rs764109067	NC_000003.12:94036663:G:A
NM_001174150.2(ARL13B):c.1252C>T (p.Arg418Ter)	ARL13B	R311*, R315*, R403*, R418*	Joubert syndrome and related disorders|Joubert syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV001076045	3	93772072	3	94053228	1076045	1059907		NC_000003.12:94053227:C:T
NM_006218.4(PIK3CA):c.241G>A (p.Glu81Lys)	PIK3CA	E81K	not provided|CLOVES syndrome	Pathogenic(Last reviewed: Feb 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000376478	3	178916854	3	179199066	376478	363357	rs1057519929	NC_000003.12:179199065:G:A
NM_006218.4(PIK3CA):c.263G>A (p.Arg88Gln)	PIK3CA	R88Q	PIK3CA related overgrowth spectrum|Cowden syndrome|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000376049	3	178916876	3	179199088	376049	362928	rs121913287	NC_000003.12:179199087:G:A
NM_006218.4(PIK3CA):c.277C>T (p.Arg93Trp)	PIK3CA	R93W	not provided|PIK3CA related overgrowth spectrum	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV001198826	3	178916890	3	179199102	1198826	1186555		NC_000003.12:179199101:C:T
NM_006218.4(PIK3CA):c.311C>T (p.Pro104Leu)	PIK3CA	P104L	Cowden syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217291	3	178916924	3	179199136	217291	213941	rs863225060	NC_000003.12:179199135:C:T
NM_006218.4(PIK3CA):c.353G>A (p.Gly118Asp)	PIK3CA	G118D	Angioosteohypertrophic syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000156446	3	178917478	3	179199690	156446	166218	rs587777790	NC_000003.12:179199689:G:A
NM_006218.4(PIK3CA):c.1030G>A (p.Val344Met)	PIK3CA	V344M	not provided|Cowden syndrome|Cowden syndrome 5	Pathogenic(Last reviewed: Apr 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000376498	3	178921548	3	179203760	376498	363377	rs1057519942	NC_000003.12:179203759:G:A
NM_006218.4(PIK3CA):c.1048G>A (p.Asp350Asn)	PIK3CA	D350N	not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000418658	3	178921566	3	179203778	418658	406149	rs1064793349	NC_000003.12:179203777:G:A
NM_006218.4(PIK3CA):c.1093G>A (p.Glu365Lys)	PIK3CA	E365K	Cowden syndrome|Megalencephaly-capillary malformation-polymicrogyria syndrome|not provided|Angioosteohypertrophic syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000419222	3	178922324	3	179204536	419222	406150	rs1064793732	NC_000003.12:179204535:G:A
NM_006218.4(PIK3CA):c.1133G>A (p.Cys378Tyr)	PIK3CA	C378Y	Cowden syndrome|Megalencephaly-capillary malformation-polymicrogyria syndrome	Pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039704	3	178922364	3	179204576	39704	48303	rs397514565	NC_000003.12:179204575:G:A
NM_006218.4(PIK3CA):c.1258T>C (p.Cys420Arg)	PIK3CA	C420R	Segmental undergrowth associated with lymphatic malformation|CLAPO syndrome|Neoplasm of ovary|not provided|Capillary malformation|CLOVES syndrome	Pathogenic(Last reviewed: Jan 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031945	3	178927980	3	179210192	31945	40610	rs121913272	NC_000003.12:179210191:T:C
NM_006218.4(PIK3CA):c.1345C>A (p.Pro449Thr)	PIK3CA	P449T	Megalencephaly-capillary malformation-polymicrogyria syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001333250	3	178928067	3	179210279	1333250	1324025		NC_000003.12:179210278:C:A
NM_006218.4(PIK3CA):c.1345C>T (p.Pro449Ser)	PIK3CA	P449S	not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000864863	3	178928067	3	179210279	864863	855106	rs1724674149	NC_000003.12:179210278:C:T
NM_006218.4(PIK3CA):c.1357G>A (p.Glu453Lys)	PIK3CA	E453K	Cowden syndrome|PIK3CA-related disorder|PIK3CA related overgrowth syndrome|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome|CLOVES syndrome	Pathogenic(Last reviewed: Oct 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000376470	3	178928079	3	179210291	376470	363349	rs1057519925	NC_000003.12:179210290:G:A
NM_006218.4(PIK3CA):c.1633G>A (p.Glu545Lys)	PIK3CA	E545K	Eccrine Angiomatous Hamartoma|PIK3CA related overgrowth spectrum|not provided|CLOVES syndrome|Segmental undergrowth associated with lymphatic malformation	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013655	3	178936091	3	179218303	13655	28694	rs104886003	NC_000003.12:179218302:G:A
NM_006218.4(PIK3CA):c.1635G>T (p.Glu545Asp)	PIK3CA	E545D	Megalencephaly-capillary malformation-polymicrogyria syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217293	3	178936093	3	179218305	217293	213943	rs121913275	NC_000003.12:179218304:G:T
NM_006218.4(PIK3CA):c.3012G>A (p.Met1004Ile)	PIK3CA	M1004I	PIK3CA related overgrowth syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV001209066	3	178951957	3	179234169	1209066	1197039		NC_000003.12:179234168:G:A
NM_006218.4(PIK3CA):c.3073A>G (p.Thr1025Ala)	PIK3CA	T1025A	not provided|Non-small cell lung carcinoma	Pathogenic(Last reviewed: Mar 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000045467	3	178952018	3	179234230	45467	54634	rs397517202	NC_000003.12:179234229:A:G
NM_006218.4(PIK3CA):c.3129G>A (p.Met1043Ile)	PIK3CA	M1043I	not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome|Non-small cell lung carcinoma|Cowden syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000179173	3	178952074	3	179234286	179173	173901	rs121913283	NC_000003.12:179234285:G:A
NM_006218.4(PIK3CA):c.3139C>T (p.His1047Tyr)	PIK3CA	H1047Y	Megalencephaly-capillary malformation-polymicrogyria syndrome|Lung carcinoma|Epidermal nevus|Neoplasm of ovary|Hepatocellular carcinoma|Familial cancer of breast|Congenital macrodactylia|Seborrheic keratosis|Neoplasm of stomach|CLAPO syndrome|CLOVES syndrome|Carcinoma of colon|Cowden syndrome 5|Cowden syndrome|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome|CLOVES syndrome|Non-small cell lung carcinoma|Segmental undergrowth associated with mainly venous malformation with capillary component	Pathogenic(Last reviewed: Mar 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000039705	3	178952084	3	179234296	39705	48304	rs121913281	NC_000003.12:179234295:C:T
NM_006218.4(PIK3CA):c.3140A>T (p.His1047Leu)	PIK3CA	H1047L	Colorectal cancer|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome|Hemihypertrophy|Cowden syndrome 1|Macrodactyly of toe|Stroke	Pathogenic(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013653	3	178952085	3	179234297	13653	28692	rs121913279	NC_000003.12:179234296:A:T
NM_006218.4(PIK3CA):c.3145G>A (p.Gly1049Ser)	PIK3CA	G1049S	Megalencephaly-capillary malformation-polymicrogyria syndrome|not provided	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000376247	3	178952090	3	179234302	376247	363126	rs121913277	NC_000003.12:179234301:G:A
NM_000142.5(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	R248C	Malignant tumor of urinary bladder|Crouzon syndrome-acanthosis nigricans syndrome|Achondroplasia|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Muenke syndrome|Carcinoma of colon|Malignant tumor of testis|Severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Connective tissue disorder|FGFR3-related chondrodysplasia|FGFR3-related disorder|not provided|Cancer of cervix|Achondroplasia|Thanatophoric dysplasia type 1|Short ribs|Growth delay|Skeletal dysplasia|Disproportionate short-limb short stature|Bowed humerus|Narrow chest|Small for gestational age|Femoral bowing|Bell-shaped thorax|Lower limb undergrowth|Upper limb undergrowth|Short stature|Lethal short-limbed short stature|Hamartoma	Pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000016332	4	1803564	4	1801837	16332	31371	rs121913482	NC_000004.12:1801836:C:T
NM_000142.5(FGFR3):c.746C>G (p.Ser249Cys)	FGFR3	S249C	Malignant tumor of urinary bladder|Crouzon syndrome-acanthosis nigricans syndrome|Achondroplasia|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Muenke syndrome|Carcinoma of colon|Malignant tumor of testis|Severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Connective tissue disorder|not provided|Cancer of cervix|Malignant tumor of urinary bladder|Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Jun 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000016339	4	1803568	4	1801841	16339	31378	rs121913483	NC_000004.12:1801840:C:G
NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)	FGFR3	P250R	Malignant tumor of urinary bladder|Crouzon syndrome-acanthosis nigricans syndrome|Achondroplasia|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Muenke syndrome|Carcinoma of colon|Malignant tumor of testis|Severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Inborn genetic diseases|FGFR3-related chondrodysplasia|Infantile axial hypotonia|Coronal craniosynostosis|Generalized non-motor (absence) seizure|Facial asymmetry|Unilateral renal agenesis|Seizure|Crouzon syndrome|Craniosynostosis syndrome|not provided|Achondroplasia|Muenke syndrome|Hypochondroplasia|Abnormality of the nervous system	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000016340	4	1803571	4	1801844	16340	31379	rs4647924	NC_000004.12:1801843:C:G
NM_000142.5(FGFR3):c.1108G>T (p.Gly370Cys)	FGFR3	G370C, G372C	not provided|Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Nov 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016359	4	1806089	4	1804362	16359	31398	rs121913479	NC_000004.12:1804361:G:T
NM_000142.5(FGFR3):c.1620C>G (p.Asn540Lys)	FGFR3	N540K, N542K, N541K, N428K	Malignant tumor of urinary bladder|Crouzon syndrome-acanthosis nigricans syndrome|Achondroplasia|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Muenke syndrome|Carcinoma of colon|Malignant tumor of testis|Severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Inborn genetic diseases|Connective tissue disorder|not provided|Larsen syndrome|Hypochondroplasia|Achondroplasia|Short stature	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000016338	4	1807371	4	1805644	16338	31377	rs28933068	NC_000004.12:1805643:C:G
NM_000142.5(FGFR3):c.1949A>C (p.Lys650Thr)	FGFR3	K650T, K652T, K538T, K651T	Achondroplasia|Crouzon syndrome-acanthosis nigricans syndrome|Levy-Hollister syndrome|Hypochondroplasia|Malignant tumor of testis|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Muenke syndrome|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Malignant tumor of urinary bladder|Severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Epidermal nevus|Carcinoma of colon|not provided|FGFR3-related disorder	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000065855	4	1807890	4	1806163	65855	76763	rs121913105	NC_000004.12:1806162:A:C
NM_006005.3(WFS1):c.124C>T (p.Arg42Ter)	WFS1	R42*	not provided|Wolfram syndrome 1|Autosomal dominant nonsyndromic hearing loss 6|Cataract 41|Type 2 diabetes mellitus|Wolfram-like syndrome|Type 2 diabetes mellitus|Wolfram syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000189251	4	6279306	4	6277579	189251	187111	rs71530923	NC_000004.12:6277578:C:T
NM_006005.3(WFS1):c.1511C>T (p.Pro504Leu)	WFS1	P504L	Wolfram-like syndrome|Wolfram syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004512	4	6303033	4	6301306	4512	19551	rs28937892	NC_000004.12:6301305:C:T
NM_006005.3(WFS1):c.2007T>G (p.Tyr669Ter)	WFS1	Y669*	not provided|WFS1-Related Spectrum Disorders|See cases|Wolfram syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000802052	4	6303529	4	6301802	802052	790480	rs1443751733	NC_000004.12:6301801:T:G
NM_006005.3(WFS1):c.2051C>T (p.Ala684Val)	WFS1	A684V	Rare genetic deafness|Wolfram syndrome 1|WFS1-related disorder|Inborn genetic diseases|not provided|Autosomal dominant nonsyndromic hearing loss 6|Wolfram-like syndrome	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000030556	4	6303573	4	6301846	30556	39513	rs387906930	NC_000004.12:6301845:C:T
NM_006005.3(WFS1):c.2146G>A (p.Ala716Thr)	WFS1	A716T	Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004520	4	6303668	4	6301941	4520	19559	rs28937893	NC_000004.12:6301940:G:A
NM_006005.3(WFS1):c.2590G>A (p.Glu864Lys)	WFS1	E864K	Rare genetic deafness|Nonsyndromic genetic hearing loss|not provided|Wolfram-like syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000004526	4	6304112	4	6302385	4526	19565	rs74315205	NC_000004.12:6302384:G:A
NM_006005.3(WFS1):c.2654C>T (p.Pro885Leu)	WFS1	P885L	Wolfram syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000437297	4	6304176	4	6302449	437297	428319	rs372855769	NC_000004.12:6302448:C:T
NM_001378615.1(CC2D2A):c.394C>T (p.Arg132Ter)	CC2D2A	R132*, R83*	Retinal dystrophy|Joubert syndrome|Meckel-Gruber syndrome|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126242	4	15504502	4	15502879	126242	131774	rs377177061	NC_000004.12:15502878:C:T
NM_001378615.1(CC2D2A):c.517C>T (p.Arg173Ter)	CC2D2A	R173*, R124*	Meckel syndrome, type 6|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056315	4	15511840	4	15510217	56315	70954	rs386833763	NC_000004.12:15510216:C:T
NM_001378615.1(CC2D2A):c.1017+1G>A	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome|not provided|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000166801	4	15517628	4	15516005	166801	177556	rs200407856	NC_000004.12:15516004:G:A
NM_001378615.1(CC2D2A):c.1267C>T (p.Arg423Ter)	CC2D2A	R423*, R374*	Joubert syndrome 1|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000411851	4	15529187	4	15527564	411851	394140	rs757208121	NC_000004.12:15527563:C:T
NM_001378615.1(CC2D2A):c.1465C>T (p.Arg489Ter)	CC2D2A	R440*, R489*	Abnormality of prenatal development or birth|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001180720	4	15530348	4	15528725	1180720	1170203		NC_000004.12:15528724:C:T
NM_001378615.1(CC2D2A):c.1558C>T (p.Arg520Ter)	CC2D2A	R520*, R471*	Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome, type 6|COACH syndrome 1|Joubert syndrome 9|Meckel syndrome, type 6|COACH syndrome 2|Joubert syndrome 9|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217618	4	15534907	4	15533284	217618	214172	rs781252161	NC_000004.12:15533283:C:T
NM_001378615.1(CC2D2A):c.1751G>A (p.Trp584Ter)	CC2D2A	W535*, W584*	Encephalocele|Polycystic kidney disease|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000978623	4	15538686	4	15537063	978623	966705	rs980305935	NC_000004.12:15537062:G:A
NM_001378615.1(CC2D2A):c.2561G>A (p.Trp854Ter)	CC2D2A	W854*, W805*	Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000634560	4	15556769	4	15555146	634560	622341	rs1560180188	NC_000004.12:15555145:G:A
NM_001378615.1(CC2D2A):c.2683C>T (p.Gln895Ter)	CC2D2A	Q895*, Q846*	Meckel syndrome, type 6|COACH syndrome 1|Joubert syndrome 9|Joubert syndrome 9	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210609	4	15558984	4	15557361	210609	207110	rs764719093	NC_000004.12:15557360:C:T
NM_001378615.1(CC2D2A):c.2728C>T (p.Arg910Ter)	CC2D2A	R861*, R910*	not provided|Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome, type 6	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000982064	4	15559029	4	15557406	982064	970207	rs781206278	NC_000004.12:15557405:C:T
NM_001378615.1(CC2D2A):c.2773C>T (p.Arg925Ter)	CC2D2A	R925*, R876*	CC2D2A-Related Disorders|Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056300	4	15559074	4	15557451	56300	70939	rs386833748	NC_000004.12:15557450:C:T
NM_001378615.1(CC2D2A):c.2848C>T (p.Arg950Ter)	CC2D2A	R950*, R901*	not provided|Inborn genetic diseases|Joubert syndrome 9	Pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000745	4	15560806	4	15559183	745	15784	rs118204053	NC_000004.12:15559182:C:T
NM_001378615.1(CC2D2A):c.3055C>T (p.Arg1019Ter)	CC2D2A	R1019*, R970*	CC2D2A-Related Disorders|Meckel-Gruber syndrome|Joubert syndrome|COACH syndrome 1|Joubert syndrome 9|Meckel syndrome, type 6|Joubert syndrome 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217602	4	15565018	4	15563395	217602	214177	rs370880399	NC_000004.12:15563394:C:T
NM_001378615.1(CC2D2A):c.3145C>T (p.Arg1049Ter)	CC2D2A	R1049*, R1000*	Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 9|Meckel syndrome, type 6|COACH syndrome 1|not provided|See cases	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000747	4	15565108	4	15563485	747	15786	rs386833750	NC_000004.12:15563484:C:T
NM_001378615.1(CC2D2A):c.3325C>T (p.Arg1109Ter)	CC2D2A	R1109*, R1060*	Neurodevelopmental disorder|not provided|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000839976	4	15569336	4	15567713	839976	828907	rs760676442	NC_000004.12:15567712:C:T
NM_001378615.1(CC2D2A):c.3652C>T (p.Arg1218Ter)	CC2D2A	R1218*, R1169*	not provided|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Mar 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000238273	4	15575830	4	15574207	238273	239337	rs375278294	NC_000004.12:15574206:C:T
NM_001378615.1(CC2D2A):c.3688C>T (p.Arg1230Ter)	CC2D2A	R1230*, R1181*	not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: May 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV001395827	4	15575866	4	15574243	1395827	1425226		NC_000004.12:15574242:C:T
NM_001378615.1(CC2D2A):c.3850C>T (p.Arg1284Cys)	CC2D2A	R1284C, R1235C	Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome, type 6|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217597	4	15581669	4	15580046	217597	214185	rs779823379	NC_000004.12:15580045:C:T
NM_001378615.1(CC2D2A):c.3989G>A (p.Arg1330Gln)	CC2D2A	R1330Q, R1281Q	Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 9	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217612	4	15587793	4	15586170	217612	214189	rs763486732	NC_000004.12:15586169:G:A
NM_001378615.1(CC2D2A):c.4065+2T>C	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000594430	4	15587871	4	15586248	594430	585493	rs1179041639	NC_000004.12:15586247:T:C
NM_001378615.1(CC2D2A):c.4333C>T (p.Arg1445Ter)	CC2D2A	R1396*, R1445*	Joubert syndrome 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV001317486	4	15597726	4	15596103	1317486	1306430		NC_000004.12:15596102:C:T
NM_001378615.1(CC2D2A):c.4550C>G (p.Thr1517Ser)	CC2D2A	T1517S, T1468S	not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372317	4	15601205	4	15599582	372317	359497	rs780673487	NC_000004.12:15599581:C:G
NM_001378615.1(CC2D2A):c.4582C>T (p.Arg1528Cys)	CC2D2A	R1528C, R1479C	not provided|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000744	4	15601237	4	15599614	744	15783	rs118204052	NC_000004.12:15599613:C:T
NM_024592.5(SRD5A3):c.57G>A (p.Trp19Ter)	SRD5A3	W19*	SRD5A3-congenital disorder of glycosylation|Abnormality of the nervous system|not provided|Kahrizi syndrome	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096125	4	56212560	4	55346393	96125	102019	rs398124401	NC_000004.12:55346392:G:A
NM_024592.5(SRD5A3):c.320G>A (p.Trp107Ter)	SRD5A3	W107*	SRD5A3-congenital disorder of glycosylation	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000018405	4	56225611	4	55359444	18405	33444	rs267607093	NC_000004.12:55359443:G:A
NM_001384732.1(CPLANE1):c.9220C>T (p.Arg3074Ter)	CPLANE1	R3020*, R3074*	Joubert syndrome 17|Orofaciodigital syndrome type 6|Joubert syndrome 17|Joubert syndrome and related disorders|See cases|Joubert syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217569	5	37120408	5	37120306	217569	214197	rs374144275	NC_000005.10:37120305:G:A
NM_001384732.1(CPLANE1):c.9046C>T (p.Arg3016Ter)	CPLANE1	R2962*, R3016*	not provided|Joubert syndrome 17	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV001030823	5	37121858	5	37121756	1030823	1016569	rs150242262	NC_000005.10:37121755:G:A
NM_001384732.1(CPLANE1):c.9017+1G>A	CPLANE1		not provided|Joubert syndrome 17|Joubert syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217564	5	37122531	5	37122429	217564	214199	rs863225154	NC_000005.10:37122428:C:T
NM_001384732.1(CPLANE1):c.8872C>T (p.Arg2958Ter)	CPLANE1	R2904*, R2958*	Joubert syndrome 17|not provided	Pathogenic(Last reviewed: Oct 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217571	5	37125432	5	37125330	217571	214202	rs141507441	NC_000005.10:37125329:G:A
NM_001384732.1(CPLANE1):c.8770G>T (p.Glu2924Ter)	CPLANE1	E2870*, E2924*	not provided|Joubert syndrome 17	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217567	5	37138844	5	37138742	217567	214203	rs863225155	NC_000005.10:37138741:C:A
NM_001384732.1(CPLANE1):c.8633-1G>C	CPLANE1		not provided|Joubert syndrome 17|Orofaciodigital syndrome type 6	Pathogenic(Last reviewed: Nov 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000575938	5	37139473	5	37139371	575938	560458	rs1561376123	NC_000005.10:37139370:C:G
NM_001384732.1(CPLANE1):c.8140C>T (p.Arg2714Ter)	CPLANE1	R2660*, R2714*	Orofaciodigital syndrome type 6|Joubert syndrome 17	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217566	5	37154075	5	37153973	217566	214207	rs147416429	NC_000005.10:37153972:G:A
NM_001384732.1(CPLANE1):c.7871T>A (p.Leu2624Ter)	CPLANE1	L2606*, L2624*	Joubert syndrome 17|Global developmental delay|Jaundice|not provided|Joubert syndrome 17|Orofaciodigital syndrome type 6|Orofaciodigital syndrome type 6	Pathogenic(Last reviewed: Aug 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217575	5	37157912	5	37157810	217575	214208	rs749523755	NC_000005.10:37157809:A:T
NM_001384732.1(CPLANE1):c.7477C>T (p.Arg2493Ter)	CPLANE1	R2493*	Orofaciodigital syndrome type 6|Joubert syndrome 17|not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Jul 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031223	5	37165697	5	37165595	31223	40180	rs139675596	NC_000005.10:37165594:G:A
NM_001384732.1(CPLANE1):c.7400+1G>A	CPLANE1		Orofaciodigital syndrome type 6|Joubert syndrome 17|Joubert syndrome 17	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031220	5	37167148	5	37167046	31220	40177	rs367543062	NC_000005.10:37167045:C:T
NM_001384732.1(CPLANE1):c.4006C>T (p.Arg1336Trp)	CPLANE1	R1336W	Joubert syndrome and related disorders|not provided|Joubert syndrome 17	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031219	5	37187590	5	37187488	31219	40176	rs367543061	NC_000005.10:37187487:G:A
NM_001384732.1(CPLANE1):c.3577C>T (p.Arg1193Cys)	CPLANE1	R1193C	Joubert syndrome 17|Joubert syndrome 17|Orofaciodigital syndrome type 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265062	5	37198899	5	37198797	265062	259826	rs149170427	NC_000005.10:37198796:G:A
NM_001384732.1(CPLANE1):c.2611C>T (p.Arg871Cys)	CPLANE1	R871C	not provided|Joubert syndrome 17	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217589	5	37221561	5	37221459	217589	214220	rs760906097	NC_000005.10:37221458:G:A
NM_001384732.1(CPLANE1):c.2353C>T (p.Arg785Ter)	CPLANE1	R785*	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217584	5	37224781	5	37224679	217584	214222	rs863225163	NC_000005.10:37224678:G:A
NM_001384732.1(CPLANE1):c.1784T>G (p.Leu595Ter)	CPLANE1	L595*	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Nov 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217580	5	37226913	5	37226811	217580	214225	rs530569572	NC_000005.10:37226810:A:C
NM_001384732.1(CPLANE1):c.1270C>T (p.Arg424Ter)	CPLANE1	R424*	Joubert syndrome 17|Orofaciodigital syndrome type 6|not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000392297	5	37227771	5	37227669	392297	368487	rs755097302	NC_000005.10:37227668:G:A
NM_003401.5(XRCC4):c.127T>C (p.Trp43Arg)	XRCC4	W43R	not provided|Short stature, microcephaly, and endocrine dysfunction	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000127246	5	82400865	5	83105046	127246	132703	rs587779351	NC_000005.10:83105045:T:C
NM_005859.5(PURA):c.1A>G (p.Met1Val)	PURA	M1V	not provided|PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000489294	5	139493767	5	140114182	489294	481724	rs793888530	NC_000005.10:140114181:A:G
NM_005859.5(PURA):c.163C>T (p.Gln55Ter)	PURA	Q55*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|not provided	Pathogenic(Last reviewed: Nov 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000426145	5	139493929	5	140114344	426145	414991	rs1085307472	NC_000005.10:140114343:C:T
NM_005859.5(PURA):c.175C>T (p.Gln59Ter)	PURA	Q59*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000582890	5	139493941	5	140114356	582890	562878	rs1561793115	NC_000005.10:140114355:C:T
NM_005859.5(PURA):c.178G>T (p.Glu60Ter)	PURA	E60*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|PURA Syndrome	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000975786	5	139493944	5	140114359	975786	964069	rs1763041722	NC_000005.10:140114358:G:T
NM_005859.5(PURA):c.205C>T (p.Gln69Ter)	PURA	Q69*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489041	5	139493971	5	140114386	489041	481725	rs1554129045	NC_000005.10:140114385:C:T
NM_005859.5(PURA):c.487C>T (p.Gln163Ter)	PURA	Q163*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451895	5	139494253	5	140114668	451895	443692	rs1554129091	NC_000005.10:140114667:C:T
NM_005859.5(PURA):c.563T>C (p.Ile188Thr)	PURA	I188T	Inborn genetic diseases|PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000192334	5	139494329	5	140114744	192334	190129	rs793888527	NC_000005.10:140114743:T:C
NM_005859.5(PURA):c.596G>C (p.Arg199Pro)	PURA	R199P	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000156413	5	139494362	5	140114777	156413	166192	rs587783001	NC_000005.10:140114776:G:C
NM_005859.5(PURA):c.640G>T (p.Glu214Ter)	PURA	E214*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|Limb dystonia|Generalized hypotonia|Apnea	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635405	5	139494406	5	140114821	635405	623231	rs1581036558	NC_000005.10:140114820:G:T
NM_005859.5(PURA):c.720C>G (p.Tyr240Ter)	PURA	Y240*	See cases|PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000959604	5	139494486	5	140114901	959604	944422	rs1763053854	NC_000005.10:140114900:C:G
NM_022455.5(NSD1):c.3839G>A (p.Trp1280Ter)	NSD1	W1280*, W1011*, W989*, W1029*, W1140*	Autism|Chronic lung disease|Hypermetropia|Bifid uvula|Cognitive impairment|Cleft palate|Seizure|Cryptorchidism|Highly arched eyebrow|Hypertelorism|Scoliosis|Patent foramen ovale|Prominent supraorbital ridges|Overfolding of the superior helices|Talipes valgus|Disproportionate tall stature|Pectus carinatum|Midface retrusion|Sotos syndrome 1	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000159315	5	176662864	5	177235863	159315	168168	rs587784105	NC_000005.10:177235862:G:A
NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys)	PPP2R5D	E198K, E166K, E92K, E47K	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome|Global developmental delay|Neurodevelopmental delay|not provided|Intellectual disability|See cases|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000190286	6	42975003	6	43007265	190286	188114		NC_000006.12:43007264:G:A
NM_006245.4(PPP2R5D):c.598G>A (p.Glu200Lys)	PPP2R5D	E200K, E168K, E94K, E49K	Inborn genetic diseases|not provided|Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217456	6	42975009	6	43007271	217456	214097	rs863225079	NC_000006.12:43007270:G:A
NM_006245.4(PPP2R5D):c.619T>C (p.Trp207Arg)	PPP2R5D	W207R, W101R, W175R, W56R	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000280435	6	42975030	6	43007292	280435	264294	rs869320691	NC_000006.12:43007291:T:C
NM_006245.4(PPP2R5D):c.632A>C (p.Gln211Pro)	PPP2R5D	Q105P, Q179P, Q211P, Q60P	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000982374	6	42975043	6	43007305	982374	970496	rs1762136390	NC_000006.12:43007304:A:C
NM_006245.4(PPP2R5D):c.748G>A (p.Glu250Lys)	PPP2R5D	E144K, E218K, E250K, E99K	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome|not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000978913	6	42975694	6	43007956	978913	966953	rs1762178779	NC_000006.12:43007955:G:A
NM_006245.4(PPP2R5D):c.751G>T (p.Asp251Tyr)	PPP2R5D	D100Y, D145Y, D219Y, D251Y	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome|Inborn genetic diseases|not provided|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000985406	6	42975697	6	43007959	985406	973548	rs1762178916	NC_000006.12:43007958:G:T
NM_006245.4(PPP2R5D):c.752A>C (p.Asp251Ala)	PPP2R5D	D251A, D100A, D219A, D145A	not provided|Inborn genetic diseases|Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000521616	6	42975698	6	43007960	521616	511680	rs1064794719	NC_000006.12:43007959:A:C
NM_006245.4(PPP2R5D):c.1258G>A (p.Glu420Lys)	PPP2R5D	E420K, E388K, E269K, E314K	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217912	6	42977066	6	43009328	217912	214565	rs863225080	NC_000006.12:43009327:G:A
NM_203290.4(POLR1C):c.70-1G>A	POLR1C		Hypomyelinating leukodystrophy 11|not provided	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280457	6	43485043	6	43517305	280457	264263	rs886041661	NC_000006.12:43517304:G:A
NM_203290.4(POLR1C):c.322C>T (p.His108Tyr)	POLR1C	H108Y	Hypomyelinating leukodystrophy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000635142	6	43487516	6	43519778	635142	622976	rs1015942660	NC_000006.12:43519777:C:T
NM_203290.4(POLR1C):c.326G>A (p.Arg109His)	POLR1C	R109H	Hypomyelinating leukodystrophy 11|Treacher Collins syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204592	6	43487520	6	43519782	204592	200982	rs796052127	NC_000006.12:43519781:G:A
NM_203290.4(POLR1C):c.699C>G (p.Tyr233Ter)	POLR1C	Y233*	Hypomyelinating leukodystrophy 11|not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280857	6	43488406	6	43520668	280857	264293	rs763593155	NC_000006.12:43520667:C:G
NM_203290.4(POLR1C):c.835C>T (p.Arg279Trp)	POLR1C	R279W	Hypomyelinating leukodystrophy 11|not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000030815	6	43488699	6	43520961	30815	39772	rs141156009	NC_000006.12:43520960:C:T
NM_203290.4(POLR1C):c.836G>A (p.Arg279Gln)	POLR1C	R279Q	POLR1C-Related Disorders|Hypomyelinating leukodystrophy 11|not provided|Treacher Collins syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000030811	6	43488700	6	43520962	30811	39768	rs191582628	NC_000006.12:43520961:G:A
NM_001134831.2(AHI1):c.2687A>G (p.His896Arg)	AHI1	H896R	not provided|Joubert syndrome|Joubert syndrome 3	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217532	6	135748382	6	135427244	217532	214231	rs863225135	NC_000006.12:135427243:T:C
NM_001134831.2(AHI1):c.2671C>T (p.Arg891Ter)	AHI1	R891*	Retinal dystrophy|Joubert syndrome 3|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000858292	6	135748398	6	135427260	858292	831586	rs1355690902	NC_000006.12:135427259:G:A
NM_001134831.2(AHI1):c.2623+1G>T	AHI1		Joubert syndrome 1|Joubert syndrome|Joubert syndrome 3	Pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000638504	6	135749766	6	135428628	638504	626308	rs751823180	NC_000006.12:135428627:C:A
NM_001134831.2(AHI1):c.2492+1G>A	AHI1		not provided|Joubert syndrome	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000661866	6	135751019	6	135429881	661866	651634	rs187245292	NC_000006.12:135429880:C:T
NM_001134831.2(AHI1):c.2361G>A (p.Trp787Ter)	AHI1	W787*	Joubert syndrome 3	Pathogenic(Last reviewed: Jan 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV001029630	6	135752358	6	135431220	1029630	1016649	rs863225146	NC_000006.12:135431219:C:T
NM_001134831.2(AHI1):c.2212C>T (p.Arg738Ter)	AHI1	R738*	Joubert syndrome|not provided|Joubert syndrome 3	Pathogenic(Last reviewed: Aug 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217525	6	135754219	6	135433081	217525	214235	rs372659908	NC_000006.12:135433080:G:A
NM_001134831.2(AHI1):c.2174G>A (p.Trp725Ter)	AHI1	W725*	Leber congenital amaurosis|Joubert syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156382	6	135754257	6	135433119	156382	166163	rs587783013	NC_000006.12:135433118:C:T
NM_001134831.2(AHI1):c.2156A>G (p.Asp719Gly)	AHI1	D719G	not provided|Joubert syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217530	6	135754275	6	135433137	217530	214239	rs863225134	NC_000006.12:135433136:T:C
NM_001134831.2(AHI1):c.1997A>T (p.Asp666Val)	AHI1	D666V	Joubert syndrome 3|not provided|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217548	6	135759552	6	135438414	217548	214244	rs863225147	NC_000006.12:135438413:T:A
NM_001134831.2(AHI1):c.1976A>T (p.Asp659Val)	AHI1	D659V	Joubert syndrome 3|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217544	6	135759573	6	135438435	217544	214245	rs541041911	NC_000006.12:135438434:T:A
NM_001134831.2(AHI1):c.1861G>T (p.Gly621Ter)	AHI1	G621*	not provided|Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000210113	6	135763771	6	135442633	210113	207326	rs797045223	NC_000006.12:135442632:C:A
NM_001134831.2(AHI1):c.1811C>G (p.Ser604Ter)	AHI1	S604*	Joubert syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000867053	6	135763821	6	135442683	867053	856416	rs781198326	NC_000006.12:135442682:G:C
NM_001134831.2(AHI1):c.1765C>T (p.Arg589Ter)	AHI1	R589*	not provided|Joubert syndrome 3|Rod-cone dystrophy|Joubert syndrome	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002014	6	135768160	6	135447022	2014	17053	rs267606641	NC_000006.12:135447021:G:A
NM_001134831.2(AHI1):c.1626+1G>A	AHI1		not provided|Joubert syndrome 3|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217535	6	135769427	6	135448289	217535	214249	rs863225137	NC_000006.12:135448288:C:T
NM_001134831.2(AHI1):c.1516C>T (p.Arg506Ter)	AHI1	R506*	Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217534	6	135769538	6	135448400	217534	214251	rs371637724	NC_000006.12:135448399:G:A
NM_001134831.2(AHI1):c.1267C>T (p.Gln423Ter)	AHI1	Q423*	Rod-cone dystrophy|Retinal dystrophy|not provided|Joubert syndrome|Joubert syndrome 3	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217523	6	135776949	6	135455811	217523	214252	rs777668842	NC_000006.12:135455810:G:A
NM_001134831.2(AHI1):c.1260G>A (p.Trp420Ter)	AHI1	W420*	Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217543	6	135776956	6	135455818	217543	214253	rs863225143	NC_000006.12:135455817:C:T
NM_001134831.2(AHI1):c.1051C>T (p.Arg351Ter)	AHI1	R351*	Joubert syndrome 3|Joubert syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002010	6	135778732	6	135457594	2010	17049	rs121434348	NC_000006.12:135457593:G:A
NM_001134831.2(AHI1):c.985C>T (p.Arg329Ter)	AHI1	R329*	Joubert syndrome|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Oct 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030760	6	135778798	6	135457660	30760	39717	rs201391050	NC_000006.12:135457659:G:A
NM_001134831.2(AHI1):c.736A>T (p.Lys246Ter)	AHI1	K246*	See cases|Joubert syndrome 3	Pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217542	6	135786965	6	135465827	217542	214257	rs863225142	NC_000006.12:135465826:T:A
NM_018718.3(CEP41):c.423-2A>C	CEP41		Joubert syndrome 15	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030840	7	130042642	7	130402801	30840	39797	rs781815473	NC_000007.14:130402800:T:G
NM_001382391.1(CSPP1):c.631C>T (p.Arg211Ter)	CSPP1	R220*, R247*, R184*, R211*	Joubert syndrome 21	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000100672	8	68007675	8	67095440	100672	106544	rs375113643	NC_000008.11:67095439:C:T
NM_001382391.1(CSPP1):c.923+1G>C	CSPP1		Joubert syndrome 21|not provided	Pathogenic(Last reviewed: Feb 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217649	8	68007968	8	67095733	217649	214261	rs863225194	NC_000008.11:67095732:G:C
NM_001382391.1(CSPP1):c.1105C>T (p.Arg369Ter)	CSPP1	R378*, R342*, R84*, R405*, R345*, R369*	not provided|Joubert syndrome 21	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217646	8	68024218	8	67111983	217646	214262	rs374703898	NC_000008.11:67111982:C:T
NM_001382391.1(CSPP1):c.1153G>T (p.Glu385Ter)	CSPP1	E394*, E100*, E421*, E385*, E358*, E361*	Joubert syndrome 21|not provided	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000289003	8	68024266	8	67112031	289003	273240	rs886044058	NC_000008.11:67112030:G:T
NM_001382391.1(CSPP1):c.2220C>A (p.Tyr740Ter)	CSPP1	Y735*, Y675*, Y702*, Y648*, Y762*, Y390*, Y713*, Y740*	Joubert syndrome 21|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000434847	8	68066350	8	67154115	434847	428857	rs1402669959	NC_000008.11:67154114:C:A
NM_001382391.1(CSPP1):c.2275C>T (p.Arg759Ter)	CSPP1	R754*, R694*, R781*, R409*, R667*, R721*, R732*, R759*	Joubert syndrome 21	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217648	8	68070715	8	67158480	217648	214264	rs771203308	NC_000008.11:67158479:C:T
NM_001382391.1(CSPP1):c.2968+1G>A	CSPP1		Joubert syndrome 21	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000100670	8	68084791	8	67172556	100670	106542	rs587777142	NC_000008.11:67172555:G:A
NM_153704.6(TMEM67):c.514C>T (p.Arg172Ter)	TMEM67	R172*, R91*	Joubert syndrome|Meckel-Gruber syndrome|Iris coloboma|Nystagmus|Generalized hypotonia|Cerebellar vermis hypoplasia|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000506012	8	94777641	8	93765413	506012	496932	rs765468645	NC_000008.11:93765412:C:T
NM_153704.6(TMEM67):c.622A>T (p.Arg208Ter)	TMEM67	R208*, R127*	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome and related disorders|RHYNS syndrome|TMEM67-Related Disorders|not provided|Joubert syndrome 6	Pathogenic(Last reviewed: Sep 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001376	8	94777845	8	93765617	1376	16415	rs137853108	NC_000008.11:93765616:A:T
NM_153704.6(TMEM67):c.725A>G (p.Asn242Ser)	TMEM67	N161S, N242S	Joubert syndrome|Meckel-Gruber syndrome|COACH syndrome 1|not provided|Inborn genetic diseases|Joubert syndrome 6|Abnormality of the nervous system	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216826	8	94792831	8	93780603	216826	212652	rs775883520	NC_000008.11:93780602:A:G
NM_153704.6(TMEM67):c.755T>C (p.Met252Thr)	TMEM67	M252T, M171T	Meckel-Gruber syndrome|Joubert syndrome|not provided|Joubert syndrome 6	Pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001387	8	94792861	8	93780633	1387	16426	rs202149403	NC_000008.11:93780632:T:C
NM_153704.6(TMEM67):c.1046T>C (p.Leu349Ser)	TMEM67	L268S, L349S	Bardet-Biedl syndrome|Bardet-Biedl syndrome 14|COACH syndrome 1|Nephronophthisis 11|Joubert syndrome 6|Meckel syndrome, type 3|Joubert syndrome|Meckel-Gruber syndrome|TMEM67-Related Disorders|not provided|Joubert syndrome 6|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000056762	8	94793953	8	93781725	56762	71401	rs386834180	NC_000008.11:93781724:T:C
NM_153704.6(TMEM67):c.1115C>A (p.Thr372Lys)	TMEM67	T291K, T372K	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 6|Meckel syndrome, type 3|Nephronophthisis 11|COACH syndrome 1|Joubert syndrome 6|Bardet-Biedl syndrome 14|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217726	8	94794672	8	93782444	217726	214280	rs863225235	NC_000008.11:93782443:C:A
NM_153704.6(TMEM67):c.1321C>T (p.Arg441Cys)	TMEM67	R360C, R441C	Kidney damage|Nystagmus|Absent speech|Barrel-shaped chest|Cerebellar vermis hypoplasia|Tremor|Infantile muscular hypotonia|Cerebellar malformation|Peritonitis|Global developmental delay|Visual impairment|Congenital ocular coloboma|Intellectual disability, severe|Pancreatitis|Joubert syndrome|Meckel-Gruber syndrome|Inborn genetic diseases|Renal cyst|Joubert syndrome|Oligohydramnios|Meckel syndrome, type 3|Nephronophthisis 11|COACH syndrome 1|Joubert syndrome 6|Bardet-Biedl syndrome 14|Joubert syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217725	8	94798483	8	93786255	217725	214282	rs752362727	NC_000008.11:93786254:C:T
NM_153704.6(TMEM67):c.1351C>T (p.Arg451Ter)	TMEM67	R370*, R451*	not provided|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 6	Pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217724	8	94798513	8	93786285	217724	214283	rs116647652	NC_000008.11:93786284:C:T
NM_153704.6(TMEM67):c.1538A>G (p.Tyr513Cys)	TMEM67	Y513C, Y432C	Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 6	Pathogenic(Last reviewed: Oct 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001371	8	94803510	8	93791282	1371	16410	rs137853107	NC_000008.11:93791281:A:G
NM_153704.6(TMEM67):c.1645C>T (p.Arg549Cys)	TMEM67	R468C, R549C	Joubert syndrome and related disorders|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: May 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000530903	8	94805495	8	93793267	530903	524078	rs747025617	NC_000008.11:93793266:C:T
NM_153704.6(TMEM67):c.1769T>C (p.Phe590Ser)	TMEM67	F590S, F509S	Meckel-Gruber syndrome|Joubert syndrome|COACH syndrome 1|Joubert syndrome 6	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001381	8	94807731	8	93795503	1381	16420	rs267607115	NC_000008.11:93795502:T:C
NM_153704.6(TMEM67):c.1843T>C (p.Cys615Arg)	TMEM67	C615R, C534R	Nephronophthisis 11|Bardet-Biedl syndrome 14|Joubert syndrome 6|COACH syndrome 1|Meckel syndrome, type 3|RHYNS syndrome|TMEM67-Related Disorders|Inborn genetic diseases|Congenital ocular coloboma|Infantile muscular hypotonia|Global developmental delay|Intellectual disability, severe|Cerebellar malformation|Peritonitis|Cerebellar vermis hypoplasia|Absent speech|Barrel-shaped chest|Visual impairment|Tremor|Kidney damage|Nystagmus|Pancreatitis|Meckel-Gruber syndrome|Joubert syndrome|not provided|Joubert syndrome 6|Oligohydramnios|Renal cyst|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001383	8	94808198	8	93795970	1383	16422	rs201893408	NC_000008.11:93795969:T:C
NM_153704.6(TMEM67):c.2410G>T (p.Glu804Ter)	TMEM67	E723*, E804*	RHYNS syndrome|Nephronophthisis 11|COACH syndrome 1|Joubert syndrome 6|Bardet-Biedl syndrome 14|Meckel syndrome, type 3|not provided	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000497982	8	94817077	8	93804849	497982	489406	rs1554558363	NC_000008.11:93804848:G:T
NM_153704.6(TMEM67):c.2498T>C (p.Ile833Thr)	TMEM67	I833T, I752T	RHYNS syndrome|Joubert syndrome 6|Bardet-Biedl syndrome 14|Meckel syndrome, type 3|COACH syndrome 1|Nephronophthisis 11|Joubert syndrome and related disorders|Meckel-Gruber syndrome|Joubert syndrome|not provided|Meckel syndrome, type 3|Joubert syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001378	8	94821126	8	93808898	1378	16417	rs267607119	NC_000008.11:93808897:T:C
NM_019892.6(INPP5E):c.1861C>T (p.Arg621Trp)	INPP5E	R621W, R620W	not provided|MORM syndrome|Joubert syndrome|Rod-cone dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000426904	9	139324201	9	136429749	426904	415175	rs142759730	NC_000009.12:136429748:G:A
NM_019892.6(INPP5E):c.1304G>A (p.Arg435Gln)	INPP5E	R435Q, R434Q	Retinal dystrophy|Joubert syndrome	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000399	9	139327014	9	136432562	399	15438	rs121918129	NC_000009.12:136432561:C:T
NM_019892.6(INPP5E):c.1132C>T (p.Arg378Cys)	INPP5E	R378C	Joubert syndrome and related disorders|Cleft palate|Skeletal dysplasia|Abnormal pulmonary interstitial morphology|Coat hanger sign of ribs|Clubfoot|Pseudoarthrosis|Absent epiphyses|Vertebral segmentation defect|Preaxial foot polydactyly|Short femur|Vertebral hypoplasia|Respiratory failure|Micrognathia|Patent ductus arteriosus|Hemivertebrae|Chronic lung disease|Inborn genetic diseases|not provided|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000400	9	139327634	9	136433182	400	15439	rs121918130	NC_000009.12:136433181:G:A
NM_019892.6(INPP5E):c.1064C>T (p.Thr355Met)	INPP5E	T355M	Joubert syndrome	Pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217655	9	139327702	9	136433250	217655	214304	rs863225198	NC_000009.12:136433249:G:A
NM_019892.6(INPP5E):c.944C>T (p.Pro315Leu)	INPP5E	P315L	Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217662	9	139328579	9	136434127	217662	214306	rs754637179	NC_000009.12:136434126:G:A
NM_020975.6(RET):c.1597G>T (p.Gly533Cys)	RET	G533C, G279C, G203C, G234C, G191C, G387C, G401C, G437C, G490C, G358C, G138C, G291C, G50C	not provided|Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013950	10	43607621	10	43112173	13950	28989	rs75873440	NC_000010.11:43112172:G:T
NM_020975.6(RET):c.1825T>C (p.Cys609Arg)	RET	C609R, C355R, C126R, C434R, C310R, C279R, C367R, C477R, C566R, C214R, C267R, C463R, C513R	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Dec 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013944	10	43609069	10	43113621	13944	28983	rs77558292	NC_000010.11:43113620:T:C
NM_020975.6(RET):c.1826G>C (p.Cys609Ser)	RET	C609S, C355S, C126S, C279S, C214S, C367S, C463S, C477S, C566S, C267S, C310S, C434S, C513S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001372611	10	43609070	10	43113622	1372611	47200	rs77939446	NC_000010.11:43113621:G:C
NM_020975.6(RET):c.1826G>T (p.Cys609Phe)	RET	C355F, C214F, C279F, C367F, C463F, C477F, C126F, C434F, C513F, C566F, C267F, C310F	not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Oct 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000038284	10	43609070	10	43113622	38284	46839	rs77939446	NC_000010.11:43113621:G:T
NM_020975.6(RET):c.1826G>A (p.Cys609Tyr)	RET	C609Y, C355Y, C279Y, C463Y, C513Y, C310Y, C477Y, C367Y, C126Y, C214Y, C267Y, C434Y, C566Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: Jan 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013933	10	43609070	10	43113622	13933	28972	rs77939446	NC_000010.11:43113621:G:A
NM_020975.6(RET):c.1832G>T (p.Cys611Phe)	RET	C357F, C269F, C281F, C128F, C216F, C312F, C436F, C465F, C568F, C369F, C479F, C515F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024899	10	43609076	10	43113628	24899	36240	rs377767397	NC_000010.11:43113627:G:T
NM_020975.6(RET):c.1832G>A (p.Cys611Tyr)	RET	C357Y, C269Y, C479Y, C128Y, C216Y, C281Y, C312Y, C369Y, C436Y, C515Y, C465Y, C568Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024898	10	43609076	10	43113628	24898	36239	rs377767397	NC_000010.11:43113627:G:A
NM_020975.6(RET):c.1852T>A (p.Cys618Ser)	RET	C618S, C364S, C472S, C522S, C575S, C319S, C486S, C223S, C288S, C376S, C135S, C276S, C443S	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000038601	10	43609096	10	43113648	38601	47205	rs76262710	NC_000010.11:43113647:T:A
NM_020975.6(RET):c.1852T>C (p.Cys618Arg)	RET	C618R, C364R, C288R, C276R, C319R, C376R, C443R, C472R, C522R, C135R, C223R, C575R, C486R	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Oct 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013929	10	43609096	10	43113648	13929	28968	rs76262710	NC_000010.11:43113647:T:C
NM_020975.6(RET):c.1852T>G (p.Cys618Gly)	RET	C618G, C364G, C288G, C472G, C135G, C575G, C276G, C319G, C522G, C223G, C376G, C443G, C486G	Pheochromocytoma|Multiple endocrine neoplasia, type 2b|Congenital central hypoventilation|Multiple endocrine neoplasia, type 2a|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: Apr 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013905	10	43609096	10	43113648	13905	28944	rs76262710	NC_000010.11:43113647:T:G
NM_020975.6(RET):c.1853G>T (p.Cys618Phe)	RET	C364F, C135F, C276F, C522F, C288F, C319F, C376F, C486F, C223F, C472F, C575F, C443F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Oct 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000024902	10	43609097	10	43113649	24902	36243	rs79781594	NC_000010.11:43113648:G:T
NM_020975.6(RET):c.1853G>A (p.Cys618Tyr)	RET	C364Y, C223Y, C288Y, C522Y, C135Y, C276Y, C443Y, C472Y, C486Y, C575Y, C319Y, C376Y	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024901	10	43609097	10	43113649	24901	36242	rs79781594	NC_000010.11:43113648:G:A
NM_020975.6(RET):c.1853G>C (p.Cys618Ser)	RET	C618S, C364S, C223S, C276S, C288S, C443S, C486S, C376S, C522S, C575S, C135S, C319S, C472S	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: Sep 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013914	10	43609097	10	43113649	13914	28953	rs79781594	NC_000010.11:43113648:G:C
NM_020975.6(RET):c.1858T>A (p.Cys620Ser)	RET	C620S, C366S, C290S, C474S, C488S, C524S, C137S, C278S, C321S, C577S, C225S, C378S, C445S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000038602	10	43609102	10	43113654	38602	47206	rs77316810	NC_000010.11:43113653:T:A
NM_020975.6(RET):c.1858T>G (p.Cys620Gly)	RET	C366G, C225G, C290G, C321G, C488G, C524G, C137G, C278G, C445G, C577G, C378G, C474G	Multiple endocrine neoplasia, type 2|Aganglionic megacolon|Hereditary cancer-predisposing syndrome|not specified|not provided|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: May 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000024905	10	43609102	10	43113654	24905	36246	rs77316810	NC_000010.11:43113653:T:G
NM_020975.6(RET):c.1858T>C (p.Cys620Arg)	RET	C620R, C366R, C137R, C321R, C474R, C524R, C278R, C445R, C378R, C225R, C290R, C488R, C577R	Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Apr 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013915	10	43609102	10	43113654	13915	28954	rs77316810	NC_000010.11:43113653:T:C
NM_020975.6(RET):c.1859G>C (p.Cys620Ser)	RET	C620S, C366S, C225S, C278S, C137S, C474S, C290S, C321S, C445S, C488S, C577S, C378S, C524S	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013943	10	43609103	10	43113655	13943	28982	rs77503355	NC_000010.11:43113654:G:C
NM_020975.6(RET):c.1859G>T (p.Cys620Phe)	RET	C620F, C366F, C225F, C321F, C488F, C290F, C278F, C474F, C137F, C378F, C445F, C524F, C577F	Hereditary cancer-predisposing syndrome|not specified|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013928	10	43609103	10	43113655	13928	28967	rs77503355	NC_000010.11:43113654:G:T
NM_020975.6(RET):c.1859G>A (p.Cys620Tyr)	RET	C620Y, C366Y, C225Y, C321Y, C445Y, C488Y, C524Y, C278Y, C290Y, C378Y, C577Y, C137Y, C474Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013916	10	43609103	10	43113655	13916	28955	rs77503355	NC_000010.11:43113654:G:A
NM_020975.6(RET):c.1860C>G (p.Cys620Trp)	RET	C620W, C366W, C137W, C278W, C378W, C225W, C321W, C524W, C290W, C445W, C474W, C488W, C577W	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Jun 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013934	10	43609104	10	43113656	13934	28973	rs79890926	NC_000010.11:43113655:C:G
NM_020975.6(RET):c.1888T>C (p.Cys630Arg)	RET	C376R, C195R, C288R, C331R, C388R, C455R, C147R, C235R, C300R, C484R, C587R, C291R, C498R, C534R	Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Nov 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024908	10	43609936	10	43114488	24908	36249	rs377767404	NC_000010.11:43114487:T:C
NM_020975.6(RET):c.1889G>A (p.Cys630Tyr)	RET	C376Y, C195Y, C291Y, C388Y, C587Y, C147Y, C235Y, C331Y, C484Y, C288Y, C300Y, C498Y, C455Y, C534Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024909	10	43609937	10	43114489	24909	36250	rs377767405	NC_000010.11:43114488:G:A
NM_020975.6(RET):c.1900T>A (p.Cys634Ser)	RET	C634S, C380S, C199S, C239S, C292S, C392S, C488S, C502S, C591S, C335S, C459S, C151S, C295S, C304S, C538S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038605	10	43609948	10	43114500	38605	47209	rs75076352	NC_000010.11:43114499:T:A
NM_020975.6(RET):c.1900T>C (p.Cys634Arg)	RET	C634R, C380R, C239R, C295R, C304R, C392R, C502R, C459R, C292R, C335R, C488R, C538R, C151R, C199R, C591R	Thyroid gland carcinoma|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: Apr 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013917	10	43609948	10	43114500	13917	28956	rs75076352	NC_000010.11:43114499:T:C
NM_020975.6(RET):c.1900T>G (p.Cys634Gly)	RET	C634G, C380G, C304G, C335G, C488G, C199G, C239G, C295G, C392G, C502G, C538G, C151G, C459G, C591G, C292G	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Familial medullary thyroid carcinoma	Pathogenic(Last reviewed: Apr 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013908	10	43609948	10	43114500	13908	28947	rs75076352	NC_000010.11:43114499:T:G
NM_020975.6(RET):c.1901G>T (p.Cys634Phe)	RET	C634F, C380F, C295F, C459F, C335F, C392F, C488F, C199F, C292F, C304F, C502F, C538F, C151F, C239F, C591F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013911	10	43609949	10	43114501	13911	28950	rs75996173	NC_000010.11:43114500:G:T
NM_020975.6(RET):c.1901G>C (p.Cys634Ser)	RET	C634S, C380S, C292S, C295S, C459S, C502S, C239S, C538S, C151S, C199S, C304S, C335S, C392S, C488S, C591S	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013910	10	43609949	10	43114501	13910	28949	rs75996173	NC_000010.11:43114500:G:C
NM_020975.6(RET):c.1901G>A (p.Cys634Tyr)	RET	C634Y, C380Y, C292Y, C392Y, C502Y, C538Y, C239Y, C335Y, C459Y, C591Y, C199Y, C304Y, C488Y, C151Y, C295Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Jun 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013909	10	43609949	10	43114501	13909	28948	rs75996173	NC_000010.11:43114500:G:A
NM_020975.6(RET):c.1902C>G (p.Cys634Trp)	RET	C634W, C380W, C199W, C292W, C304W, C459W, C538W, C239W, C335W, C591W, C295W, C392W, C151W, C488W, C502W	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: May 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013918	10	43609950	10	43114502	13918	28957	rs77709286	NC_000010.11:43114501:C:G
NM_020975.6(RET):c.1947G>A (p.Ser649_Val650=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2b|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000024929	10	43609995	10	43114547	24929	36270	rs377767412	NC_000010.11:43114546:G:A
NM_020975.6(RET):c.1996A>G (p.Lys666Glu)	RET	K412E, K336E, K534E, K183E, K231E, K367E, K424E, K491E, K623E, K271E, K327E, K520E, K324E, K570E	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024931	10	43610044	10	43114596	24931	36272	rs143795581	NC_000010.11:43114595:A:G
NM_020975.6(RET):c.1998G>C (p.Lys666Asn)	RET	K666N, K412N, K183N, K491N, K570N, K623N, K336N, K424N, K271N, K327N, K231N, K324N, K367N, K520N, K534N	Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230926	10	43610046	10	43114598	230926	233786	rs146646971	NC_000010.11:43114597:G:C
NM_020975.6(RET):c.1998G>T (p.Lys666Asn)	RET	K412N, K324N, K336N, K570N, K183N, K231N, K271N, K367N, K491N, K534N, K623N, K520N, K327N, K424N	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000024932	10	43610046	10	43114598	24932	36273	rs146646971	NC_000010.11:43114597:G:T
NM_020975.6(RET):c.2304G>T (p.Glu768Asp)	RET	E768D, E514D, E333D, E426D, E469D, E424D, E723D, E725D, E373D, E438D, E636D, E672D, E285D, E429D, E526D, E593D, E622D, E680D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000038611	10	43613840	10	43118392	38611	47215	rs78014899	NC_000010.11:43118391:G:T
NM_020975.6(RET):c.2304G>C (p.Glu768Asp)	RET	E768D, E514D, E636D, E333D, E424D, E526D, E593D, E723D, E285D, E426D, E429D, E438D, E622D, E672D, E680D, E725D, E373D, E469D	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013931	10	43613840	10	43118392	13931	28970	rs78014899	NC_000010.11:43118391:G:C
NM_020975.6(RET):c.2370G>C (p.Leu790Phe)	RET	L790F, L536F, L307F, L355F, L395F, L448F, L615F, L745F, L446F, L460F, L644F, L702F, L658F, L694F, L747F, L451F, L491F, L548F	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013935	10	43613906	10	43118458	13935	28974	rs75030001	NC_000010.11:43118457:G:C
NM_020975.6(RET):c.2410G>C (p.Val804Leu)	RET	V804L, V550L, V369L, V460L, V462L, V505L, V629L, V759L, V761L, V409L, V465L, V474L, V562L, V716L, V321L, V658L, V672L, V708L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Nov 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000038613	10	43614996	10	43119548	38613	47217	rs79658334	NC_000010.11:43119547:G:C
NM_020975.6(RET):c.2410G>A (p.Val804Met)	RET	V804M, V550M, V321M, V460M, V672M, V759M, V369M, V409M, V462M, V658M, V708M, V465M, V505M, V629M, V716M, V474M, V562M, V761M	Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2b|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000037102	10	43614996	10	43119548	37102	28984	rs79658334	NC_000010.11:43119547:G:A
NM_020975.6(RET):c.2410G>T (p.Val804Leu)	RET	V804L, V550L, V409L, V460L, V658L, V321L, V629L, V672L, V716L, V759L, V369L, V462L, V474L, V505L, V562L, V708L, V465L, V761L	Multiple endocrine neoplasia|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a	Pathogenic(Last reviewed: Mar 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013946	10	43614996	10	43119548	13946	28985	rs79658334	NC_000010.11:43119547:G:T
NM_020975.6(RET):c.2671T>G (p.Ser891Ala)	RET	S891A, S637A, S716A, S745A, S795A, S848A, S547A, S549A, S846A, S456A, S496A, S592A, S649A, S759A, S408A, S552A, S561A, S803A	not specified|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma	Pathogenic(Last reviewed: Dec 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013951	10	43615592	10	43120144	13951	28990	rs75234356	NC_000010.11:43120143:T:G
NM_020975.6(RET):c.2689C>T (p.Arg897Ter)	RET	R897*, R643*, R558*, R598*, R765*, R414*, R567*, R722*, R502*, R553*, R751*, R462*, R555*, R655*, R801*, R809*, R852*, R854*	not provided|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Apr 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000405536	10	43615610	10	43120162	405536	397472	rs1060500759	NC_000010.11:43120161:C:T
NM_020975.6(RET):c.2753T>C (p.Met918Thr)	RET	M918T, M664T, M579T, M676T, M772T, M786T, M875T, M830T, M873T, M483T, M574T, M588T, M743T, M822T, M435T, M576T, M619T, M523T	Inborn genetic diseases|not specified|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 2a|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Constipation|Thick vermilion border|Hypothyroidism|Joint hypermobility|Gingival overgrowth|Short stature|Tetralogy of Fallot|Hypertelorism	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000013919	10	43617416	10	43121968	13919	28958	rs74799832	NC_000010.11:43121967:T:C
NM_018344.6(SLC29A3):c.300+1G>A	SLC29A3		H syndrome	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000130339	10	73082812	10	71323055	130339	135786	rs587780463	NC_000010.11:71323054:G:A
NM_018344.6(SLC29A3):c.479G>A (p.Trp160Ter)	SLC29A3	W160*, W82*	H syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000573984	10	73111414	10	71351657	573984	566470	rs776960135	NC_000010.11:71351656:G:A
NM_018344.6(SLC29A3):c.1087C>T (p.Arg363Trp)	SLC29A3	R363W, R285W	not provided|H syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030949	10	73122024	10	71362267	30949	39906	rs387907067	NC_000010.11:71362266:C:T
NM_018344.6(SLC29A3):c.1228C>T (p.Gln410Ter)	SLC29A3	Q410*, Q332*	not provided|H syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000130338	10	73122165	10	71362408	130338	135785	rs587780462	NC_000010.11:71362407:C:T
NM_018344.6(SLC29A3):c.1279G>A (p.Gly427Ser)	SLC29A3	G427S, G349S	not provided|H syndrome	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000563	10	73122216	10	71362459	563	15602	rs121912583	NC_000010.11:71362458:G:A
NM_018344.6(SLC29A3):c.1309G>A (p.Gly437Arg)	SLC29A3	G437R, G359R	not provided|H syndrome	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000565	10	73122246	10	71362489	565	15604	rs121912584	NC_000010.11:71362488:G:A
NM_007055.4(POLR3A):c.2617-1G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031146	10	79753126	10	77993368	31146	40103	rs181087667	NC_000010.11:77993367:C:T
NM_007055.4(POLR3A):c.2119C>T (p.Gln707Ter)	POLR3A	Q707*	not provided|Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2015)	criteria provided, multiple submitters, no conflicts	VCV000430255	10	79764602	10	78004844	430255	421801	rs780839834	NC_000010.11:78004843:G:A
NM_007055.4(POLR3A):c.2005C>T (p.Arg669Ter)	POLR3A	R669*	not provided|Neonatal pseudo-hydrocephalic progeroid syndrome	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000617891	10	79767529	10	78007771	617891	609288	rs774007232	NC_000010.11:78007770:G:A
NM_007055.4(POLR3A):c.1909+18G>A	POLR3A		Neonatal pseudo-hydrocephalic progeroid syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031144	10	79769277	10	78009519	31144	40101	rs267608677	NC_000010.11:78009518:C:T
NM_007055.4(POLR3A):c.1771-6C>G	POLR3A		Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome|not provided	Pathogenic(Last reviewed: May 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000976718	10	79769439	10	78009681	976718	964843	rs115020338	NC_000010.11:78009680:G:C
NM_007055.4(POLR3A):c.1051C>T (p.Arg351Ter)	POLR3A	R351*	Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000684773	10	79781438	10	78021680	684773	672365	rs769791060	NC_000010.11:78021679:G:A
NM_015631.6(TCTN3):c.3G>A (p.Met1Ile)	TCTN3	M1I	Joubert syndrome 18|Joubert syndrome 18|Orofacial-digital syndrome IV	Pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217703	10	97453654	10	95693897	217703	214308	rs745688122	NC_000010.11:95693896:C:T
NM_005343.4(HRAS):c.179G>T (p.Gly60Val)	HRAS|LRRC56	G60V	Linear nevus sebaceous syndrome|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Malignant tumor of urinary bladder|Costello syndrome|not provided	Pathogenic(Last reviewed: Sep 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000391700	11	533877	11	533877	391700	374144	rs730880460	NC_000011.10:533876:C:A
NM_005343.4(HRAS):c.37G>C (p.Gly13Arg)	HRAS|LRRC56	G13R	Noonan syndrome and Noonan-related syndrome|Non-immune hydrops fetalis	Pathogenic(Last reviewed: May 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000035554	11	534286	11	534286	35554	44227	rs104894228	NC_000011.10:534285:C:G
NM_005343.4(HRAS):c.35G>C (p.Gly12Ala)	HRAS|LRRC56	G12A	Thyroid cancer, nonmedullary, 2|Costello syndrome|Malignant tumor of urinary bladder|Epidermal nevus|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|Noonan syndrome and Noonan-related syndrome|Inborn genetic diseases|not provided|Costello syndrome	Pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012603	11	534288	11	534288	12603	27642	rs104894230	NC_000011.10:534287:C:G
NM_005343.4(HRAS):c.35G>T (p.Gly12Val)	HRAS|LRRC56	G12V	not provided|Costello syndrome	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	VCV000012600	11	534288	11	534288	12600	27639	rs104894230	NC_000011.10:534287:C:A
NM_005343.4(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	G12C	Thyroid cancer, nonmedullary, 2|Costello syndrome|Malignant tumor of urinary bladder|Epidermal nevus|Large congenital melanocytic nevus|Linear nevus sebaceous syndrome|not provided|Costello syndrome	Pathogenic(Last reviewed: Sep 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012613	11	534289	11	534289	12613	27652	rs104894229	NC_000011.10:534288:C:A
NM_016464.5(TMEM138):c.128+5G>A	TMEM138		Joubert syndrome and related disorders|Joubert syndrome 16	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031187	11	61131995	11	61364523	31187	40144	rs917404097	NC_000011.10:61364522:G:A
NM_016464.5(TMEM138):c.287A>G (p.His96Arg)	TMEM138	H96R, H38R	not provided|Joubert syndrome 16	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031188	11	61133675	11	61366203	31188	40145	rs387907132	NC_000011.10:61366202:A:G
NM_001173990.3(TMEM216):c.218G>T (p.Arg73Leu)	TMEM216	R73L, R12L	TMEM216-Related Disorders|Meckel syndrome, type 2|Joubert syndrome 2|Inborn genetic diseases|not provided|Meckel syndrome, type 2|Joubert syndrome 2|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000197	11	61161437	11	61393965	197	15236	rs201108965	NC_000011.10:61393964:G:T
NM_001173990.3(TMEM216):c.253C>T (p.Arg85Ter)	TMEM216	R24*, R85*	Joubert syndrome 2|Meckel syndrome, type 2|TMEM216-Related Disorders|not provided|Joubert syndrome|Joubert syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056384	11	61165269	11	61397797	56384	71023	rs11230683	NC_000011.10:61397796:C:T
NM_001173990.3(TMEM216):c.398T>G (p.Leu133Ter)	TMEM216	L133*, L72*	not provided|Joubert syndrome|Joubert syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217704	11	61165414	11	61397942	217704	214311	rs755459875	NC_000011.10:61397941:T:G
NM_001370259.2(MEN1):c.1664G>A (p.Ser555Asn)	MEN1	S555N, S560N, S597N, S520N	not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216134	11	64571975	11	64804503	216134	212931	rs863224527	NC_000011.10:64804502:C:T
NM_001370259.2(MEN1):c.1660C>T (p.Gln554Ter)	MEN1	Q554*, Q559*, Q519*, Q596*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200988	11	64571979	11	64804507	200988	197519	rs794728631	NC_000011.10:64804506:G:A
NM_001370259.2(MEN1):c.1579C>T (p.Arg527Ter)	MEN1	R527*, R532*, R569*, R492*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016688	11	64572060	11	64804588	16688	31727	rs104894261	NC_000011.10:64804587:G:A
NM_001370259.2(MEN1):c.1549A>T (p.Lys517Ter)	MEN1	K517*, K522*, K482*, K559*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200986	11	64572090	11	64804618	200986	197523	rs794728630	NC_000011.10:64804617:T:A
NM_001370259.2(MEN1):c.1429G>T (p.Glu477Ter)	MEN1	E477*, E482*, E519*, E442*	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216133	11	64572210	11	64804738	216133	212934	rs863224526	NC_000011.10:64804737:C:A
NM_001370259.2(MEN1):c.1413G>A (p.Trp471Ter)	MEN1	W471*, W436*, W476*, W513*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000943203	11	64572226	11	64804754	943203	935669	rs1941556077	NC_000011.10:64804753:C:T
NM_001370259.2(MEN1):c.1378C>T (p.Arg460Ter)	MEN1	R460*, R465*, R502*, R425*	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016692	11	64572261	11	64804789	16692	31731	rs104894267	NC_000011.10:64804788:G:A
NM_001370259.2(MEN1):c.1354C>T (p.Arg452Trp)	MEN1	R452W, R457W, R417W, R494W	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216815	11	64572285	11	64804813	216815	212935	rs863224810	NC_000011.10:64804812:G:A
NM_001370259.2(MEN1):c.1324C>T (p.Gln442Ter)	MEN1	Q442*, Q447*, Q407*, Q484*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201016	11	64572532	11	64805060	201016	197530	rs794728654	NC_000011.10:64805059:G:A
NM_001370259.2(MEN1):c.1308G>T (p.Trp436Cys)	MEN1	W436C, W441C, W401C, W478C	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096250	11	64572548	11	64805076	96250	102144	rs398124435	NC_000011.10:64805075:C:A
NM_001370259.2(MEN1):c.1307G>A (p.Trp436Ter)	MEN1	W436*, W441*, W478*, W401*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016687	11	64572549	11	64805077	16687	31726	rs104894260	NC_000011.10:64805076:C:T
NM_001370259.2(MEN1):c.1306T>C (p.Trp436Arg)	MEN1	W436R, W441R, W401R, W478R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428003	11	64572550	11	64805078	428003	419793	rs104894259	NC_000011.10:64805077:A:G
NM_001370259.2(MEN1):c.1306T>A (p.Trp436Arg)	MEN1	W436R, W441R, W478R, W401R	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016686	11	64572550	11	64805078	16686	31725	rs104894259	NC_000011.10:64805077:A:T
NM_001370259.2(MEN1):c.1269G>A (p.Trp423Ter)	MEN1	W423*, W428*, W388*, W465*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428077	11	64572587	11	64805115	428077	419797	rs1114167533	NC_000011.10:64805114:C:T
NM_001370259.2(MEN1):c.1252G>C (p.Asp418His)	MEN1	D418H, D423H, D460H, D383H	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201015	11	64572604	11	64805132	201015	197531	rs104894264	NC_000011.10:64805131:C:G
NM_001370259.2(MEN1):c.1252G>A (p.Asp418Asn)	MEN1	D418N, D423N, D383N, D460N	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Mar 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000016703	11	64572604	11	64805132	16703	31742	rs104894264	NC_000011.10:64805131:C:T
NM_001370259.2(MEN1):c.1243C>T (p.Arg415Ter)	MEN1	R415*, R420*, R457*, R380*	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000403802	11	64572613	11	64805141	403802	398266	rs1060499974	NC_000011.10:64805140:G:A
NM_001370259.2(MEN1):c.1213C>T (p.Gln405Ter)	MEN1	Q410*, Q405*, Q447*, Q370*	not provided|Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220643	11	64572643	11	64805171	220643	222156	rs864622615	NC_000011.10:64805170:G:A
NM_001370259.2(MEN1):c.1198C>T (p.Gln400Ter)	MEN1	Q400*, Q405*, Q442*, Q365*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265240	11	64572658	11	64805186	265240	259994	rs886039419	NC_000011.10:64805185:G:A
NM_001370259.2(MEN1):c.1177C>T (p.Gln393Ter)	MEN1	Q393*, Q398*, Q435*, Q358*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428027	11	64573115	11	64805643	428027	419804	rs1060499984	NC_000011.10:64805642:G:A
NM_001370259.2(MEN1):c.1174G>T (p.Glu392Ter)	MEN1	E397*, E392*, E434*, E357*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000403811	11	64573118	11	64805646	403811	398854	rs772588551	NC_000011.10:64805645:C:A
NM_001370259.2(MEN1):c.1049+1G>A	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000527268	11	64573703	11	64806231	527268	526627	rs1114167489	NC_000011.10:64806230:C:T
NM_001370259.2(MEN1):c.1022G>A (p.Trp341Ter)	MEN1	W341*, W346*, W306*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428018	11	64573731	11	64806259	428018	419813	rs1114167482	NC_000011.10:64806258:C:T
NM_001370259.2(MEN1):c.1010C>A (p.Ala337Asp)	MEN1	A302D, A337D, A342D	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001070417	11	64573743	11	64806271	1070417	1062425		NC_000011.10:64806270:G:T
NM_001370259.2(MEN1):c.969C>G (p.Tyr323Ter)	MEN1	Y323*, Y328*, Y288*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449058	11	64573784	11	64806312	449058	444850	rs750904332	NC_000011.10:64806311:G:C
NM_001370259.2(MEN1):c.969C>A (p.Tyr323Ter)	MEN1	Y323*, Y328*, Y288*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000403838	11	64573784	11	64806312	403838	398284	rs750904332	NC_000011.10:64806311:G:T
NM_001370259.2(MEN1):c.936C>G (p.Tyr312Ter)	MEN1	Y312*, Y317*, Y277*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036537	11	64573817	11	64806345	36537	45199	rs386134260	NC_000011.10:64806344:G:C
NM_001370259.2(MEN1):c.923C>A (p.Ser308Ter)	MEN1	S308*, S313*, S273*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618712	11	64573830	11	64806358	618712	609801	rs1565644366	NC_000011.10:64806357:G:T
NM_001370259.2(MEN1):c.913-1G>A	MEN1		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000373724	11	64573841	11	64806369	373724	360059	rs1057518572	NC_000011.10:64806368:C:T
NM_001370259.2(MEN1):c.913-2A>G	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428037	11	64573842	11	64806370	428037	419823	rs1114167498	NC_000011.10:64806369:T:C
NM_001370259.2(MEN1):c.912+1G>C	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428012	11	64574482	11	64807010	428012	419824	rs398124437	NC_000011.10:64807009:C:G
NM_001370259.2(MEN1):c.912+1G>A	MEN1		not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000096254	11	64574482	11	64807010	96254	102148	rs398124437	NC_000011.10:64807009:C:T
NM_001370259.2(MEN1):c.828C>A (p.Tyr276Ter)	MEN1	Y276*, Y281*, Y241*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000418292	11	64574567	11	64807095	418292	408406	rs1060503789	NC_000011.10:64807094:G:T
NM_001370259.2(MEN1):c.824G>A (p.Arg275Lys)	MEN1	R240K, R280K, R275K	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000662978	11	64574651	11	64807179	662978	640288	rs1187634059	NC_000011.10:64807178:C:T
NM_001370259.2(MEN1):c.795G>A (p.Trp265Ter)	MEN1	W230*, W265*, W270*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000653034	11	64574680	11	64807208	653034	640291	rs1592647398	NC_000011.10:64807207:C:T
NM_001370259.2(MEN1):c.794G>A (p.Trp265Ter)	MEN1	W270*, W230*, W265*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV001452903	11	64574681	11	64807209	1452903	1432045		NC_000011.10:64807208:C:T
NM_001370259.2(MEN1):c.784-1G>C	MEN1		Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449445	11	64574692	11	64807220	449445	444851	rs1555165377	NC_000011.10:64807219:C:G
NM_001370259.2(MEN1):c.784-9G>A	MEN1		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000200981	11	64574700	11	64807228	200981	197538	rs794728625	NC_000011.10:64807227:C:T
NM_001370259.2(MEN1):c.783+1G>C	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000810855	11	64575023	11	64807551	810855	799658	rs794728652	NC_000011.10:64807550:C:G
NM_001370259.2(MEN1):c.783+1G>A	MEN1		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428081	11	64575023	11	64807551	428081	419830	rs794728652	NC_000011.10:64807550:C:T
NM_001370259.2(MEN1):c.781C>T (p.Gln261Ter)	MEN1	Q261*, Q266*, Q226*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000379789	11	64575026	11	64807554	379789	372280	rs1057520733	NC_000011.10:64807553:G:A
NM_001370259.2(MEN1):c.772C>T (p.Gln258Ter)	MEN1	Q258*, Q263*, Q223*	not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Oct 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000265237	11	64575035	11	64807563	265237	259997	rs886039416	NC_000011.10:64807562:G:A
NM_001370259.2(MEN1):c.681C>A (p.Tyr227Ter)	MEN1	Y227*, Y232*, Y192*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457331	11	64575126	11	64807654	457331	461846	rs778921501	NC_000011.10:64807653:G:T
NM_001370259.2(MEN1):c.668T>C (p.Leu223Pro)	MEN1	L223P, L228P, L188P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265236	11	64575139	11	64807667	265236	259998	rs886039415	NC_000011.10:64807666:A:G
NM_001370259.2(MEN1):c.660G>A (p.Trp220Ter)	MEN1	W220*, W225*, W185*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265235	11	64575147	11	64807675	265235	259999	rs886039414	NC_000011.10:64807674:C:T
NM_001370259.2(MEN1):c.655-1G>C	MEN1		Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000826480	11	64575153	11	64807681	826480	815506	rs1592649615	NC_000011.10:64807680:C:G
NM_001370259.2(MEN1):c.654+1G>T	MEN1		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200978	11	64575362	11	64807890	200978	197545	rs794728622	NC_000011.10:64807889:C:A
NM_001370259.2(MEN1):c.654+1G>A	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039763	11	64575362	11	64807890	39763	48362	rs794728622	NC_000011.10:64807889:C:T
NM_001370259.2(MEN1):c.594G>A (p.Trp198Ter)	MEN1	W198*, W203*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201010	11	64575423	11	64807951	201010	197549	rs104894257	NC_000011.10:64807950:C:T
NM_001370259.2(MEN1):c.548G>A (p.Trp183Ter)	MEN1	W183*, W188*	Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201009	11	64575469	11	64807997	201009	197550	rs794728650	NC_000011.10:64807996:C:T
NM_001370259.2(MEN1):c.526G>C (p.Ala176Pro)	MEN1	A176P, A181P	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200975	11	64575491	11	64808019	200975	197552	rs376872829	NC_000011.10:64808018:C:G
NM_001370259.2(MEN1):c.503T>C (p.Leu168Pro)	MEN1	L168P, L173P	Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036532	11	64575514	11	64808042	36532	45194	rs386134256	NC_000011.10:64808041:A:G
NM_001370259.2(MEN1):c.478G>C (p.Ala160Pro)	MEN1	A160P, A165P	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000579050	11	64575539	11	64808067	579050	570807	rs1565648656	NC_000011.10:64808066:C:G
NM_001370259.2(MEN1):c.467G>A (p.Gly156Asp)	MEN1	G156D, G161D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000381625	11	64575550	11	64808078	381625	371566	rs794728648	NC_000011.10:64808077:C:T
NM_001370259.2(MEN1):c.466G>T (p.Gly156Cys)	MEN1	G156C, G161C	not provided|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000988303	11	64575551	11	64808079	988303	976351	rs1085307471	NC_000011.10:64808078:C:A
NM_001370259.2(MEN1):c.446-1G>A	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000419140	11	64575572	11	64808100	419140	408412	rs1064793672	NC_000011.10:64808099:C:T
NM_001370259.2(MEN1):c.446-2A>G	MEN1		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428001	11	64575573	11	64808101	428001	419842	rs886042035	NC_000011.10:64808100:T:C
NM_001370259.2(MEN1):c.421C>T (p.Gln141Ter)	MEN1	Q141*	Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Sep 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265450	11	64577161	11	64809689	265450	260000	rs886039553	NC_000011.10:64809688:G:A
NM_001370259.2(MEN1):c.415C>G (p.His139Asp)	MEN1	H139D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016699	11	64577167	11	64809695	16699	31738	rs104894263	NC_000011.10:64809694:G:C
NM_001370259.2(MEN1):c.346G>T (p.Glu116Ter)	MEN1	E116*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000403842	11	64577236	11	64809764	403842	398411	rs1060499992	NC_000011.10:64809763:C:A
NM_001370259.2(MEN1):c.322C>T (p.Arg108Ter)	MEN1	R108*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000201006	11	64577260	11	64809788	201006	197558	rs794728647	NC_000011.10:64809787:G:A
NM_001370259.2(MEN1):c.292C>T (p.Arg98Ter)	MEN1	R98*	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265234	11	64577290	11	64809818	265234	260001	rs886039413	NC_000011.10:64809817:G:A
NM_001370259.2(MEN1):c.231C>G (p.Tyr77Ter)	MEN1	Y77*	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527270	11	64577351	11	64809879	527270	526405	rs1555166567	NC_000011.10:64809878:G:C
NM_001370259.2(MEN1):c.135G>C (p.Glu45Asp)	MEN1	E45D	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000403819	11	64577447	11	64809975	403819	398338	rs778670301	NC_000011.10:64809974:C:G
NM_001370259.2(MEN1):c.133G>A (p.Glu45Lys)	MEN1	E45K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428029	11	64577449	11	64809977	428029	419861	rs1114167491	NC_000011.10:64809976:C:T
NM_001370259.2(MEN1):c.113C>T (p.Ser38Phe)	MEN1	S38F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200971	11	64577469	11	64809997	200971	197562	rs794728616	NC_000011.10:64809996:G:A
NM_001370259.2(MEN1):c.85C>T (p.Arg29Ter)	MEN1	R29*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000200970	11	64577497	11	64810025	200970	197564	rs794728615	NC_000011.10:64810024:G:A
NM_001370259.2(MEN1):c.76G>A (p.Glu26Lys)	MEN1	E26K	not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016689	11	64577506	11	64810034	16689	31728	rs28931612	NC_000011.10:64810033:C:T
NM_001370259.2(MEN1):c.65T>G (p.Leu22Arg)	MEN1	L22R	not provided|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016677	11	64577517	11	64810045	16677	31716	rs104894256	NC_000011.10:64810044:A:C
NM_001370259.2(MEN1):c.3G>A (p.Met1Ile)	MEN1	M1I	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188376	11	64577579	11	64810107	188376	186159	rs786204242	NC_000011.10:64810106:C:T
NM_001370259.2(MEN1):c.1A>T (p.Met1Leu)	MEN1	M1L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: May 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428034	11	64577581	11	64810109	428034	419865	rs386134250	NC_000011.10:64810108:T:A
NM_001370259.2(MEN1):c.1A>G (p.Met1Val)	MEN1	M1V	Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036525	11	64577581	11	64810109	36525	45187	rs386134250	NC_000011.10:64810108:T:C
NM_003977.4(AIP):c.910C>T (p.Arg304Ter)	AIP	R304*, R245*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004888	11	67258381	11	67490910	4888	19927	rs104894195	NC_000011.10:67490909:C:T
NM_000190.4(HMBS):c.331G>A (p.Gly111Arg)	HMBS	G111R, G94R	not provided|Acute intermittent porphyria	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001464	11	118960457	11	119089747	1464	16503	rs118204107	NC_000011.10:119089746:G:A
NM_000190.4(HMBS):c.346C>T (p.Arg116Trp)	HMBS	R116W, R99W	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Sep 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001445	11	118960701	11	119089991	1445	16484	rs118204094	NC_000011.10:119089990:C:T
NM_000190.4(HMBS):c.445C>T (p.Arg149Ter)	HMBS	R149*, R132*	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001486	11	118960922	11	119090212	1486	16525	rs118204120	NC_000011.10:119090211:C:T
NM_000190.4(HMBS):c.499C>T (p.Arg167Trp)	HMBS	R167W, R150W	not provided	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001456	11	118962123	11	119091413	1456	16495	rs118204101	NC_000011.10:119091412:C:T
NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	HMBS	R167Q, R150Q	not provided|Acute intermittent porphyria	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001446	11	118962124	11	119091414	1446	16485	rs118204095	NC_000011.10:119091413:G:A
NM_000190.4(HMBS):c.517C>T (p.Arg173Trp)	HMBS	R173W, R156W	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000649348	11	118962141	11	119091431	649348	639782	rs575222284	NC_000011.10:119091430:C:T
NM_000190.4(HMBS):c.601C>T (p.Arg201Trp)	HMBS	R201W, R184W	not provided|Acute intermittent porphyria	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001462	11	118962225	11	119091515	1462	16501	rs118204109	NC_000011.10:119091514:C:T
NM_000190.4(HMBS):c.849G>A (p.Trp283Ter)	HMBS	W283*, W266*, W226*, W243*	not provided	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001483	11	118963668	11	119092958	1483	16522	rs118204117	NC_000011.10:119092957:G:A
NM_000190.4(HMBS):c.973C>T (p.Arg325Ter)	HMBS	R268*, R285*, R308*, R325*	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV001070048	11	118963880	11	119093170	1070048	1062260		NC_000011.10:119093169:C:T
NM_004064.5(CDKN1B):c.58C>T (p.Gln20Ter)	CDKN1B	Q20*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 4	Pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000843386	12	12870831	12	12717897	843386	839385	rs1946487230	NC_000012.12:12717896:C:T
NM_004064.5(CDKN1B):c.421C>T (p.Gln141Ter)	CDKN1B	Q141*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 4	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV001439402	12	12871194	12	12718260	1439402	1349802		NC_000012.12:12718259:C:T
NM_004064.5(CDKN1B):c.460C>T (p.Arg154Ter)	CDKN1B	R154*	Multiple endocrine neoplasia type 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV001398606	12	12871233	12	12718299	1398606	1021003	rs1292160956	NC_000012.12:12718298:C:T
NM_004064.5(CDKN1B):c.487C>T (p.Gln163Ter)	CDKN1B	Q163*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 4	Pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001452550	12	12871770	12	12718836	1452550	1364270		NC_000012.12:12718835:C:T
NM_020297.4(ABCC9):c.3460C>T (p.Arg1154Trp)	ABCC9	R1154W, R865W	Micrognathia|Left ventricular hypertrophy|Depressed nasal bridge|Coarse facial features|Patent ductus arteriosus|Joint hypermobility|Epicanthal fold|Thick upper lip vermilion|Abnormality of the face|Low anterior hairline|Abnormal facial shape|Macrocephaly|Large hands|Bulbous nose|Tapered finger|not provided|Hypertrichotic osteochondrodysplasia Cantu type|Dilated cardiomyopathy 1O	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031946	12	21995261	12	21842327	31946	40611	rs387907208	NC_000012.12:21842326:G:A
NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	KRAS	G12D	not provided|RASopathy|Linear nevus sebaceous syndrome	Pathogenic(Last reviewed: Oct 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012582	12	25398284	12	25245350	12582	27621	rs121913529	NC_000012.12:25245349:C:T
NM_012062.5(DNM1L):c.1207C>T (p.Arg403Cys)	DNM1L	R403C, R416C, R200C	not provided|Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1|Optic atrophy 5|Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000214313	12	32884296	12	32731362	214313	211619	rs863223953	NC_000012.12:32731361:C:T
NM_006009.4(TUBA1A):c.1226T>C (p.Val409Ala)	TUBA1A	V409A, V374A	not provided|Tubulinopathies	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208490	12	49578923	12	49185140	208490	205017	rs797045005	NC_000012.12:49185139:A:G
NM_025114.4(CEP290):c.7048C>T (p.Gln2350Ter)	CEP290	Q2350*	not provided|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000806915	12	88447510	12	88053733	806915	796873	rs375548374	NC_000012.12:88053732:G:A
NM_025114.4(CEP290):c.6836T>A (p.Leu2279Ter)	CEP290	L2279*	Retinal dystrophy|Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000858111	12	88449477	12	88055700	858111	840348	rs2033943937	NC_000012.12:88055699:A:T
NM_025114.4(CEP290):c.6798G>A (p.Trp2266Ter)	CEP290	W2266*	not provided|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|Leber congenital amaurosis 10|Kidney disease|CEP290-Related Disorders	Pathogenic(Last reviewed: Jul 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000497937	12	88452645	12	88058868	497937	489361	rs760540562	NC_000012.12:88058867:C:T
NM_025114.4(CEP290):c.6271-8T>G	CEP290		Joubert syndrome 1|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|See cases	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000802875	12	88456563	12	88062786	802875	791280	rs1039146791	NC_000012.12:88062785:A:C
NM_025114.4(CEP290):c.6012-2A>G	CEP290		Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|Joubert syndrome 5	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000931558	12	88462424	12	88068647	931558	920320	rs555755221	NC_000012.12:88068646:T:C
NM_025114.4(CEP290):c.5932C>T (p.Arg1978Ter)	CEP290	R1978*	not provided|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome 5	Pathogenic(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217637	12	88465150	12	88071373	217637	214324	rs371525247	NC_000012.12:88071372:G:A
NM_025114.4(CEP290):c.5803G>T (p.Glu1935Ter)	CEP290	E1935*	Leber congenital amaurosis|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000282259	12	88465610	12	88071833	282259	266496	rs886042360	NC_000012.12:88071832:C:A
NM_025114.4(CEP290):c.5777G>C (p.Arg1926Pro)	CEP290	R1926P	Joubert syndrome 1|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000659046	12	88465636	12	88071859	659046	641418	rs778030031	NC_000012.12:88071858:C:G
NM_025114.4(CEP290):c.5776C>T (p.Arg1926Ter)	CEP290	R1926*	Joubert syndrome 5|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000635021	12	88465637	12	88071860	635021	622900	rs561598805	NC_000012.12:88071859:G:A
NM_025114.4(CEP290):c.5704G>T (p.Glu1902Ter)	CEP290	E1902*	Joubert syndrome 5|Meckel syndrome, type 6	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000001345	12	88471004	12	88077227	1345	16384	rs267606719	NC_000012.12:88077226:C:A
NM_025114.4(CEP290):c.5668G>T (p.Gly1890Ter)	CEP290	G1890*	Joubert syndrome 5|Bardet-Biedl syndrome 14|Meckel syndrome, type 4|Senior-Loken syndrome 6|Meckel syndrome, type 6|Retinal dystrophy|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 5|Bardet-Biedl syndrome 14|not provided|Abnormality of the nervous system|Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Joubert syndrome 5|Bardet-Biedl syndrome 14|Meckel syndrome, type 4|Senior-Loken syndrome 6|COG7 congenital disorder of glycosylation|Meckel syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001333	12	88471040	12	88077263	1333	16372	rs137852832	NC_000012.12:88077262:C:A
NM_025114.4(CEP290):c.5587-1G>C	CEP290		Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000636006	12	88471122	12	88077345	636006	623936	rs968692633	NC_000012.12:88077344:C:G
NM_025114.4(CEP290):c.5344C>T (p.Arg1782Ter)	CEP290	R1782*	Meckel syndrome, type 4|Joubert syndrome 5|Bardet-Biedl syndrome 14|Leber congenital amaurosis 10|Senior-Loken syndrome 6|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|not provided|Joubert syndrome 5	Pathogenic(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217636	12	88472889	12	88079112	217636	214325	rs575767207	NC_000012.12:88079111:G:A
NM_025114.4(CEP290):c.5329C>T (p.Gln1777Ter)	CEP290	Q1777*	Severe hydrocephalus|Encephalocele|Polycystic kidney disease|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000978630	12	88472904	12	88079127	978630	966722	rs774410421	NC_000012.12:88079126:G:A
NM_025114.4(CEP290):c.5182G>T (p.Glu1728Ter)	CEP290	E1728*	Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis|Meckel syndrome, type 4|Leber congenital amaurosis 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000197044	12	88474003	12	88080226	197044	194205	rs370119681	NC_000012.12:88080225:C:A
NM_025114.4(CEP290):c.4966G>T (p.Glu1656Ter)	CEP290	E1656*	CEP290-Related Disorders|Leber congenital amaurosis 10|Senior-Loken syndrome 6|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000099857	12	88476854	12	88083077	99857	105746	rs62638179	NC_000012.12:88083076:C:A
NM_025114.4(CEP290):c.4882C>T (p.Gln1628Ter)	CEP290	Q1628*	Joubert syndrome 5|Global developmental delay|Blindness|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|not provided|Cystic renal dysplasia|Occipital encephalocele|Bardet-Biedl syndrome 14|Leber congenital amaurosis 10|Senior-Loken syndrome 6|Joubert syndrome 5|Meckel syndrome, type 4	Pathogenic(Last reviewed: Dec 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217635	12	88476938	12	88083161	217635	214327	rs376493409	NC_000012.12:88083160:G:A
NM_025114.4(CEP290):c.4813-2A>G	CEP290		CEP290-Related Disorders|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Retinal dystrophy|Leber congenital amaurosis 10|Senior-Loken syndrome 6|Meckel syndrome, type 4|Joubert syndrome 5|Bardet-Biedl syndrome 14|not provided|Joubert syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000432415	12	88477009	12	88083232	432415	426028	rs369523378	NC_000012.12:88083231:T:C
NM_025114.4(CEP290):c.4723A>T (p.Lys1575Ter)	CEP290	K1575*	Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 5|Leber congenital amaurosis 10|Meckel syndrome, type 4|Bardet-Biedl syndrome 14|Senior-Loken syndrome 6|Retinal dystrophy|not specified|not provided|Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Blindness	Pathogenic(Last reviewed: May 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001339	12	88477713	12	88083936	1339	16378	rs137852834	NC_000012.12:88083935:T:A
NM_025114.4(CEP290):c.4705-1G>T	CEP290		Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|not provided|Joubert syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000420091	12	88477732	12	88083955	420091	408765	rs777464278	NC_000012.12:88083954:C:A
NM_025114.4(CEP290):c.4522C>T (p.Arg1508Ter)	CEP290	R1508*	Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|not provided|Leber congenital amaurosis 10|Joubert syndrome 5	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217639	12	88478545	12	88084768	217639	214328	rs749439750	NC_000012.12:88084767:G:A
NM_025114.4(CEP290):c.4393C>T (p.Arg1465Ter)	CEP290	R1465*	Occipital encephalocele|Meckel syndrome, type 4|Meckel syndrome, type 4|Joubert syndrome 5|Bardet-Biedl syndrome 14|Leber congenital amaurosis 10|Senior-Loken syndrome 6|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Leber congenital amaurosis 10|Joubert syndrome 5	Pathogenic(Last reviewed: Nov 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217626	12	88479860	12	88086083	217626	214330	rs539400286	NC_000012.12:88086082:G:A
NM_025114.4(CEP290):c.3904C>T (p.Gln1302Ter)	CEP290	Q1302*	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome 5	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000156385	12	88482934	12	88089157	156385	166166	rs587783016	NC_000012.12:88089156:G:A
NM_025114.4(CEP290):c.3814C>T (p.Arg1272Ter)	CEP290	R1272*	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome 5	Pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000099852	12	88483024	12	88089247	99852	105741	rs62640581	NC_000012.12:88089246:G:A
NM_025114.4(CEP290):c.3811C>T (p.Arg1271Ter)	CEP290	R1271*	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|Bardet-Biedl syndrome 14	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000950504	12	88483027	12	88089250	950504	926758	rs1412133967	NC_000012.12:88089249:G:A
NM_025114.4(CEP290):c.3461+1G>A	CEP290		not provided|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423910	12	88486457	12	88092680	423910	408769	rs766952056	NC_000012.12:88092679:C:T
NM_025114.4(CEP290):c.2991+1655A>G	CEP290		CEP290-Related Disorders|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|Joubert syndrome 5|Senior-Loken syndrome 6|Leber congenital amaurosis 10|Bardet-Biedl syndrome 14|Meckel syndrome, type 4|Retinal dystrophy|not provided|Joubert syndrome 1|Joubert syndrome 5|Leber congenital amaurosis 10|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001337	12	88494960	12	88101183	1337	16376	rs281865192	NC_000012.12:88101182:T:C
NM_025114.4(CEP290):c.2722C>T (p.Arg908Ter)	CEP290	R908*	not provided|CEP290-Related Disorders|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome 1	Pathogenic(Last reviewed: Mar 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000281411	12	88500547	12	88106770	281411	265648	rs886042153	NC_000012.12:88106769:G:A
NM_025114.4(CEP290):c.2668C>T (p.Gln890Ter)	CEP290	Q890*	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Jul 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000290022	12	88500601	12	88106824	290022	274259	rs886044332	NC_000012.12:88106823:G:A
NM_025114.4(CEP290):c.2605C>T (p.Gln869Ter)	CEP290	Q869*	Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Abnormality of prenatal development or birth	Pathogenic(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000843406	12	88500664	12	88106887	843406	840382	rs903257336	NC_000012.12:88106886:G:A
NM_025114.4(CEP290):c.2251C>T (p.Arg751Ter)	CEP290	R751*	Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 5	Pathogenic(Last reviewed: Sep 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000585307	12	88505095	12	88111318	585307	576354	rs753884599	NC_000012.12:88111317:G:A
NM_025114.4(CEP290):c.1984C>T (p.Gln662Ter)	CEP290	Q662*	Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|not provided|Leber congenital amaurosis 10|Joubert syndrome 5	Pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000056733	12	88508265	12	88114488	56733	71372	rs386834152	NC_000012.12:88114487:G:A
NM_025114.4(CEP290):c.1936C>T (p.Gln646Ter)	CEP290	Q646*	Retinal dystrophy|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 5|not provided	Pathogenic(Last reviewed: Nov 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279751	12	88508313	12	88114536	279751	264538	rs780225183	NC_000012.12:88114535:G:A
NM_025114.4(CEP290):c.1915G>T (p.Glu639Ter)	CEP290	E639*	Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000452628	12	88508334	12	88114557	452628	445097	rs1555220625	NC_000012.12:88114556:C:A
NM_025114.4(CEP290):c.1781T>A (p.Leu594Ter)	CEP290	L594*	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not provided	Pathogenic(Last reviewed: Nov 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000236468	12	88510853	12	88117076	236468	238060	rs371496675	NC_000012.12:88117075:A:T
NM_025114.4(CEP290):c.1645C>T (p.Arg549Ter)	CEP290	R549*	not provided|Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000654447	12	88512326	12	88118549	654447	641431	rs760415289	NC_000012.12:88118548:G:A
NM_025114.4(CEP290):c.1623+1G>A	CEP290		Meckel syndrome, type 4|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome 5	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217631	12	88512419	12	88118642	217631	214338	rs863225186	NC_000012.12:88118641:C:T
NM_025114.4(CEP290):c.1606C>T (p.Gln536Ter)	CEP290	Q536*	Joubert syndrome 5|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000635030	12	88512437	12	88118660	635030	622902	rs1465414886	NC_000012.12:88118659:G:A
NM_025114.4(CEP290):c.1429C>T (p.Arg477Ter)	CEP290	R477*	not provided|CEP290-Related Disorders|Meckel-Gruber syndrome|Nephronophthisis|Joubert syndrome|Leber congenital amaurosis 10|Meckel syndrome, type 4|Senior-Loken syndrome 6|Joubert syndrome 5|Bardet-Biedl syndrome 14	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523768	12	88513984	12	88120207	523768	514649	rs1170451277	NC_000012.12:88120206:G:A
NM_025114.4(CEP290):c.1190-2A>G	CEP290		not provided|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000450433	12	88514945	12	88121168	450433	445098	rs200818935	NC_000012.12:88121167:T:C
NM_025114.4(CEP290):c.1189+1G>A	CEP290		Bardet-Biedl syndrome 14|Joubert syndrome 5|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Pathogenic(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000857949	12	88519022	12	88125245	857949	852510	rs2039659434	NC_000012.12:88125244:C:T
NM_025114.4(CEP290):c.1078C>T (p.Arg360Ter)	CEP290	R360*	Joubert syndrome 5|Meckel syndrome, type 4|Leber congenital amaurosis 10|Bardet-Biedl syndrome 14|Senior-Loken syndrome 6|not provided|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Pathogenic(Last reviewed: Nov 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000530911	12	88519134	12	88125357	530911	527675	rs776645403	NC_000012.12:88125356:G:A
NM_025114.4(CEP290):c.1066-1G>A	CEP290		Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Meckel syndrome, type 4|Bardet-Biedl syndrome 14|Senior-Loken syndrome 6|Joubert syndrome 5|Leber congenital amaurosis 10|not specified	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439474	12	88519147	12	88125370	439474	433122	rs965522059	NC_000012.12:88125369:C:T
NM_025114.4(CEP290):c.829G>T (p.Glu277Ter)	CEP290	E277*	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|Leber congenital amaurosis 10	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000813995	12	88523494	12	88129717	813995	802180	rs45502896	NC_000012.12:88129716:C:A
NM_025114.4(CEP290):c.712G>T (p.Glu238Ter)	CEP290	E238*	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV001185813	12	88523611	12	88129834	1185813	1177671		NC_000012.12:88129833:C:A
NM_025114.4(CEP290):c.654T>G (p.Tyr218Ter)	CEP290	Y218*	Joubert syndrome 5|Meckel syndrome, type 4	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217630	12	88524060	12	88130283	217630	214339	rs863225185	NC_000012.12:88130282:A:C
NM_025114.4(CEP290):c.613C>T (p.Arg205Ter)	CEP290	R205*	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|Polycystic kidney disease|Severe hydrocephalus|Encephalocele|Leber congenital amaurosis 10	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001342	12	88524101	12	88130324	1342	16381	rs137852835	NC_000012.12:88130323:G:A
NM_025114.4(CEP290):c.508A>T (p.Lys170Ter)	CEP290	K170*	Nephronophthisis|Joubert syndrome|Meckel-Gruber syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578618	12	88524330	12	88130553	578618	568186	rs772170760	NC_000012.12:88130552:T:A
NM_025114.4(CEP290):c.451C>T (p.Arg151Ter)	CEP290	R151*	not specified|Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372761	12	88524986	12	88131209	372761	360113	rs757641323	NC_000012.12:88131208:G:A
NM_025114.4(CEP290):c.322C>T (p.Arg108Ter)	CEP290	R108*	Night blindness|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Leber congenital amaurosis 10	Pathogenic(Last reviewed: May 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000654881	12	88530539	12	88136762	654881	641434	rs1290241933	NC_000012.12:88136761:G:A
NM_025114.4(CEP290):c.289G>T (p.Glu97Ter)	CEP290	E97*	not provided|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Meckel syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056734	12	88532930	12	88139153	56734	71373	rs386834153	NC_000012.12:88139152:C:A
NM_025114.4(CEP290):c.181-2A>G	CEP290		not provided|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000282257	12	88533343	12	88139566	282257	266494	rs886042359	NC_000012.12:88139565:T:C
NM_025114.4(CEP290):c.180+1G>A	CEP290		Meckel syndrome, type 4|not provided|Retinitis pigmentosa|Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000461777	12	88534732	12	88140955	461777	463360	rs758593134	NC_000012.12:88140954:C:T
NM_025114.4(CEP290):c.21G>T (p.Trp7Cys)	CEP290	W7C	Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome 5	Pathogenic(Last reviewed: Sep 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001335	12	88535064	12	88141287	1335	16374	rs62635288	NC_000012.12:88141286:C:A
NM_025114.4(CEP290):c.2T>A (p.Met1Lys)	CEP290	M1K	not provided|Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000871409	12	88535083	12	88141306	871409	860018	rs368984997	NC_000012.12:88141305:A:T
NM_018082.6(POLR3B):c.1263+2T>C	POLR3B		not provided|Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism|Hypogonadotropic hypogonadism 7 with or without anosmia|Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488794	12	106821138	12	106427360	488794	482006	rs774526181	NC_000012.12:106427359:T:C
NM_018082.5(POLR3B):c.1568T>A	POLR3B	V523E, V465E	Pol III-related leukodystrophy|POLR3-related leukodystrophy|Hypogonadotropic hypogonadism 7 with or without anosmia|Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome|Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism|not specified|not provided|Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism|See cases	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000031166	12	106826199	12	106432421	31166	40123	rs138249161	NC_000012.12:106432420:T:A
NM_018082.6(POLR3B):c.2084-6A>G	POLR3B		not provided|Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism	Pathogenic(Last reviewed: Feb 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000419962	12	106848274	12	106454496	419962	408505	rs747912710	NC_000012.12:106454495:A:G
NM_018082.6(POLR3B):c.2413C>T (p.Arg805Ter)	POLR3B	R747*, R805*	not provided|Pol III-related leukodystrophy	Pathogenic(Last reviewed: Mar 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001069879	12	106851035	12	106457257	1069879	1062569		NC_000012.12:106457256:C:T
NM_018082.6(POLR3B):c.2570+1G>A	POLR3B		Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism|not provided	Pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620581	12	106853147	12	106459369	620581	611987	rs753943393	NC_000012.12:106459368:G:A
NM_001082538.3(TCTN1):c.342-2A>G	TCTN1		Joubert syndrome 13	Pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183312	12	111064165	12	110626360	183312	181433	rs730882221	NC_000012.12:110626359:A:G
NM_001082538.3(TCTN1):c.736A>T (p.Lys246Ter)	TCTN1	K186*, K246*, K68*, K190*	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 13	Pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001410963	12	111072498	12	110634693	1410963	1510400		NC_000012.12:110634692:A:T
NM_024809.5(TCTN2):c.1751T>A (p.Ile584Lys)	TCTN2	I584K, I583K	Joubert syndrome and related disorders|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217698	12	124189217	12	123704670	217698	214320	rs201010803	NC_000012.12:123704669:T:A
NM_001329943.3(KIAA0586):c.1000C>T (p.Gln334Ter)	KIAA0586	Q387*, Q194*, Q249*, Q290*, Q319*, Q334*	not provided|Joubert syndrome 23	Pathogenic(Last reviewed: Jan 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000204595	14	58917335	14	58450617	204595	200985	rs796052128	NC_000014.9:58450616:C:T
NM_001329943.3(KIAA0586):c.1254-1G>C	KIAA0586		Joubert syndrome 23|not provided|Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000204594	14	58923419	14	58456701	204594	200984	rs757350052	NC_000014.9:58456700:G:C
NM_001329943.3(KIAA0586):c.1656G>A (p.Gln552=)	KIAA0586		not provided|Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23	Pathogenic(Last reviewed: Oct 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208813	14	58925263	14	58458545	208813	205374	rs762081862	NC_000014.9:58458544:G:A
NM_001329943.3(KIAA0586):c.2353C>T (p.Arg785Ter)	KIAA0586	R709*, R838*, R770*, R700*, R785*, R645*, R741*	Short-rib thoracic dysplasia 14 with polydactyly|Joubert syndrome 23|not provided	Pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000418265	14	58934551	14	58467833	418265	409140	rs1064793157	NC_000014.9:58467832:C:T
NM_001329943.3(KIAA0586):c.3144G>A (p.Pro1048=)	KIAA0586		Joubert syndrome 23|Joubert syndrome 23|Short-rib thoracic dysplasia 14 with polydactyly	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217667	14	58949430	14	58482712	217667	214347	rs540255320	NC_000014.9:58482711:G:A
NM_198525.3(KIF7):c.3331C>T (p.Arg1111Ter)	KIF7	R1111*	Acrocallosal syndrome	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217670	15	90172792	15	89629561	217670	214348	rs778139192	NC_000015.10:89629560:G:A
NM_198525.3(KIF7):c.3281C>G (p.Ser1094Ter)	KIF7	S1094*	Acrocallosal syndrome|not provided	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451951	15	90173555	15	89630324	451951	445466	rs1555423165	NC_000015.10:89630323:G:C
NM_198525.3(KIF7):c.3001C>T (p.Gln1001Ter)	KIF7	Q1001*	Acrocallosal syndrome	Pathogenic(Last reviewed: Aug 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030897	15	90174836	15	89631605	30897	39854	rs387907045	NC_000015.10:89631604:G:A
NM_198525.3(KIF7):c.2944G>T (p.Glu982Ter)	KIF7	E982*	Acrocallosal syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000208593	15	90174893	15	89631662	208593	205178	rs797045093	NC_000015.10:89631661:C:A
NM_198525.3(KIF7):c.2917C>T (p.Arg973Ter)	KIF7	R973*	Acrocallosal syndrome	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217671	15	90174920	15	89631689	217671	214349	rs202229910	NC_000015.10:89631688:G:A
NM_198525.3(KIF7):c.2593-3C>G	KIF7		Acrocallosal syndrome	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000427889	15	90176500	15	89633269	427889	418968	rs774403667	NC_000015.10:89633268:G:C
NM_198525.3(KIF7):c.434A>C (p.Tyr145Ser)	KIF7	Y145S	Acrocallosal syndrome|Postaxial hand polydactyly|Cerebellar ataxia|Postaxial foot polydactyly|Ventriculomegaly|Spasticity|Nystagmus|Strabismus	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000374124	15	90193067	15	89649836	374124	360982	rs758361736	NC_000015.10:89649835:T:G
NM_198525.3(KIF7):c.328+2T>G	KIF7		not provided|Inborn genetic diseases|Acrocallosal syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520764	15	90195832	15	89652601	520764	512159	rs781752990	NC_000015.10:89652600:A:C
NM_198525.3(KIF7):c.61C>T (p.Arg21Ter)	KIF7	R21*	not provided|Acrocallosal syndrome	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000195441	15	90196101	15	89652870	195441	192602	rs794727316	NC_000015.10:89652869:G:A
NM_000243.3(MEFV):c.2080A>G (p.Met694Val)	MEFV		Deep plantar creases|Central hypotonia|Cryptorchidism|Macrocephaly|Global developmental delay|Abnormal cerebral white matter morphology|Abnormality of the anterior fontanelle|Seizure|Abnormal nonverbal communicative behavior|Microcephaly|Autistic behavior|Abnormal facial shape|Brachydactyly|Generalized hypotonia|Profound global developmental delay|Synophrys|Motor stereotypy|Inborn genetic diseases|Acute febrile neutrophilic dermatosis|Autoinflammatory syndrome|Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant|not provided|Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000002538	16	3293407	16	3243407	2538	17577	rs61752717	NC_000016.10:3243406:T:C
NM_015202.5(KATNIP):c.49C>T (p.Arg17Ter)	KATNIP	R17*	not provided|Joubert syndrome 26	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000828110	16	27585263	16	27573942	828110	816484	rs142375551	NC_000016.10:27573941:C:T
NM_015272.5(RPGRIP1L):c.3529C>T (p.Arg1177Ter)	RPGRIP1L	R1097*, R1177*, R1131*, R1143*	Joubert syndrome 7|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217694	16	53653024	16	53619112	217694	214351	rs778533826	NC_000016.10:53619111:G:A
NM_015272.5(RPGRIP1L):c.2560C>T (p.Arg854Ter)	RPGRIP1L	R854*	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 7	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000931964	16	53679660	16	53645748	931964	919662	rs770291169	NC_000016.10:53645747:G:A
NM_015272.5(RPGRIP1L):c.2451C>G (p.Tyr817Ter)	RPGRIP1L	Y817*	Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620438	16	53679769	16	53645857	620438	611826	rs145807002	NC_000016.10:53645856:G:C
NM_015272.5(RPGRIP1L):c.2413C>T (p.Arg805Ter)	RPGRIP1L	R805*	Joubert syndrome|Meckel-Gruber syndrome|not provided|Joubert syndrome 7	Pathogenic(Last reviewed: Nov 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001079	16	53679807	16	53645895	1079	16118	rs145665129	NC_000016.10:53645894:G:A
NM_015272.5(RPGRIP1L):c.2200C>T (p.Arg734Ter)	RPGRIP1L	R734*	Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic(Last reviewed: Jul 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000421673	16	53682980	16	53649068	421673	409650	rs751128300	NC_000016.10:53649067:G:A
NM_015272.5(RPGRIP1L):c.2125C>T (p.Arg709Ter)	RPGRIP1L	R709*	not provided|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000596520	16	53686474	16	53652562	596520	587581	rs1037406858	NC_000016.10:53652561:G:A
NM_015272.5(RPGRIP1L):c.2050C>T (p.Gln684Ter)	RPGRIP1L	Q684*	Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 7|COACH syndrome 1|Meckel syndrome, type 5|not provided|Abnormality of prenatal development or birth|Joubert syndrome 7	Pathogenic(Last reviewed: Apr 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001076	16	53686549	16	53652637	1076	16115	rs121918204	NC_000016.10:53652636:G:A
NM_015272.5(RPGRIP1L):c.1843A>C (p.Thr615Pro)	RPGRIP1L	T615P	Joubert syndrome|Meckel-Gruber syndrome|not provided|Joubert syndrome 7	Pathogenic(Last reviewed: May 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000001069	16	53686756	16	53652844	1069	16108	rs121918198	NC_000016.10:53652843:T:G
NM_015272.5(RPGRIP1L):c.1804C>T (p.Arg602Ter)	RPGRIP1L	R602*	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000931963	16	53686795	16	53652883	931963	919663	rs745413543	NC_000016.10:53652882:G:A
NM_015272.5(RPGRIP1L):c.1700-1G>A	RPGRIP1L		Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000379927	16	53686900	16	53652988	379927	374412	rs1057520790	NC_000016.10:53652987:C:T
NM_015272.5(RPGRIP1L):c.1489G>T (p.Glu497Ter)	RPGRIP1L	E497*	Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279885	16	53691457	16	53657545	279885	264717	rs756821449	NC_000016.10:53657544:C:A
NM_015272.5(RPGRIP1L):c.1372G>T (p.Glu458Ter)	RPGRIP1L	E458*	not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV001071757	16	53692355	16	53658443	1071757	1063665		NC_000016.10:53658442:C:A
NM_015272.5(RPGRIP1L):c.1243+1G>A	RPGRIP1L		Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 7	Pathogenic(Last reviewed: Aug 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217693	16	53698781	16	53664869	217693	214354	rs863225218	NC_000016.10:53664868:C:T
NM_015272.5(RPGRIP1L):c.751C>T (p.Arg251Ter)	RPGRIP1L	R251*	Joubert syndrome 7|Joubert syndrome and related disorders|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000931822	16	53720370	16	53686458	931822	919664	rs993394322	NC_000016.10:53686457:G:A
NM_015272.5(RPGRIP1L):c.196C>T (p.Gln66Ter)	RPGRIP1L	Q66*	not provided|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome and related disorders	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000640372	16	53730097	16	53696185	640372	644757	rs751444506	NC_000016.10:53696184:G:A
NM_001077418.3(TMEM231):c.664+4A>G	TMEM231		Meckel syndrome, type 11|Joubert syndrome 20|Meckel syndrome, type 11	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437009	16	75576496	16	75542598	437009	429844	rs760426025	NC_000016.10:75542597:T:C
NM_001077418.3(TMEM231):c.625G>A (p.Asp209Asn)	TMEM231	D209N, D262N	Meckel syndrome, type 11|Joubert syndrome 20|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000039822	16	75576539	16	75542641	39822	48421	rs200799769	NC_000016.10:75542640:C:T
NM_001077418.3(TMEM231):c.438+1G>A	TMEM231		Meckel syndrome, type 11|Joubert syndrome 20|Meckel syndrome, type 11	Pathogenic(Last reviewed: Jul 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000437010	16	75579723	16	75545825	437010	429845	rs1415483600	NC_000016.10:75545824:C:T
NM_001077418.3(TMEM231):c.139+47C>A	TMEM231	S83*	Meckel syndrome, type 11|Joubert syndrome 20|Joubert syndrome and related disorders	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000565503	16	75589922	16	75556024	565503	570534	rs200063331	NC_000016.10:75556023:G:T
NM_005360.5(MAF):c.173C>T (p.Thr58Ile)	MAF	T58I	not provided	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000162514	16	79633627	16	79599730	162514	172189	rs727502769	NC_000016.10:79599729:G:A
NM_014804.3(KIAA0753):c.970C>T (p.Arg324Ter)	KIAA0753	R324*, R25*	Orofaciodigital syndrome XV|Jeune thoracic dystrophy|not provided	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428613	17	6526336	17	6623016	428613	420432	rs746068882	NC_000017.11:6623015:G:A
NM_015681.6(B9D1):c.341+2T>C	B9D1		Joubert syndrome 27|Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome, type 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031102	17	19251095	17	19347782	31102	40059	rs143149764	NC_000017.11:19347781:A:G
NM_001042492.3(NF1):c.1A>T (p.Met1Leu)	LOC111811965|NF1	M1L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV001455045	17	29422328	17	31095310	1455045	1441531		NC_000017.11:31095309:A:T
NM_001042492.3(NF1):c.1A>G (p.Met1Val)	LOC111811965|NF1	M1V	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404429	17	29422328	17	31095310	404429	401594	rs1060500252	NC_000017.11:31095309:A:G
NM_001042492.3(NF1):c.2T>A (p.Met1Lys)	LOC111811965|NF1	M1K	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547562	17	29422329	17	31095311	547562	538099	rs886041346	NC_000017.11:31095310:T:A
NM_001042492.3(NF1):c.2T>G (p.Met1Arg)	LOC111811965|NF1	M1R	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000426634	17	29422329	17	31095311	426634	415542	rs886041346	NC_000017.11:31095310:T:G
NM_001042492.3(NF1):c.2T>C (p.Met1Thr)	LOC111811965|NF1	M1T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Oct 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000280054	17	29422329	17	31095311	280054	265013	rs886041346	NC_000017.11:31095310:T:C
NM_001042492.3(NF1):c.3G>A (p.Met1Ile)	LOC111811965|NF1	M1I	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000647845	17	29422330	17	31095312	647845	645433	rs1598173737	NC_000017.11:31095311:G:A
NM_001042492.3(NF1):c.31C>T (p.Gln11Ter)	LOC111811965|NF1	Q11*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Abnormality of the skin	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230597	17	29422358	17	31095340	230597	231989	rs876658658	NC_000017.11:31095339:C:T
NM_001042492.3(NF1):c.55G>T (p.Glu19Ter)	LOC111811965|NF1	E19*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000186896	17	29422382	17	31095364	186896	184496	rs786203307	NC_000017.11:31095363:G:T
NM_001042492.3(NF1):c.58C>T (p.Gln20Ter)	NF1	Q20*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000576465	17	29422385	17	31095367	576465	574343	rs1567786905	NC_000017.11:31095366:C:T
NM_001042492.3(NF1):c.60+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV001216575	17	29422388	17	31095370	1216575	1206555		NC_000017.11:31095369:G:A
NM_001042492.3(NF1):c.60+2T>C	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV001069238	17	29422389	17	31095371	1069238	1063883		NC_000017.11:31095370:T:C
NM_001042492.3(NF1):c.61-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457782	17	29482999	17	31155981	457782	466393	rs1131691100	NC_000017.11:31155980:A:G
NM_001042492.3(NF1):c.79C>T (p.Gln27Ter)	NF1	Q27*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404581	17	29483019	17	31156001	404581	402309	rs1060500363	NC_000017.11:31156000:C:T
NM_001042492.3(NF1):c.82C>T (p.Gln28Ter)	NF1	Q28*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000429015	17	29483022	17	31156004	429015	420761	rs771764281	NC_000017.11:31156003:C:T
NM_001042492.3(NF1):c.128T>C (p.Leu43Pro)	NF1	L43P	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457527	17	29483068	17	31156050	457527	467390	rs1555604899	NC_000017.11:31156049:T:C
NM_001042492.3(NF1):c.204+1G>T	NF1		not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449419	17	29483145	17	31156127	449419	445726	rs886039548	NC_000017.11:31156126:G:T
NM_001042492.3(NF1):c.204+1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000265442	17	29483145	17	31156127	265442	260163	rs886039548	NC_000017.11:31156126:G:A
NM_001042492.3(NF1):c.204+2T>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000650586	17	29483146	17	31156128	650586	653214	rs1597626161	NC_000017.11:31156127:T:G
NM_001042492.3(NF1):c.205-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996426	17	29486026	17	31159008	996426	984087	rs1597629679	NC_000017.11:31159007:A:C
NM_001042492.3(NF1):c.205-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000652752	17	29486026	17	31159008	652752	652701	rs1597629679	NC_000017.11:31159007:A:G
NM_001042492.3(NF1):c.205-1G>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547564	17	29486027	17	31159009	547564	538101	rs1555605362	NC_000017.11:31159008:G:C
NM_001042492.3(NF1):c.236T>G (p.Leu79Ter)	NF1	L79*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000655362	17	29486059	17	31159041	655362	645444	rs1597629765	NC_000017.11:31159040:T:G
NM_001042492.3(NF1):c.247C>T (p.Gln83Ter)	NF1	Q83*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000642883	17	29486070	17	31159052	642883	645447	rs746824139	NC_000017.11:31159051:C:T
NM_001042492.3(NF1):c.248A>C (p.Gln83Pro)	NF1	Q83P	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000641956	17	29486071	17	31159053	641956	645448	rs1060500360	NC_000017.11:31159052:A:C
NM_001042492.3(NF1):c.269T>C (p.Leu90Pro)	NF1	L90P	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000857101	17	29486092	17	31159074	857101	844850	rs1555605393	NC_000017.11:31159073:T:C
NM_001042492.3(NF1):c.279T>G (p.Cys93Trp)	NF1	C93W	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000930967	17	29486102	17	31159084	930967	919718	rs1597629882	NC_000017.11:31159083:T:G
NM_001042492.3(NF1):c.288+1G>T	NF1		not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000571198	17	29486112	17	31159094	571198	568760	rs1567816131	NC_000017.11:31159093:G:T
NM_001042492.3(NF1):c.288+5G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000642764	17	29486116	17	31159098	642764	652705	rs1555605409	NC_000017.11:31159097:G:A
NM_001042492.3(NF1):c.311T>G (p.Leu104Ter)	NF1	L104*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000381605	17	29490226	17	31163208	381605	374910	rs1057521097	NC_000017.11:31163207:T:G
NM_001042492.3(NF1):c.334C>T (p.Gln112Ter)	NF1	Q112*	not specified|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439975	17	29490249	17	31163231	439975	433234	rs1555606061	NC_000017.11:31163230:C:T
NM_001042492.3(NF1):c.412G>C (p.Ala138Pro)	NF1	A138P	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000651033	17	29490327	17	31163309	651033	645456	rs1597635936	NC_000017.11:31163308:G:C
NM_001042492.3(NF1):c.479G>C (p.Arg160Thr)	NF1	R160T	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068353	17	29490394	17	31163376	68353	79244	rs199474752	NC_000017.11:31163375:G:C
NM_001042492.3(NF1):c.479+1G>T	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561965	17	29490395	17	31163377	561965	552878	rs1555606137	NC_000017.11:31163376:G:T
NM_001042492.3(NF1):c.479+1G>A	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457722	17	29490395	17	31163377	457722	466407	rs1555606137	NC_000017.11:31163376:G:A
NM_001042492.3(NF1):c.480-1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000845305	17	29496908	17	31169890	845305	852857	rs2065902916	NC_000017.11:31169889:G:A
NM_001042492.3(NF1):c.484C>T (p.Gln162Ter)	NF1	Q162*	Neurofibromatosis, type 1|not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000481882	17	29496913	17	31169895	481882	478065	rs1555607073	NC_000017.11:31169894:C:T
NM_001042492.3(NF1):c.487G>T (p.Glu163Ter)	NF1	E163*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000977199	17	29496916	17	31169898	977199	965335	rs2065903080	NC_000017.11:31169897:G:T
NM_001042492.3(NF1):c.503C>G (p.Ser168Ter)	NF1	S168*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000430497	17	29496932	17	31169914	430497	422155	rs1131691994	NC_000017.11:31169913:C:G
NM_001042492.3(NF1):c.541C>T (p.Gln181Ter)	NF1	Q181*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Jul 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000492874	17	29496970	17	31169952	492874	485766	rs753529924	NC_000017.11:31169951:C:T
NM_001042492.3(NF1):c.569T>G (p.Leu190Ter)	NF1	L190*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431974	17	29496998	17	31169980	431974	426210	rs1555607112	NC_000017.11:31169979:T:G
NM_001042492.3(NF1):c.574C>T (p.Arg192Ter)	NF1	R192*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|Focal T2 hyperintense basal ganglia lesion|Cafe au lait spots, multiple|Axillary freckling|not provided	Pathogenic(Last reviewed: Sep 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000040093	17	29497003	17	31169985	40093	48599	rs397514641	NC_000017.11:31169984:C:T
NM_001042492.3(NF1):c.586+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547567	17	29497016	17	31169998	547567	538104	rs1555607126	NC_000017.11:31169997:G:A
NM_001042492.3(NF1):c.587-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457770	17	29508438	17	31181420	457770	467538	rs1057518360	NC_000017.11:31181419:A:G
NM_001042492.3(NF1):c.625C>T (p.Gln209Ter)	NF1	Q209*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000187069	17	29508478	17	31181460	187069	184516	rs786203448	NC_000017.11:31181459:C:T
NM_001042492.3(NF1):c.654+1G>A	NF1		not specified|not provided|Neurofibromatosis, type 1|Tibial pseudarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439982	17	29508508	17	31181490	439982	433236	rs1060500245	NC_000017.11:31181489:G:A
NM_001042492.3(NF1):c.654+1G>T	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404420	17	29508508	17	31181490	404420	402340	rs1060500245	NC_000017.11:31181489:G:T
NM_001042492.3(NF1):c.654+2T>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001409345	17	29508509	17	31181491	1409345	1340416		NC_000017.11:31181490:T:A
NM_001042492.3(NF1):c.655-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547569	17	29508726	17	31181708	547569	538106	rs1555608734	NC_000017.11:31181707:A:C
NM_001042492.3(NF1):c.655-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV001075101	17	29508727	17	31181709	1075101	1063897		NC_000017.11:31181708:G:A
NM_001042492.3(NF1):c.667T>C (p.Trp223Arg)	NF1	W223R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547570	17	29508740	17	31181722	547570	538107	rs1555608740	NC_000017.11:31181721:T:C
NM_001042492.3(NF1):c.669G>A (p.Trp223Ter)	NF1	W223*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000372756	17	29508742	17	31181724	372756	360415	rs1057517967	NC_000017.11:31181723:G:A
NM_001042492.3(NF1):c.730+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547571	17	29508804	17	31181786	547571	538108	rs1060500274	NC_000017.11:31181785:G:T
NM_001042492.3(NF1):c.730+1G>A	NF1		not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000503700	17	29508804	17	31181786	503700	495833	rs1060500274	NC_000017.11:31181785:G:A
NM_001042492.3(NF1):c.731-2A>C	NF1		Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000818181	17	29509524	17	31182506	818181	806405	rs1555608924	NC_000017.11:31182505:A:C
NM_001042492.3(NF1):c.731-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000805084	17	29509524	17	31182506	805084	794063	rs1555608924	NC_000017.11:31182505:A:G
NM_001042492.3(NF1):c.731-1G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996510	17	29509525	17	31182507	996510	984092	rs1555608928	NC_000017.11:31182506:G:T
NM_001042492.3(NF1):c.731-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488814	17	29509525	17	31182507	488814	482122	rs1555608928	NC_000017.11:31182506:G:A
NM_001042492.3(NF1):c.739G>T (p.Glu247Ter)	NF1	E247*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV001075677	17	29509534	17	31182516	1075677	1063901		NC_000017.11:31182515:G:T
NM_001042492.3(NF1):c.801G>A (p.Trp267Ter)	NF1	W267*	not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000420075	17	29509596	17	31182578	420075	409860	rs1064794273	NC_000017.11:31182577:G:A
NM_001042492.3(NF1):c.808C>T (p.Gln270Ter)	NF1	Q270*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000664218	17	29509603	17	31182585	664218	645476	rs1555608970	NC_000017.11:31182584:C:T
NM_001042492.3(NF1):c.827T>A (p.Leu276Ter)	NF1	L276*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000915297	17	29509622	17	31182604	915297	903617	rs2066158230	NC_000017.11:31182603:T:A
NM_001042492.3(NF1):c.844C>T (p.Gln282Ter)	NF1	Q282*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000637000	17	29509639	17	31182621	637000	624623	rs753054046	NC_000017.11:31182620:C:T
NM_001042492.3(NF1):c.888+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803340	17	29509684	17	31182666	803340	791693	rs1135402799	NC_000017.11:31182665:G:T
NM_001042492.3(NF1):c.888+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547573	17	29509684	17	31182666	547573	538110	rs1135402799	NC_000017.11:31182665:G:A
NM_001042492.3(NF1):c.888+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431573	17	29509684	17	31182666	431573	425078	rs1135402799	NC_000017.11:31182665:G:C
NM_001042492.3(NF1):c.889-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431574	17	29527439	17	31200421	431574	425079	rs587781517	NC_000017.11:31200420:G:A
NM_001042492.3(NF1):c.910C>T (p.Arg304Ter)	NF1	R304*	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|not provided	Pathogenic(Last reviewed: Aug 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000187722	17	29527461	17	31200443	187722	184531	rs786203950	NC_000017.11:31200442:C:T
NM_001042492.3(NF1):c.943C>T (p.Gln315Ter)	NF1	Q315*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547574	17	29527494	17	31200476	547574	538111	rs766011053	NC_000017.11:31200475:C:T
NM_001042492.3(NF1):c.972T>A (p.Cys324Ter)	NF1	C324*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000662589	17	29527523	17	31200505	662589	645484	rs1597680938	NC_000017.11:31200504:T:A
NM_001042492.3(NF1):c.989C>T (p.Ala330Val)	NF1	A330V	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547578	17	29527540	17	31200522	547578	538115	rs1555610898	NC_000017.11:31200521:C:T
NM_001042492.3(NF1):c.999C>A (p.Tyr333Ter)	NF1	Y333*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996500	17	29527550	17	31200532	996500	984098	rs1466912192	NC_000017.11:31200531:C:A
NM_001042492.3(NF1):c.1008G>A (p.Trp336Ter)	NF1	W336*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001207499	17	29527559	17	31200541	1207499	1198918		NC_000017.11:31200540:G:A
NM_001042492.3(NF1):c.1039C>T (p.Gln347Ter)	NF1	Q347*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431975	17	29527590	17	31200572	431975	426212	rs1555610910	NC_000017.11:31200571:C:T
NM_001042492.3(NF1):c.1062G>T (p.Lys354Asn)	NF1	K354N	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV001511188	17	29527613	17	31200595	1511188	1378003		NC_000017.11:31200594:G:T
NM_001042492.3(NF1):c.1062G>A (p.Lys354=)	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428998	17	29527613	17	31200595	428998	420767	rs1131691118	NC_000017.11:31200594:G:A
NM_001042492.3(NF1):c.1062+2T>C	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000956905	17	29527615	17	31200597	956905	960196	rs2066510391	NC_000017.11:31200596:T:C
NM_001042492.3(NF1):c.1062+3A>G	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000381606	17	29527616	17	31200598	381606	378108	rs1057521098	NC_000017.11:31200597:A:G
NM_001042492.3(NF1):c.1063-2A>G	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404575	17	29528053	17	31201035	404575	401633	rs1060500358	NC_000017.11:31201034:A:G
NM_001042492.3(NF1):c.1063-1G>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547580	17	29528054	17	31201036	547580	538117	rs1555610955	NC_000017.11:31201035:G:C
NM_001042492.3(NF1):c.1094C>G (p.Ser365Ter)	NF1	S365*	Neurofibromatosis, type 1|not provided|not specified	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439995	17	29528086	17	31201068	439995	433241	rs864622107	NC_000017.11:31201067:C:G
NM_001042492.3(NF1):c.1139T>C (p.Leu380Pro)	NF1	L380P	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457516	17	29528131	17	31201113	457516	467415	rs1555611004	NC_000017.11:31201112:T:C
NM_001042492.3(NF1):c.1174C>T (p.Gln392Ter)	NF1	Q392*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000640314	17	29528166	17	31201148	640314	645495	rs1597682137	NC_000017.11:31201147:C:T
NM_001042492.3(NF1):c.1185+1G>T	NF1		Neurofibromatosis, type 1|Abnormality of the skin	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000962619	17	29528178	17	31201160	962619	960197	rs864622161	NC_000017.11:31201159:G:T
NM_001042492.3(NF1):c.1185+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000219572	17	29528178	17	31201160	219572	222572	rs864622161	NC_000017.11:31201159:G:A
NM_001042492.3(NF1):c.1185+2T>G	NF1		Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439976	17	29528179	17	31201161	439976	433243	rs1555611043	NC_000017.11:31201160:T:G
NM_001042492.3(NF1):c.1186-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001173030	17	29528427	17	31201409	1173030	1162225		NC_000017.11:31201408:A:G
NM_001042492.3(NF1):c.1186-1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803341	17	29528428	17	31201410	803341	791694	rs876660782	NC_000017.11:31201409:G:A
NM_001042492.3(NF1):c.1198C>T (p.Gln400Ter)	NF1	Q400*	not provided|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000818183	17	29528441	17	31201423	818183	806389	rs1597682751	NC_000017.11:31201422:C:T
NM_001042492.3(NF1):c.1238C>G (p.Ser413Ter)	NF1	S413*	not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000570504	17	29528481	17	31201463	570504	574368	rs1241533665	NC_000017.11:31201462:C:G
NM_001042492.3(NF1):c.1246C>T (p.Arg416Ter)	NF1	R416*	not provided|not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404597	17	29528489	17	31201471	404597	402141	rs764079291	NC_000017.11:31201470:C:T
NM_001042492.3(NF1):c.1260+1G>C	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000848717	17	29528504	17	31201486	848717	852699	rs267606603	NC_000017.11:31201485:G:C
NM_001042492.3(NF1):c.1260+1G>T	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000570670	17	29528504	17	31201486	570670	570960	rs267606603	NC_000017.11:31201485:G:T
NM_001042492.3(NF1):c.1260+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000356	17	29528504	17	31201486	356	15395	rs267606603	NC_000017.11:31201485:G:A
NM_001042492.3(NF1):c.1260+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000836228	17	29528505	17	31201487	836228	852700	rs1555611110	NC_000017.11:31201486:T:C
NM_001042492.3(NF1):c.1260+2T>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527471	17	29528505	17	31201487	527471	530702	rs1555611110	NC_000017.11:31201486:T:G
NM_001042492.3(NF1):c.1260+1604A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428941	17	29530107	17	31203089	428941	420770	rs1131691067	NC_000017.11:31203088:A:G
NM_001042492.3(NF1):c.1261-19G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816753	17	29533239	17	31206221	816753	804935	rs1597688663	NC_000017.11:31206220:G:A
NM_001042492.3(NF1):c.1261-2A>G	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000855635	17	29533256	17	31206238	855635	851699	rs2066618684	NC_000017.11:31206237:A:G
NM_001042492.3(NF1):c.1261-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV001073144	17	29533257	17	31206239	1073144	1063916		NC_000017.11:31206238:G:A
NM_001042492.3(NF1):c.1299T>G (p.Tyr433Ter)	NF1	Y433*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404617	17	29533296	17	31206278	404617	402352	rs876660099	NC_000017.11:31206277:T:G
NM_001042492.3(NF1):c.1318C>T (p.Arg440Ter)	NF1	R440*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Abnormality of the skin	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230673	17	29533315	17	31206297	230673	235548	rs778405030	NC_000017.11:31206296:C:T
NM_001042492.3(NF1):c.1381C>T (p.Arg461Ter)	NF1	R461*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237514	17	29533378	17	31206360	237514	242637	rs878853865	NC_000017.11:31206359:C:T
NM_001042492.3(NF1):c.1392+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000585289	17	29533390	17	31206372	585289	576342	rs267604791	NC_000017.11:31206371:G:C
NM_001042492.3(NF1):c.1392+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000080403	17	29533390	17	31206372	80403	91294	rs267604791	NC_000017.11:31206371:G:A
NM_001042492.3(NF1):c.1393-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000492877	17	29541467	17	31214449	492877	485768	rs1555612266	NC_000017.11:31214448:A:G
NM_001042492.3(NF1):c.1408G>T (p.Glu470Ter)	NF1	E470*	RASopathy|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000819135	17	29541484	17	31214466	819135	813143	rs1597698330	NC_000017.11:31214465:G:T
NM_001042492.3(NF1):c.1453G>T (p.Glu485Ter)	NF1	E485*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000429817	17	29541529	17	31214511	429817	422157	rs1131691610	NC_000017.11:31214510:G:T
NM_001042492.3(NF1):c.1466A>G (p.Tyr489Cys)	NF1	Y489C	Neurofibromatosis, type 1|Tibial pseudarthrosis|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Abnormality of the skin	Pathogenic(Last reviewed: Apr 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000354	17	29541542	17	31214524	354	15393	rs137854557	NC_000017.11:31214523:A:G
NM_001042492.3(NF1):c.1527+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000503701	17	29541604	17	31214586	503701	495835	rs1060500331	NC_000017.11:31214585:G:A
NM_001042492.3(NF1):c.1527+1G>T	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404540	17	29541604	17	31214586	404540	402162	rs1060500331	NC_000017.11:31214585:G:T
NM_001042492.3(NF1):c.1527+1159C>T	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237518	17	29542762	17	31215744	237518	242640	rs878853868	NC_000017.11:31215743:C:T
NM_001042492.3(NF1):c.1540C>T (p.Gln514Ter)	NF1	Q514*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547594	17	29546035	17	31219017	547594	538131	rs1316926587	NC_000017.11:31219016:C:T
NM_001042492.3(NF1):c.1591C>T (p.Gln531Ter)	NF1	Q531*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373005	17	29546086	17	31219068	373005	360229	rs1057518134	NC_000017.11:31219067:C:T
NM_001042492.3(NF1):c.1595T>G (p.Leu532Arg)	NF1	L532R	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237521	17	29546090	17	31219072	237521	242642	rs199474737	NC_000017.11:31219071:T:G
NM_001042492.3(NF1):c.1603C>T (p.Gln535Ter)	NF1	Q535*	Neurofibromatosis, type 1|Tibial pseudarthrosis|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Sep 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000571976	17	29546098	17	31219080	571976	574378	rs1567843917	NC_000017.11:31219079:C:T
NM_001042492.3(NF1):c.1607C>G (p.Ser536Ter)	NF1	S536*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547597	17	29546102	17	31219084	547597	538134	rs1555612859	NC_000017.11:31219083:C:G
NM_001042492.3(NF1):c.1607C>A (p.Ser536Ter)	NF1	S536*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547596	17	29546102	17	31219084	547596	538133	rs1555612859	NC_000017.11:31219083:C:A
NM_001042492.3(NF1):c.1627C>T (p.Gln543Ter)	NF1	Q543*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000485943	17	29546122	17	31219104	485943	478042	rs894292181	NC_000017.11:31219103:C:T
NM_001042492.3(NF1):c.1641+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996419	17	29546137	17	31219119	996419	984109	rs1555612866	NC_000017.11:31219118:G:C
NM_001042492.3(NF1):c.1642-8A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000352	17	29548860	17	31221842	352	15391	rs267606602	NC_000017.11:31221841:A:G
NM_001042492.3(NF1):c.1642-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547599	17	29548867	17	31221849	547599	538136	rs1555613185	NC_000017.11:31221848:G:A
NM_001042492.3(NF1):c.1646T>C (p.Leu549Pro)	NF1	L549P	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068303	17	29548872	17	31221854	68303	79194	rs199474758	NC_000017.11:31221853:T:C
NM_001042492.3(NF1):c.1658A>C (p.His553Pro)	NF1	H553P	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV001454369	17	29548884	17	31221866	1454369	1366974		NC_000017.11:31221865:A:C
NM_001042492.3(NF1):c.1658A>G (p.His553Arg)	NF1	H553R	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000420076	17	29548884	17	31221866	420076	409863	rs1064794274	NC_000017.11:31221865:A:G
NM_001042492.3(NF1):c.1660C>T (p.Gln554Ter)	NF1	Q554*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547601	17	29548886	17	31221868	547601	538138	rs953440640	NC_000017.11:31221867:C:T
NM_001042492.3(NF1):c.1713G>A (p.Trp571Ter)	NF1	W571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216061	17	29548939	17	31221921	216061	213253	rs863224489	NC_000017.11:31221920:G:A
NM_001042492.3(NF1):c.1721G>A (p.Ser574Asn)	NF1	S574N, R574K	Neurofibromatosis, type 1|not provided|Cafe au lait spots, multiple|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431976	17	29548947	17	31221929	431976	426213	rs1555613206	NC_000017.11:31221928:G:A
NM_001042492.3(NF1):c.1721+1G>C	NF1	R574S	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000586169	17	29548948	17	31221930	586169	577622	rs1131691096	NC_000017.11:31221929:G:C
NM_001042492.3(NF1):c.1721+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457545	17	29548948	17	31221930	457545	467579	rs1131691096	NC_000017.11:31221929:G:A
NM_001042492.3(NF1):c.1721+1G>T	NF1	R574S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428975	17	29548948	17	31221930	428975	420775	rs1131691096	NC_000017.11:31221929:G:T
NM_001042492.3(NF1):c.1721+3A>G	NF1	Y575C	Neurofibromatosis, type 1|Cafe au lait spots, multiple|Neurofibroma|Optic nerve glioma|Cafe au lait spots, multiple|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000374108	17	29548950	17	31221932	374108	361009	rs1057518904	NC_000017.11:31221931:A:G
NM_001042492.3(NF1):c.1722-11T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000873035	17	29550451	17	31223433	873035	861165	rs2066961306	NC_000017.11:31223432:T:G
NM_001042492.3(NF1):c.1722-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000430965	17	29550460	17	31223442	430965	424506	rs763983337	NC_000017.11:31223441:A:G
NM_001042492.3(NF1):c.1722-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561743	17	29550461	17	31223443	561743	552914	rs1567845818	NC_000017.11:31223442:G:A
NM_001042492.3(NF1):c.1724C>G (p.Ser575Ter)	NF1	S575*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000568718	17	29550464	17	31223446	568718	570898	rs915463951	NC_000017.11:31223445:C:G
NM_001042492.3(NF1):c.1726C>T (p.Gln576Ter)	NF1	Q576*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404467	17	29550466	17	31223448	404467	401648	rs1060500278	NC_000017.11:31223447:C:T
NM_001042492.3(NF1):c.1748A>G (p.Lys583Arg)	NF1	K583R	not provided|Neurofibromatosis, type 1|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068306	17	29550488	17	31223470	68306	79197	rs199474760	NC_000017.11:31223469:A:G
NM_001042492.3(NF1):c.1754T>G (p.Leu585Ter)	NF1	L585*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561952	17	29550494	17	31223476	561952	552915	rs775670722	NC_000017.11:31223475:T:G
NM_001042492.3(NF1):c.1765C>T (p.Gln589Ter)	NF1	Q589*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000573696	17	29550505	17	31223487	573696	568805	rs1282299543	NC_000017.11:31223486:C:T
NM_001042492.3(NF1):c.1796G>A (p.Trp599Ter)	NF1	W599*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000429013	17	29550536	17	31223518	429013	420776	rs1131691130	NC_000017.11:31223517:G:A
NM_001042492.3(NF1):c.1797G>A (p.Trp599Ter)	NF1	W599*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000580246	17	29550537	17	31223519	580246	568806	rs1567845906	NC_000017.11:31223518:G:A
NM_001042492.3(NF1):c.1818C>A (p.Cys606Ter)	NF1	C606*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000572601	17	29550558	17	31223540	572601	570899	rs1567845937	NC_000017.11:31223539:C:A
NM_001042492.3(NF1):c.1845G>A (p.Lys615=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000578879	17	29550585	17	31223567	578879	570901	rs1131691080	NC_000017.11:31223566:G:A
NM_001042492.3(NF1):c.1845+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000579615	17	29550586	17	31223568	579615	568808	rs1567845945	NC_000017.11:31223567:G:A
NM_001042492.3(NF1):c.1884C>A (p.Tyr628Ter)	NF1	Y628*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457554	17	29552151	17	31225133	457554	467287	rs555635097	NC_000017.11:31225132:C:A
NM_001042492.3(NF1):c.1885G>A (p.Gly629Arg)	NF1	G629R	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudarthrosis|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068308	17	29552152	17	31225134	68308	79199	rs199474738	NC_000017.11:31225133:G:A
NM_001042492.3(NF1):c.1912G>T (p.Gly638Ter)	NF1	G638*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527439	17	29552179	17	31225161	527439	531214	rs1555613567	NC_000017.11:31225160:G:T
NM_001042492.3(NF1):c.1924C>T (p.Gln642Ter)	NF1	Q642*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000952282	17	29552191	17	31225173	952282	928118	rs2066991605	NC_000017.11:31225172:C:T
NM_001042492.3(NF1):c.2002-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488815	17	29553452	17	31226434	488815	482123	rs1555613743	NC_000017.11:31226433:G:A
NM_001042492.3(NF1):c.2041C>T (p.Arg681Ter)	NF1	R681*	Neurofibromatosis-Noonan syndrome|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Cafe-au-lait spot|Axillary freckling|Optic nerve glioma|not specified	Pathogenic(Last reviewed: Jun 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000188280	17	29553492	17	31226474	188280	186247	rs768638173	NC_000017.11:31226473:C:T
NM_001042492.3(NF1):c.2044C>T (p.Gln682Ter)	NF1	Q682*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000818186	17	29553495	17	31226477	818186	806392	rs1597712392	NC_000017.11:31226476:C:T
NM_001042492.3(NF1):c.2084T>C (p.Leu695Pro)	NF1	L695P	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068309	17	29553535	17	31226517	68309	79200	rs199474761	NC_000017.11:31226516:T:C
NM_001042492.3(NF1):c.2125T>C (p.Cys709Arg)	NF1	C709R	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428974	17	29553576	17	31226558	428974	420783	rs1131691095	NC_000017.11:31226557:T:C
NM_001042492.3(NF1):c.2163T>A (p.Cys721Ter)	NF1	C721*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488882	17	29553614	17	31226596	488882	482124	rs1555613816	NC_000017.11:31226595:T:A
NM_001042492.3(NF1):c.2246C>G (p.Ser749Ter)	NF1	S749*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV001354203	17	29553697	17	31226679	1354203	1341321		NC_000017.11:31226678:C:G
NM_001042492.3(NF1):c.2251G>C (p.Gly751Arg)	NF1	G751R	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000584927	17	29553702	17	31226684	584927	575976	rs1567847681	NC_000017.11:31226683:G:C
NM_001042492.3(NF1):c.2251+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527548	17	29553703	17	31226685	527548	531223	rs1555613843	NC_000017.11:31226684:G:C
NM_001042492.3(NF1):c.2251+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000492878	17	29553703	17	31226685	492878	485770	rs1555613843	NC_000017.11:31226684:G:A
NM_001042492.3(NF1):c.2251+2T>G	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000219531	17	29553704	17	31226686	219531	222580	rs864622142	NC_000017.11:31226685:T:G
NM_001042492.3(NF1):c.2252-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428984	17	29554234	17	31227216	428984	420784	rs1131691105	NC_000017.11:31227215:A:G
NM_001042492.3(NF1):c.2252-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457575	17	29554235	17	31227217	457575	467605	rs587781577	NC_000017.11:31227216:G:A
NM_001042492.3(NF1):c.2252-1G>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000141209	17	29554235	17	31227217	141209	150923	rs587781577	NC_000017.11:31227216:G:C
NM_001042492.3(NF1):c.2266C>T (p.Gln756Ter)	NF1	Q756*	Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000576444	17	29554250	17	31227232	576444	570918	rs1567847905	NC_000017.11:31227231:C:T
NM_001042492.3(NF1):c.2288T>G (p.Leu763Arg)	NF1	L763R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216396	17	29554272	17	31227254	216396	213257	rs199474762	NC_000017.11:31227253:T:G
NM_001042492.3(NF1):c.2288T>C (p.Leu763Pro)	NF1	L763P	Hereditary cancer-predisposing syndrome|not specified|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068312	17	29554272	17	31227254	68312	79203	rs199474762	NC_000017.11:31227253:T:C
NM_001042492.3(NF1):c.2325G>C (p.Glu775Asp)	NF1	E775D	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000937015	17	29554309	17	31227291	937015	937784	rs1555613932	NC_000017.11:31227290:G:C
NM_001042492.3(NF1):c.2325+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000575838	17	29554310	17	31227292	575838	574384	rs1555613933	NC_000017.11:31227291:G:T
NM_001042492.3(NF1):c.2325+1G>A	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not specified	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000546100	17	29554310	17	31227292	546100	536933	rs1555613933	NC_000017.11:31227291:G:A
NM_001042492.3(NF1):c.2325+2T>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561504	17	29554311	17	31227293	561504	552923	rs1567847972	NC_000017.11:31227292:T:C
NM_001042492.3(NF1):c.2325+3A>G	NF1		not provided|Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000372550	17	29554312	17	31227294	372550	360327	rs1057517848	NC_000017.11:31227293:A:G
NM_001042492.3(NF1):c.2326-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816728	17	29554535	17	31227517	816728	804945	rs1597713670	NC_000017.11:31227516:T:G
NM_001042492.3(NF1):c.2326-2A>G	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000480183	17	29554539	17	31227521	480183	478174	rs1555613975	NC_000017.11:31227520:A:G
NM_001042492.3(NF1):c.2329T>C (p.Trp777Arg)	NF1	W777R	not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000652361	17	29554544	17	31227526	652361	645541	rs876658853	NC_000017.11:31227525:T:C
NM_001042492.3(NF1):c.2329T>A (p.Trp777Arg)	NF1	W777R	not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230937	17	29554544	17	31227526	230937	235592	rs876658853	NC_000017.11:31227525:T:A
NM_001042492.3(NF1):c.2330G>C (p.Trp777Ser)	NF1	W777S	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudarthrosis	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068315	17	29554545	17	31227527	68315	79206	rs199474745	NC_000017.11:31227526:G:C
NM_001042492.3(NF1):c.2331G>A (p.Trp777Ter)	NF1	W777*	not specified|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439992	17	29554546	17	31227528	439992	433247	rs1555613983	NC_000017.11:31227527:G:A
NM_001042492.3(NF1):c.2339C>G (p.Thr780Arg)	NF1	T780R	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457581	17	29554554	17	31227536	457581	467330	rs199474746	NC_000017.11:31227535:C:G
NM_001042492.3(NF1):c.2339C>A (p.Thr780Lys)	NF1	T780K	not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068316	17	29554554	17	31227536	68316	79207	rs199474746	NC_000017.11:31227535:C:A
NM_001042492.3(NF1):c.2350T>C (p.Trp784Arg)	NF1	W784R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068318	17	29554565	17	31227547	68318	79209	rs199474730	NC_000017.11:31227546:T:C
NM_001042492.3(NF1):c.2352G>C (p.Trp784Cys)	NF1	W784C	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068319	17	29554567	17	31227549	68319	79210	rs199474778	NC_000017.11:31227548:G:C
NM_001042492.3(NF1):c.2356C>T (p.Gln786Ter)	NF1	Q786*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547610	17	29554571	17	31227553	547610	538147	rs1555613999	NC_000017.11:31227552:C:T
NM_001042492.3(NF1):c.2407C>T (p.Gln803Ter)	NF1	Q803*	Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000565792	17	29554622	17	31227604	565792	574387	rs1567848213	NC_000017.11:31227603:C:T
NM_001042492.3(NF1):c.2409+1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000648121	17	29554625	17	31227607	648121	653416	rs1555614022	NC_000017.11:31227606:G:A
NM_001042492.3(NF1):c.2409+1G>C	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000484037	17	29554625	17	31227607	484037	478205	rs1555614022	NC_000017.11:31227606:G:C
NM_001042492.3(NF1):c.2409+1G>T	NF1		not provided|Neurofibromatosis|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449423	17	29554625	17	31227607	449423	445735	rs1555614022	NC_000017.11:31227606:G:T
NM_001042492.3(NF1):c.2409+2T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000234062	17	29554626	17	31227608	234062	235595	rs876660826	NC_000017.11:31227607:T:G
NM_001042492.3(NF1):c.2410-16A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000572474	17	29556027	17	31229009	572474	571021	rs1567848704	NC_000017.11:31229008:A:G
NM_001042492.3(NF1):c.2410-13A>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000804167	17	29556030	17	31229012	804167	792537	rs1567848711	NC_000017.11:31229011:A:G
NM_001042492.3(NF1):c.2410-1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373947	17	29556042	17	31229024	373947	361011	rs1057518792	NC_000017.11:31229023:G:A
NM_001042492.3(NF1):c.2440A>T (p.Lys814Ter)	NF1	K814*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV001352720	17	29556073	17	31229055	1352720	1505928		NC_000017.11:31229054:A:T
NM_001042492.3(NF1):c.2446C>T (p.Arg816Ter)	NF1	R816*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Cafe au lait spots, multiple|Inguinal freckling|Axillary freckling|Large cafe-au-lait macules with irregular margins|Lisch nodules|Delayed fine motor development|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000280055	17	29556079	17	31229061	280055	264844	rs886041347	NC_000017.11:31229060:C:T
NM_001042492.3(NF1):c.2503C>T (p.Gln835Ter)	NF1	Q835*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000523904	17	29556136	17	31229118	523904	514712	rs1555614207	NC_000017.11:31229117:C:T
NM_001042492.3(NF1):c.2506G>T (p.Glu836Ter)	NF1	E836*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000931332	17	29556139	17	31229121	931332	919720	rs2067066435	NC_000017.11:31229120:G:T
NM_001042492.3(NF1):c.2510G>A (p.Trp837Ter)	NF1	W837*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561498	17	29556143	17	31229125	561498	552926	rs1348129244	NC_000017.11:31229124:G:A
NM_001042492.3(NF1):c.2511G>A (p.Trp837Ter)	NF1	W837*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000492879	17	29556144	17	31229126	492879	485771	rs1555614211	NC_000017.11:31229125:G:A
NM_001042492.3(NF1):c.2530C>T (p.Leu844Phe)	NF1	L844F	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068321	17	29556163	17	31229145	68321	79212	rs199474785	NC_000017.11:31229144:C:T
NM_001042492.3(NF1):c.2531T>C (p.Leu844Pro)	NF1	L844P	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068322	17	29556164	17	31229146	68322	79213	rs137854566	NC_000017.11:31229145:T:C
NM_001042492.3(NF1):c.2531T>G (p.Leu844Arg)	NF1	L844R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000373	17	29556164	17	31229146	373	15412	rs137854566	NC_000017.11:31229145:T:G
NM_001042492.3(NF1):c.2533T>C (p.Cys845Arg)	NF1	C845R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404431	17	29556166	17	31229148	404431	401687	rs1060500254	NC_000017.11:31229147:T:C
NM_001042492.3(NF1):c.2534G>A (p.Cys845Tyr)	NF1	C845Y	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404587	17	29556167	17	31229149	404587	401689	rs1060500367	NC_000017.11:31229148:G:A
NM_001042492.3(NF1):c.2537C>A (p.Ala846Asp)	NF1	A846D	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457588	17	29556170	17	31229152	457588	467630	rs1555614229	NC_000017.11:31229151:C:A
NM_001042492.3(NF1):c.2540T>G (p.Leu847Arg)	NF1	L847R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000573019	17	29556173	17	31229155	573019	571033	rs199474747	NC_000017.11:31229154:T:G
NM_001042492.3(NF1):c.2540T>C (p.Leu847Pro)	NF1	L847P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068323	17	29556173	17	31229155	68323	79214	rs199474747	NC_000017.11:31229154:T:C
NM_001042492.3(NF1):c.2542G>A (p.Gly848Arg)	NF1	G848R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000640216	17	29556175	17	31229157	640216	645548	rs1060500368	NC_000017.11:31229156:G:A
NM_001042492.3(NF1):c.2542G>C (p.Gly848Arg)	NF1	G848R	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404588	17	29556175	17	31229157	404588	402419	rs1060500368	NC_000017.11:31229156:G:C
NM_001042492.3(NF1):c.2543G>A (p.Gly848Glu)	NF1	G848E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068324	17	29556176	17	31229158	68324	79215	rs199474748	NC_000017.11:31229157:G:A
NM_001042492.3(NF1):c.2553C>A (p.Cys851Ter)	NF1	C851*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000811157	17	29556186	17	31229168	811157	800013	rs2230852	NC_000017.11:31229167:C:A
NM_001042492.3(NF1):c.2557C>T (p.Gln853Ter)	NF1	Q853*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001318665	17	29556190	17	31229172	1318665	1307177		NC_000017.11:31229171:C:T
NM_001042492.3(NF1):c.2560C>T (p.Gln854Ter)	NF1	Q854*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547612	17	29556193	17	31229175	547612	538149	rs1555614261	NC_000017.11:31229174:C:T
NM_001042492.3(NF1):c.2650G>T (p.Glu884Ter)	NF1	E884*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV001710067	17	29556283	17	31229265	1710067	1708420		NC_000017.11:31229264:G:T
NM_001042492.3(NF1):c.2693T>C (p.Leu898Pro)	NF1	L898P	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068326	17	29556326	17	31229308	68326	79217	rs199474786	NC_000017.11:31229307:T:C
NM_001042492.3(NF1):c.2709G>A (p.Val903=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373958	17	29556342	17	31229324	373958	361012	rs771820789	NC_000017.11:31229323:G:A
NM_001042492.3(NF1):c.2734C>T (p.Gln912Ter)	NF1	Q912*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000654419	17	29556367	17	31229349	654419	645552	rs1597715673	NC_000017.11:31229348:C:T
NM_001042492.3(NF1):c.2764G>A (p.Gly922Ser)	NF1	G922S	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431608	17	29556397	17	31229379	431608	425113	rs1135402831	NC_000017.11:31229378:G:A
NM_001042492.3(NF1):c.2827A>T (p.Lys943Ter)	NF1	K943*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000585292	17	29556460	17	31229442	585292	576343	rs1567849199	NC_000017.11:31229441:A:T
NM_001042492.3(NF1):c.2842C>T (p.Gln948Ter)	NF1	Q948*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000618249	17	29556475	17	31229457	618249	610075	rs1567849237	NC_000017.11:31229456:C:T
NM_001042492.3(NF1):c.2848C>T (p.Gln950Ter)	NF1	Q950*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404574	17	29556481	17	31229463	404574	402194	rs1060500357	NC_000017.11:31229462:C:T
NM_001042492.3(NF1):c.2850G>A (p.Gln950=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561684	17	29556483	17	31229465	561684	552930	rs863224446	NC_000017.11:31229464:G:A
NM_001042492.3(NF1):c.2850+1G>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547617	17	29556484	17	31229466	547617	538154	rs1131691122	NC_000017.11:31229465:G:A
NM_001042492.3(NF1):c.2850+1G>T	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000429002	17	29556484	17	31229466	429002	420790	rs1131691122	NC_000017.11:31229465:G:T
NM_001042492.3(NF1):c.2887C>T (p.Gln963Ter)	NF1	Q963*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000233495	17	29556889	17	31229871	233495	235619	rs876660444	NC_000017.11:31229870:C:T
NM_001042492.3(NF1):c.2953C>T (p.Gln985Ter)	NF1	Q985*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457608	17	29556955	17	31229937	457608	467482	rs1555614455	NC_000017.11:31229936:C:T
NM_001042492.3(NF1):c.2978T>G (p.Leu993Ter)	NF1	L993*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000493211	17	29556980	17	31229962	493211	486174	rs1555614460	NC_000017.11:31229961:T:G
NM_001042492.3(NF1):c.2990G>A (p.Arg997Lys)	NF1	R997K	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000654334	17	29556992	17	31229974	654334	645562	rs1555614462	NC_000017.11:31229973:G:A
NM_001042492.3(NF1):c.2990+1G>C	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996434	17	29556993	17	31229975	996434	984132	rs1135402836	NC_000017.11:31229974:G:C
NM_001042492.3(NF1):c.2990+1G>A	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431613	17	29556993	17	31229975	431613	425118	rs1135402836	NC_000017.11:31229974:G:A
NM_001042492.3(NF1):c.2990+5G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527465	17	29556997	17	31229979	527465	530771	rs1555614464	NC_000017.11:31229978:G:A
NM_001042492.3(NF1):c.2991-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000987118	17	29557276	17	31230258	987118	975470	rs1555614495	NC_000017.11:31230257:A:G
NM_001042492.3(NF1):c.2991-2A>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547620	17	29557276	17	31230258	547620	538157	rs1555614495	NC_000017.11:31230257:A:C
NM_001042492.3(NF1):c.2991-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404458	17	29557277	17	31230259	404458	401699	rs1060500273	NC_000017.11:31230258:G:A
NM_001042492.3(NF1):c.3028C>T (p.Gln1010Ter)	NF1	Q1010*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001069645	17	29557315	17	31230297	1069645	1063975		NC_000017.11:31230296:C:T
NM_001042492.3(NF1):c.3046T>C (p.Cys1016Arg)	NF1	C1016R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237543	17	29557333	17	31230315	237543	242663	rs878853880	NC_000017.11:31230314:T:C
NM_001042492.3(NF1):c.3049C>T (p.Gln1017Ter)	NF1	Q1017*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000935938	17	29557336	17	31230318	935938	937799	rs2067091604	NC_000017.11:31230317:C:T
NM_001042492.3(NF1):c.3058G>T (p.Glu1020Ter)	NF1	E1020*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000839592	17	29557345	17	31230327	839592	844974	rs2067091885	NC_000017.11:31230326:G:T
NM_001042492.3(NF1):c.3076A>T (p.Arg1026Ter)	NF1	R1026*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439974	17	29557363	17	31230345	439974	433248	rs1555614529	NC_000017.11:31230344:A:T
NM_001042492.3(NF1):c.3089C>G (p.Ser1030Ter)	NF1	S1030*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580002	17	29557376	17	31230358	580002	574399	rs1567849864	NC_000017.11:31230357:C:G
NM_001042492.3(NF1):c.3097C>T (p.Gln1033Ter)	NF1	Q1033*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428983	17	29557384	17	31230366	428983	420792	rs1131691104	NC_000017.11:31230365:C:T
NM_001042492.3(NF1):c.3113+1G>C	NF1		not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000976156	17	29557401	17	31230383	976156	964689	rs267606599	NC_000017.11:31230382:G:C
NM_001042492.3(NF1):c.3113+1G>T	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216062	17	29557401	17	31230383	216062	213264	rs267606599	NC_000017.11:31230382:G:T
NM_001042492.3(NF1):c.3113+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Tibial pseudarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000345	17	29557401	17	31230383	345	15384	rs267606599	NC_000017.11:31230382:G:A
NM_001042492.3(NF1):c.3113+2T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000231169	17	29557402	17	31230384	231169	235627	rs876658997	NC_000017.11:31230383:T:G
NM_001042492.3(NF1):c.3113+5G>A	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457622	17	29557405	17	31230387	457622	467386	rs1555614549	NC_000017.11:31230386:G:A
NM_001042492.3(NF1):c.3144G>A (p.Trp1048Ter)	NF1	W1048*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457626	17	29557890	17	31230872	457626	466532	rs1555614635	NC_000017.11:31230871:G:A
NM_001042492.3(NF1):c.3158C>G (p.Ser1053Ter)	NF1	S1053*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000665851	17	29557904	17	31230886	665851	645576	rs1597717610	NC_000017.11:31230885:C:G
NM_001042492.3(NF1):c.3189T>A (p.Cys1063Ter)	NF1	C1063*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431620	17	29557935	17	31230917	431620	425125	rs1135402841	NC_000017.11:31230916:T:A
NM_001042492.3(NF1):c.3197+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000503702	17	29557944	17	31230926	503702	495410	rs1555614653	NC_000017.11:31230925:G:A
NM_001042492.3(NF1):c.3198-314G>A	NF1		not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000936187	17	29558777	17	31231759	936187	940397	rs2067116490	NC_000017.11:31231758:G:A
NM_001042492.3(NF1):c.3198-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428967	17	29559089	17	31232071	428967	420794	rs1131691089	NC_000017.11:31232070:A:G
NM_001042492.3(NF1):c.3233C>G (p.Ser1078Ter)	NF1	S1078*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000956966	17	29559126	17	31232108	956966	949794	rs2067122696	NC_000017.11:31232107:C:G
NM_001042492.3(NF1):c.3239T>C (p.Leu1080Pro)	NF1	L1080P	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431978	17	29559132	17	31232114	431978	426215	rs1555614833	NC_000017.11:31232113:T:C
NM_001042492.3(NF1):c.3251C>G (p.Pro1084Arg)	NF1	P1084R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001199076	17	29559144	17	31232126	1199076	1188513		NC_000017.11:31232125:C:G
NM_001042492.3(NF1):c.3256C>T (p.Gln1086Ter)	NF1	Q1086*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996428	17	29559149	17	31232131	996428	984147	rs2067123355	NC_000017.11:31232130:C:T
NM_001042492.3(NF1):c.3262G>T (p.Glu1088Ter)	NF1	E1088*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV001421828	17	29559155	17	31232137	1421828	1337443		NC_000017.11:31232136:G:T
NM_001042492.3(NF1):c.3299C>A (p.Ser1100Ter)	NF1	S1100*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000952266	17	29559192	17	31232174	952266	928143	rs2067124341	NC_000017.11:31232173:C:A
NM_001042492.3(NF1):c.3301C>T (p.Gln1101Ter)	NF1	Q1101*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV001074271	17	29559194	17	31232176	1074271	1063985		NC_000017.11:31232175:C:T
NM_001042492.3(NF1):c.3313A>T (p.Lys1105Ter)	NF1	K1105*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547625	17	29559206	17	31232188	547625	538162	rs1555614867	NC_000017.11:31232187:A:T
NM_001042492.3(NF1):c.3315-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816766	17	29559715	17	31232697	816766	804954	rs752318318	NC_000017.11:31232696:C:G
NM_001042492.3(NF1):c.3315-2A>G	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000484086	17	29559716	17	31232698	484086	478125	rs1555614914	NC_000017.11:31232697:A:G
NM_001042492.3(NF1):c.3318C>A (p.Tyr1106Ter)	NF1	Y1106*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547626	17	29559721	17	31232703	547626	538163	rs876659289	NC_000017.11:31232702:C:A
NM_001042492.3(NF1):c.3367G>T (p.Glu1123Ter)	NF1	E1123*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000481993	17	29559770	17	31232752	481993	478232	rs1555614940	NC_000017.11:31232751:G:T
NM_001042492.3(NF1):c.3376C>T (p.Gln1126Ter)	NF1	Q1126*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449424	17	29559779	17	31232761	449424	445739	rs1555614947	NC_000017.11:31232760:C:T
NM_001042492.3(NF1):c.3445A>G (p.Met1149Val)	NF1	M1149V	not provided|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527517	17	29559848	17	31232830	527517	530962	rs1187097568	NC_000017.11:31232829:A:G
NM_001042492.3(NF1):c.3447G>C (p.Met1149Ile)	NF1	M1149I	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000566155	17	29559850	17	31232832	566155	570952	rs1064794277	NC_000017.11:31232831:G:C
NM_001042492.3(NF1):c.3447G>T (p.Met1149Ile)	NF1	M1149I	Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457650	17	29559850	17	31232832	457650	466548	rs1064794277	NC_000017.11:31232831:G:T
NM_001042492.3(NF1):c.3447G>A (p.Met1149Ile)	NF1	M1149I	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000420079	17	29559850	17	31232832	420079	409869	rs1064794277	NC_000017.11:31232831:G:A
NM_001042492.3(NF1):c.3449C>G (p.Ser1150Ter)	NF1	S1150*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000432961	17	29559852	17	31232834	432961	426216	rs1555614972	NC_000017.11:31232833:C:G
NM_001042492.3(NF1):c.3461A>T (p.Asn1154Ile)	NF1	N1154I	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404612	17	29559864	17	31232846	404612	402439	rs371544233	NC_000017.11:31232845:A:T
NM_001042492.3(NF1):c.3496G>A (p.Gly1166Ser)	NF1	G1166S	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000651126	17	29559899	17	31232881	651126	645594	rs1597719704	NC_000017.11:31232880:G:A
NM_001042492.3(NF1):c.3496+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV001359259	17	29559900	17	31232882	1359259	1370440		NC_000017.11:31232881:G:A
NM_001042492.3(NF1):c.3497-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457652	17	29560019	17	31233001	457652	467721	rs1555615004	NC_000017.11:31233000:G:A
NM_001042492.3(NF1):c.3500T>G (p.Leu1167Ter)	NF1	L1167*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000188394	17	29560023	17	31233005	188394	186251	rs786204253	NC_000017.11:31233004:T:G
NM_001042492.3(NF1):c.3520C>T (p.Gln1174Ter)	NF1	Q1174*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000978806	17	29560043	17	31233025	978806	966887	rs868450405	NC_000017.11:31233024:C:T
NM_001042492.3(NF1):c.3544G>T (p.Val1182Phe)	NF1	V1182F	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457654	17	29560067	17	31233049	457654	467729	rs1555615027	NC_000017.11:31233048:G:T
NM_001042492.3(NF1):c.3562C>T (p.Gln1188Ter)	NF1	Q1188*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996506	17	29560085	17	31233067	996506	984152	rs2067142295	NC_000017.11:31233066:C:T
NM_001042492.3(NF1):c.3565C>T (p.Gln1189Ter)	NF1	Q1189*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237551	17	29560088	17	31233070	237551	242671	rs878853884	NC_000017.11:31233069:C:T
NM_001042492.3(NF1):c.3610C>T (p.Arg1204Trp)	NF1	R1204W	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068338	17	29560133	17	31233115	68338	79229	rs199474732	NC_000017.11:31233114:C:T
NM_001042492.3(NF1):c.3610C>G (p.Arg1204Gly)	NF1	R1204G	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068337	17	29560133	17	31233115	68337	79228	rs199474732	NC_000017.11:31233114:C:G
NM_001042492.3(NF1):c.3662T>G (p.Leu1221Arg)	NF1	L1221R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000843506	17	29560185	17	31233167	843506	844999	rs1597720167	NC_000017.11:31233166:T:G
NM_001042492.3(NF1):c.3703C>T (p.Gln1235Ter)	NF1	Q1235*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000523788	17	29560226	17	31233208	523788	514714	rs1555615109	NC_000017.11:31233207:C:T
NM_001042492.3(NF1):c.3708G>A (p.Trp1236Ter)	NF1	W1236*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000946140	17	29560231	17	31233213	946140	928150	rs2067145586	NC_000017.11:31233212:G:A
NM_001042492.3(NF1):c.3709-2A>G	NF1		not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000937830	17	29562627	17	31235609	937830	940398	rs1597722374	NC_000017.11:31235608:A:G
NM_001042492.3(NF1):c.3712G>T (p.Glu1238Ter)	NF1	E1238*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404559	17	29562632	17	31235614	404559	402450	rs1060500346	NC_000017.11:31235613:G:T
NM_001042492.3(NF1):c.3721C>T (p.Arg1241Ter)	NF1	R1241*	Inborn genetic diseases|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000361	17	29562641	17	31235623	361	15400	rs137854562	NC_000017.11:31235622:C:T
NM_001042492.3(NF1):c.3763C>T (p.Gln1255Ter)	NF1	Q1255*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404504	17	29562683	17	31235665	404504	401707	rs1060500308	NC_000017.11:31235664:C:T
NM_001042492.3(NF1):c.3790G>T (p.Glu1264Ter)	NF1	E1264*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439986	17	29562710	17	31235692	439986	433254	rs863224660	NC_000017.11:31235691:G:T
NM_001042492.3(NF1):c.3790G>A (p.Glu1264Lys)	NF1	E1264K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216402	17	29562710	17	31235692	216402	213269	rs863224660	NC_000017.11:31235691:G:A
NM_001042492.3(NF1):c.3814C>T (p.Gln1272Ter)	NF1	Q1272*	not provided|Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000943279	17	29562734	17	31235716	943279	937817	rs2067188361	NC_000017.11:31235715:C:T
NM_001042492.3(NF1):c.3826C>T (p.Arg1276Ter)	NF1	R1276*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237556	17	29562746	17	31235728	237556	242675	rs199474742	NC_000017.11:31235727:C:T
NM_001042492.3(NF1):c.3826C>G (p.Arg1276Gly)	NF1	R1276G	Neurofibromatosis, type 1|not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068340	17	29562746	17	31235728	68340	79231	rs199474742	NC_000017.11:31235727:C:G
NM_001042492.3(NF1):c.3827G>T (p.Arg1276Leu)	NF1	R1276L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000694608	17	29562747	17	31235729	694608	682681	rs137854556	NC_000017.11:31235728:G:T
NM_001042492.3(NF1):c.3827G>A (p.Arg1276Gln)	NF1	R1276Q	Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068341	17	29562747	17	31235729	68341	79232	rs137854556	NC_000017.11:31235728:G:A
NM_001042492.3(NF1):c.3827G>C (p.Arg1276Pro)	NF1	R1276P	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000353	17	29562747	17	31235729	353	15392	rs137854556	NC_000017.11:31235728:G:C
NM_001042492.3(NF1):c.3834C>G (p.Asn1278Lys)	NF1	N1278K	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431630	17	29562754	17	31235736	431630	425135	rs1135402850	NC_000017.11:31235735:C:G
NM_001042492.3(NF1):c.3870+1G>T	NF1		Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000565498	17	29562791	17	31235773	565498	574403	rs1131691075	NC_000017.11:31235772:G:T
NM_001042492.3(NF1):c.3870+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428951	17	29562791	17	31235773	428951	420798	rs1131691075	NC_000017.11:31235772:G:A
NM_001042492.3(NF1):c.3871-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428953	17	29562934	17	31235916	428953	420799	rs1131691077	NC_000017.11:31235915:A:G
NM_001042492.3(NF1):c.3871-1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571095	17	29562935	17	31235917	571095	570968	rs1567852753	NC_000017.11:31235916:G:A
NM_001042492.3(NF1):c.3892C>T (p.Gln1298Ter)	NF1	Q1298*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000859602	17	29562957	17	31235939	859602	845007	rs2067193761	NC_000017.11:31235938:C:T
NM_001042492.3(NF1):c.3916C>T (p.Arg1306Ter)	NF1	R1306*	not provided|Tibial pseudarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404592	17	29562981	17	31235963	404592	401712	rs376576925	NC_000017.11:31235962:C:T
NM_001042492.3(NF1):c.3942G>A (p.Trp1314Ter)	NF1	W1314*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000849712	17	29563007	17	31235989	849712	845012	rs2067194816	NC_000017.11:31235988:G:A
NM_001042492.3(NF1):c.3943C>T (p.Gln1315Ter)	NF1	Q1315*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000938573	17	29563008	17	31235990	938573	937822	rs2067194846	NC_000017.11:31235989:C:T
NM_001042492.3(NF1):c.3974G>C (p.Arg1325Thr)	NF1	R1325T	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000215990	17	29563039	17	31236021	215990	213270	rs863224447	NC_000017.11:31236020:G:C
NM_001042492.3(NF1):c.3974+1G>A	NF1		Neurofibromatosis, type 1|not specified|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000661977	17	29563040	17	31236022	661977	653248	rs1567852849	NC_000017.11:31236021:G:A
NM_001042492.3(NF1):c.3974+1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000571920	17	29563040	17	31236022	571920	570971	rs1567852849	NC_000017.11:31236021:G:C
NM_001042492.3(NF1):c.3975-2A>T	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000963827	17	29576000	17	31248982	963827	960204	rs864622431	NC_000017.11:31248981:A:T
NM_001042492.3(NF1):c.3975-2A>G	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220232	17	29576000	17	31248982	220232	222596	rs864622431	NC_000017.11:31248981:A:G
NM_001042492.3(NF1):c.3975-1G>A	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV001073774	17	29576001	17	31248983	1073774	1064012		NC_000017.11:31248982:G:A
NM_001042492.3(NF1):c.3977T>G (p.Leu1326Ter)	NF1	L1326*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000949855	17	29576004	17	31248986	949855	928158	rs2067447633	NC_000017.11:31248985:T:G
NM_001042492.3(NF1):c.4016T>G (p.Leu1339Arg)	NF1	L1339R	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000872180	17	29576043	17	31249025	872180	860367	rs1567858306	NC_000017.11:31249024:T:G
NM_001042492.3(NF1):c.4021C>T (p.Gln1341Ter)	NF1	Q1341*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000357	17	29576048	17	31249030	357	15396	rs137854559	NC_000017.11:31249029:C:T
NM_001042492.3(NF1):c.4078C>T (p.Gln1360Ter)	NF1	Q1360*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000480204	17	29576105	17	31249087	480204	478856	rs1555617368	NC_000017.11:31249086:C:T
NM_001042492.3(NF1):c.4084C>T (p.Arg1362Ter)	NF1	R1362*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000344	17	29576111	17	31249093	344	15383	rs137854560	NC_000017.11:31249092:C:T
NM_001042492.3(NF1):c.4107C>A (p.Tyr1369Ter)	NF1	Y1369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV001071205	17	29576134	17	31249116	1071205	1064014		NC_000017.11:31249115:C:A
NM_001042492.3(NF1):c.4110+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000582401	17	29576138	17	31249120	582401	574406	rs1555617383	NC_000017.11:31249119:G:T
NM_001042492.3(NF1):c.4110+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457679	17	29576138	17	31249120	457679	466602	rs1555617383	NC_000017.11:31249119:G:A
NM_001042492.3(NF1):c.4174-2A>G	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000481997	17	29585360	17	31258342	481997	478184	rs1555618489	NC_000017.11:31258341:A:G
NM_001042492.3(NF1):c.4183C>T (p.Gln1395Ter)	NF1	Q1374*, Q1395*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547641	17	29585371	17	31258353	547641	538178	rs1555618494	NC_000017.11:31258352:C:T
NM_001042492.3(NF1):c.4195C>T (p.Gln1399Ter)	NF1	Q1378*, Q1399*	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428946	17	29585383	17	31258365	428946	420801	rs1131691072	NC_000017.11:31258364:C:T
NM_001042492.3(NF1):c.4231C>G (p.Leu1411Val)	NF1	L1390V, L1411V	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547642	17	29585419	17	31258401	547642	538179	rs199474789	NC_000017.11:31258400:C:G
NM_001042492.3(NF1):c.4231C>T (p.Leu1411Phe)	NF1	L1390F, L1411F	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000030992	17	29585419	17	31258401	30992	39949	rs199474789	NC_000017.11:31258400:C:T
NM_001042492.3(NF1):c.4234A>G (p.Arg1412Gly)	NF1	R1391G, R1412G	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457686	17	29585422	17	31258404	457686	467765	rs1555618515	NC_000017.11:31258403:A:G
NM_001042492.3(NF1):c.4236A>T (p.Arg1412Ser)	NF1	R1391S, R1412S	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000348	17	29585424	17	31258406	348	15387	rs137854554	NC_000017.11:31258405:A:T
NM_001042492.3(NF1):c.4280T>G (p.Leu1427Ter)	NF1	L1406*, L1427*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000957201	17	29585468	17	31258450	957201	949812	rs1177433867	NC_000017.11:31258449:T:G
NM_001042492.3(NF1):c.4300A>T (p.Arg1434Ter)	NF1	R1413*, R1434*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV001070436	17	29585488	17	31258470	1070436	1064019		NC_000017.11:31258469:A:T
NM_001042492.3(NF1):c.4306G>T (p.Glu1436Ter)	NF1	E1415*, E1436*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547643	17	29585494	17	31258476	547643	538180	rs876660428	NC_000017.11:31258475:G:T
NM_001042492.3(NF1):c.4316T>A (p.Leu1439Ter)	NF1	L1418*, L1439*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000623196	17	29585504	17	31258486	623196	612164	rs1567862071	NC_000017.11:31258485:T:A
NM_001042492.3(NF1):c.4330A>C (p.Lys1444Gln)	NF1	K1423Q, K1444Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431637	17	29585518	17	31258500	431637	425142	rs137854550	NC_000017.11:31258499:A:C
NM_001042492.3(NF1):c.4330A>G (p.Lys1444Glu)	NF1	K1423E, K1444E	Neurofibroma|Cafe au lait spots, multiple|Optic nerve glioma|Axillary freckling|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Pheochromocytoma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000336	17	29585518	17	31258500	336	15375	rs137854550	NC_000017.11:31258499:A:G
NM_001042492.3(NF1):c.4331A>G (p.Lys1444Arg)	NF1	K1423R, K1444R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068344	17	29585519	17	31258501	68344	79235	rs199474781	NC_000017.11:31258500:A:G
NM_001042492.3(NF1):c.4332G>C (p.Lys1444Asn)	NF1	K1444N, K1423N	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404485	17	29585520	17	31258502	404485	401735	rs199474750	NC_000017.11:31258501:G:C
NM_001042492.3(NF1):c.4332+1G>T	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000663586	17	29585521	17	31258503	663586	652754	rs1555618572	NC_000017.11:31258502:G:T
NM_001042492.3(NF1):c.4332+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000492881	17	29585521	17	31258503	492881	485773	rs1555618572	NC_000017.11:31258502:G:A
NM_001042492.3(NF1):c.4332+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000188306	17	29585522	17	31258504	188306	186252	rs786204207	NC_000017.11:31258503:T:C
NM_001042492.3(NF1):c.4333-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449427	17	29586048	17	31259030	449427	445742	rs1555618634	NC_000017.11:31259029:A:G
NM_001042492.3(NF1):c.4339C>G (p.Gln1447Glu)	NF1	Q1447E, Q1426E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000639280	17	29586056	17	31259038	639280	645626	rs1135402857	NC_000017.11:31259037:C:G
NM_001042492.3(NF1):c.4339C>T (p.Gln1447Ter)	NF1	Q1426*, Q1447*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431638	17	29586056	17	31259038	431638	425143	rs1135402857	NC_000017.11:31259037:C:T
NM_001042492.3(NF1):c.4340A>C (p.Gln1447Pro)	NF1	Q1426P, Q1447P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428987	17	29586057	17	31259039	428987	420804	rs786204157	NC_000017.11:31259038:A:C
NM_001042492.3(NF1):c.4341G>C (p.Gln1447His)	NF1	Q1426H, Q1447H	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000233115	17	29586058	17	31259040	233115	235682	rs876660206	NC_000017.11:31259039:G:C
NM_001042492.3(NF1):c.4369A>G (p.Lys1457Glu)	NF1	K1436E, K1457E	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237563	17	29586086	17	31259068	237563	242681	rs878853893	NC_000017.11:31259067:A:G
NM_001042492.3(NF1):c.4372G>T (p.Glu1458Ter)	NF1	E1458*, E1437*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000872182	17	29586089	17	31259071	872182	860369	rs1135402858	NC_000017.11:31259070:G:T
NM_001042492.3(NF1):c.4372G>A (p.Glu1458Lys)	NF1	E1437K, E1458K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431639	17	29586089	17	31259071	431639	425144	rs1135402858	NC_000017.11:31259070:G:A
NM_001042492.3(NF1):c.4430+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000640358	17	29586148	17	31259130	640358	653430	rs773151680	NC_000017.11:31259129:G:A
NM_001042492.3(NF1):c.4430+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547645	17	29586148	17	31259130	547645	538182	rs773151680	NC_000017.11:31259129:G:C
NM_001042492.3(NF1):c.4431-9T>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816763	17	29587378	17	31260360	816763	804957	rs1597746884	NC_000017.11:31260359:T:G
NM_001042492.3(NF1):c.4431-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000835743	17	29587386	17	31260368	835743	852720	rs1597746891	NC_000017.11:31260367:G:A
NM_001042492.3(NF1):c.4431-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803359	17	29587386	17	31260368	803359	791712	rs1597746891	NC_000017.11:31260367:G:T
NM_001042492.3(NF1):c.4465A>G (p.Ser1489Gly)	NF1	S1468G, S1489G	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068351	17	29587421	17	31260403	68351	79242	rs199474743	NC_000017.11:31260402:A:G
NM_001042492.3(NF1):c.4532T>C (p.Leu1511Pro)	NF1	L1490P, L1511P	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV001209570	17	29587488	17	31260470	1209570	1198921		NC_000017.11:31260469:T:C
NM_001042492.3(NF1):c.4535G>A (p.Trp1512Ter)	NF1	W1491*, W1512*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996438	17	29587491	17	31260473	996438	984174	rs1267947462	NC_000017.11:31260472:G:A
NM_001042492.3(NF1):c.4536G>A (p.Trp1512Ter)	NF1	W1512*, W1491*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000872183	17	29587492	17	31260474	872183	860370	rs878853897	NC_000017.11:31260473:G:A
NM_001042492.3(NF1):c.4543C>T (p.Gln1515Ter)	NF1	Q1494*, Q1515*	Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000570950	17	29587499	17	31260481	570950	570990	rs1567862991	NC_000017.11:31260480:C:T
NM_001042492.3(NF1):c.4556G>A (p.Gly1519Glu)	NF1	G1498E, G1519E	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000565475	17	29587512	17	31260494	565475	571117	rs1567863004	NC_000017.11:31260493:G:A
NM_001042492.3(NF1):c.4558C>T (p.Gln1520Ter)	NF1	Q1520*, Q1499*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404417	17	29587514	17	31260496	404417	402465	rs1060500242	NC_000017.11:31260495:C:T
NM_001042492.3(NF1):c.4577+1G>A	NF1		not provided|Optic nerve glioma|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439997	17	29587534	17	31260516	439997	433256	rs1279529138	NC_000017.11:31260515:G:A
NM_001042492.3(NF1):c.4578-1G>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000489292	17	29588728	17	31261710	489292	482125	rs1555618999	NC_000017.11:31261709:G:C
NM_001042492.3(NF1):c.4600C>T (p.Arg1534Ter)	NF1	R1534*, R1513*	not provided|Subcutaneous neurofibromas|Thoracic scoliosis|Cafe au lait spots, multiple|Abnormality of the skin|not specified|Tibial pseudarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220152	17	29588751	17	31261733	220152	222607	rs760703505	NC_000017.11:31261732:C:T
NM_001042492.3(NF1):c.4635C>G (p.Tyr1545Ter)	NF1	Y1524*, Y1545*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547647	17	29588786	17	31261768	547647	538184	rs754023358	NC_000017.11:31261767:C:G
NM_001042492.3(NF1):c.4676G>A (p.Trp1559Ter)	NF1	W1538*, W1559*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996467	17	29588827	17	31261809	996467	984177	rs2067691658	NC_000017.11:31261808:G:A
NM_001042492.3(NF1):c.4677G>A (p.Trp1559Ter)	NF1	W1538*, W1559*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000350	17	29588828	17	31261810	350	15389	rs137854555	NC_000017.11:31261809:G:A
NM_001042492.3(NF1):c.4700C>A (p.Ser1567Ter)	NF1	S1546*, S1567*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000940807	17	29588851	17	31261833	940807	937834	rs1555619051	NC_000017.11:31261832:C:A
NM_001042492.3(NF1):c.4724+1G>A	NF1		Neurofibromatosis, type 1|not specified	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457713	17	29588876	17	31261858	457713	467795	rs1555619056	NC_000017.11:31261857:G:A
NM_001042492.3(NF1):c.4724+2T>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000825080	17	29588877	17	31261859	825080	815655	rs1597748995	NC_000017.11:31261858:T:G
NM_001042492.3(NF1):c.4725-1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000484015	17	29592246	17	31265228	484015	478907	rs1555619391	NC_000017.11:31265227:G:A
NM_001042492.3(NF1):c.4729C>T (p.Gln1577Ter)	NF1	Q1556*, Q1577*	Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000208766	17	29592251	17	31265233	208766	205301	rs797044942	NC_000017.11:31265232:C:T
NM_001042492.3(NF1):c.4747G>T (p.Glu1583Ter)	NF1	E1583*, E1562*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000971976	17	29592269	17	31265251	971976	958053	rs2067765099	NC_000017.11:31265250:G:T
NM_001042492.3(NF1):c.4769T>A (p.Leu1590Ter)	NF1	L1590*, L1569*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000934165	17	29592291	17	31265273	934165	937835	rs2067765689	NC_000017.11:31265272:T:A
NM_001042492.3(NF1):c.4783C>T (p.Gln1595Ter)	NF1	Q1595*, Q1574*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000649568	17	29592305	17	31265287	649568	645644	rs1597753263	NC_000017.11:31265286:C:T
NM_001042492.3(NF1):c.4824T>G (p.Tyr1608Ter)	NF1	Y1608*, Y1587*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV001460057	17	29592346	17	31265328	1460057	1481414		NC_000017.11:31265327:T:G
NM_001042492.3(NF1):c.4835+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547652	17	29592358	17	31265340	547652	538189	rs1085307819	NC_000017.11:31265339:G:A
NM_001042492.3(NF1):c.4836-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373285	17	29652837	17	31325819	373285	360299	rs1057518326	NC_000017.11:31325818:G:A
NM_001042492.3(NF1):c.4986G>A (p.Trp1662Ter)	NF1	W1641*, W1662*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001048716	17	29652988	17	31325970	1048716	1036814		NC_000017.11:31325969:G:A
NM_001042492.3(NF1):c.5055G>A (p.Trp1685Ter)	NF1	W1664*, W1685*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457738	17	29653057	17	31326039	457738	466633	rs1555533354	NC_000017.11:31326038:G:A
NM_001042492.3(NF1):c.5067C>A (p.Tyr1689Ter)	NF1	Y1668*, Y1689*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001256430	17	29653069	17	31326051	1256430	1246359		NC_000017.11:31326050:C:A
NM_001042492.3(NF1):c.5167C>T (p.Gln1723Ter)	NF1	Q1702*, Q1723*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001333529	17	29653169	17	31326151	1333529	1324300		NC_000017.11:31326150:C:T
NM_001042492.3(NF1):c.5268+1G>T	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996474	17	29653271	17	31326253	996474	984189	rs2069338793	NC_000017.11:31326252:G:T
NM_001042492.3(NF1):c.5268+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547656	17	29653272	17	31326254	547656	538193	rs1555533416	NC_000017.11:31326253:T:G
NM_001042492.3(NF1):c.5268+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220498	17	29653275	17	31326257	220498	222614	rs864622551	NC_000017.11:31326256:G:A
NM_001042492.3(NF1):c.5269-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547657	17	29654515	17	31327497	547657	538194	rs1555533548	NC_000017.11:31327496:A:G
NM_001042492.3(NF1):c.5269-1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000233026	17	29654516	17	31327498	233026	235732	rs876660141	NC_000017.11:31327497:G:A
NM_001042492.3(NF1):c.5287C>T (p.Gln1763Ter)	NF1	Q1742*, Q1763*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000987429	17	29654535	17	31327517	987429	975472	rs2069375606	NC_000017.11:31327516:C:T
NM_001042492.3(NF1):c.5297C>G (p.Ser1766Ter)	NF1	S1745*, S1766*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449426	17	29654545	17	31327527	449426	445746	rs1555533555	NC_000017.11:31327526:C:G
NM_001042492.3(NF1):c.5305C>T (p.Arg1769Ter)	NF1	R1748*, R1769*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000228381	17	29654553	17	31327535	228381	230767	rs876657714	NC_000017.11:31327534:C:T
NM_001042492.3(NF1):c.5327C>G (p.Ser1776Ter)	NF1	S1776*, S1755*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000960019	17	29654575	17	31327557	960019	949822	rs2069376973	NC_000017.11:31327556:C:G
NM_001042492.3(NF1):c.5357C>A (p.Ser1786Ter)	NF1	S1765*, S1786*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547660	17	29654605	17	31327587	547660	538197	rs1555533569	NC_000017.11:31327586:C:A
NM_001042492.3(NF1):c.5376C>A (p.Cys1792Ter)	NF1	C1771*, C1792*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000825640	17	29654624	17	31327606	825640	813371	rs1597832002	NC_000017.11:31327605:C:A
NM_001042492.3(NF1):c.5392C>T (p.Gln1798Ter)	NF1	Q1777*, Q1798*	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudarthrosis	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000818196	17	29654640	17	31327622	818196	806399	rs1597832043	NC_000017.11:31327621:C:T
NM_001042492.3(NF1):c.5464C>T (p.Gln1822Ter)	NF1	Q1801*, Q1822*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996430	17	29654712	17	31327694	996430	984196	rs2069381323	NC_000017.11:31327693:C:T
NM_001042492.3(NF1):c.5488C>G (p.Arg1830Gly)	NF1	R1809G, R1830G	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000208857	17	29654736	17	31327718	208857	205415	rs797045139	NC_000017.11:31327717:C:G
NM_001042492.3(NF1):c.5488C>T (p.Arg1830Cys)	NF1	R1809C, R1830C	not specified|Intellectual disability|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurodevelopmental delay|not provided|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000208853	17	29654736	17	31327718	208853	205416	rs797045139	NC_000017.11:31327717:C:T
NM_001042492.3(NF1):c.5489G>T (p.Arg1830Leu)	NF1	R1809L, R1830L	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000208854	17	29654737	17	31327719	208854	205418	rs771529172	NC_000017.11:31327718:G:T
NM_001042492.3(NF1):c.5492G>A (p.Trp1831Ter)	NF1	W1810*, W1831*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431656	17	29654740	17	31327722	431656	425161	rs1135402872	NC_000017.11:31327721:G:A
NM_001042492.3(NF1):c.5501C>G (p.Ser1834Ter)	NF1	S1834*, S1813*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000647087	17	29654749	17	31327731	647087	645674	rs1597832235	NC_000017.11:31327730:C:G
NM_001042492.3(NF1):c.5503C>T (p.Gln1835Ter)	NF1	Q1814*, Q1835*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000852381	17	29654751	17	31327733	852381	845067	rs786202177	NC_000017.11:31327732:C:T
NM_001042492.3(NF1):c.5521C>T (p.Gln1841Ter)	NF1	Q1841*, Q1820*	not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000220317	17	29654769	17	31327751	220317	222618	rs786203570	NC_000017.11:31327750:C:T
NM_001042492.3(NF1):c.5561T>G (p.Leu1854Arg)	NF1	L1833R, L1854R	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237576	17	29654809	17	31327791	237576	242694	rs878853903	NC_000017.11:31327790:T:G
NM_001042492.3(NF1):c.5606T>G (p.Leu1869Ter)	NF1	L1848*, L1869*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000661533	17	29654854	17	31327836	661533	645679	rs1597832482	NC_000017.11:31327835:T:G
NM_001042492.3(NF1):c.5609G>A (p.Arg1870Gln)	NF1	R1849Q, R1870Q	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000185354	17	29654857	17	31327839	185354	184694	rs786202112	NC_000017.11:31327838:G:A
NM_001042492.3(NF1):c.5609+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428997	17	29654858	17	31327840	428997	420812	rs1131691117	NC_000017.11:31327839:G:A
NM_001042492.3(NF1):c.5610-2A>G	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457756	17	29657312	17	31330294	457756	467628	rs1135402876	NC_000017.11:31330293:A:G
NM_001042492.3(NF1):c.5610-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431660	17	29657312	17	31330294	431660	425165	rs1135402876	NC_000017.11:31330293:A:T
NM_001042492.3(NF1):c.5610-1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561746	17	29657313	17	31330295	561746	552971	rs1567613569	NC_000017.11:31330294:G:C
NM_001042492.3(NF1):c.5665G>T (p.Glu1889Ter)	NF1	E1868*, E1889*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV001454435	17	29657369	17	31330351	1454435	1444778		NC_000017.11:31330350:G:T
NM_001042492.3(NF1):c.5671C>T (p.Gln1891Ter)	NF1	Q1870*, Q1891*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000237577	17	29657375	17	31330357	237577	242695	rs878853904	NC_000017.11:31330356:C:T
NM_001042492.3(NF1):c.5687C>G (p.Ser1896Ter)	NF1	S1875*, S1896*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431663	17	29657391	17	31330373	431663	425168	rs1135402879	NC_000017.11:31330372:C:G
NM_001042492.3(NF1):c.5782G>T (p.Glu1928Ter)	NF1	E1907*, E1928*	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000187652	17	29657486	17	31330468	187652	184701	rs786203896	NC_000017.11:31330467:G:T
NM_001042492.3(NF1):c.5785G>T (p.Glu1929Ter)	NF1	E1908*, E1929*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000852822	17	29657489	17	31330471	852822	845083	rs2069454068	NC_000017.11:31330470:G:T
NM_001042492.3(NF1):c.5788T>C (p.Cys1930Arg)	NF1	C1909R, C1930R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000971853	17	29657492	17	31330474	971853	958063	rs2069454402	NC_000017.11:31330473:T:C
NM_001042492.3(NF1):c.5812+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230938	17	29657517	17	31330499	230938	235752	rs876658854	NC_000017.11:31330498:G:A
NM_001042492.3(NF1):c.5812+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547669	17	29657518	17	31330500	547669	538206	rs1555533887	NC_000017.11:31330499:T:C
NM_001042492.3(NF1):c.5812+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457764	17	29657521	17	31330503	457764	467501	rs1555533889	NC_000017.11:31330502:G:A
NM_001042492.3(NF1):c.5812+332A>G	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216065	17	29657848	17	31330830	216065	213285	rs863224491	NC_000017.11:31330829:A:G
NM_001042492.3(NF1):c.5813-1G>A	NF1		not provided|Neurofibromatosis, type 1|Axillary freckling|Plexiform neurofibroma|Cafe-au-lait spot	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000374204	17	29661855	17	31334837	374204	361013	rs1057518974	NC_000017.11:31334836:G:A
NM_001042492.3(NF1):c.5818G>T (p.Glu1940Ter)	NF1	E1919*, E1940*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV001361439	17	29661861	17	31334843	1361439	1476163		NC_000017.11:31334842:G:T
NM_001042492.3(NF1):c.5839G>T (p.Glu1947Ter)	NF1	E1926*, E1947*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000141892	17	29661882	17	31334864	141892	151606	rs587782088	NC_000017.11:31334863:G:T
NM_001042492.3(NF1):c.5854T>C (p.Trp1952Arg)	NF1	W1931R, W1952R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000068357	17	29661897	17	31334879	68357	79248	rs199474791	NC_000017.11:31334878:T:C
NM_001042492.3(NF1):c.5856G>A (p.Trp1952Ter)	NF1	W1931*, W1952*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488816	17	29661899	17	31334881	488816	482126	rs1555534393	NC_000017.11:31334880:G:A
NM_001042492.3(NF1):c.5861C>G (p.Ser1954Ter)	NF1	S1933*, S1954*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000834435	17	29661904	17	31334886	834435	845085	rs2069602711	NC_000017.11:31334885:C:G
NM_001042492.3(NF1):c.5902C>T (p.Arg1968Ter)	NF1	R1947*, R1968*	Tibial pseudarthrosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000343	17	29661945	17	31334927	343	15382	rs137854552	NC_000017.11:31334926:C:T
NM_001042492.3(NF1):c.5959C>T (p.Gln1987Ter)	NF1	Q1966*, Q1987*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000620128	17	29662002	17	31334984	620128	611851	rs876659070	NC_000017.11:31334983:C:T
NM_001042492.3(NF1):c.5967C>G (p.Tyr1989Ter)	NF1	Y1968*, Y1989*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000561857	17	29662010	17	31334992	561857	552978	rs1567615902	NC_000017.11:31334991:C:G
NM_001042492.3(NF1):c.5991G>A (p.Trp1997Ter)	NF1	W1976*, W1997*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000233869	17	29662034	17	31335016	233869	235758	rs876660696	NC_000017.11:31335015:G:A
NM_001042492.3(NF1):c.6004C>T (p.Gln2002Ter)	NF1	Q2002*, Q1981*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000578868	17	29662047	17	31335029	578868	574420	rs1567615941	NC_000017.11:31335028:C:T
NM_001042492.3(NF1):c.6006G>A (p.Gln2002=)	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001298697	17	29662049	17	31335031	1298697	1288559		NC_000017.11:31335030:G:A
NM_001042492.3(NF1):c.6006+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996372	17	29662050	17	31335032	996372	984211	rs1555534433	NC_000017.11:31335031:G:T
NM_001042492.3(NF1):c.6006+1G>A	NF1		Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488817	17	29662050	17	31335032	488817	482128	rs1555534433	NC_000017.11:31335031:G:A
NM_001042492.3(NF1):c.6007-5A>G	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000000359	17	29663346	17	31336328	359	15398	rs267606604	NC_000017.11:31336327:A:G
NM_001042492.3(NF1):c.6007-2A>G	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547672	17	29663349	17	31336331	547672	538208	rs1555534595	NC_000017.11:31336330:A:G
NM_001042492.3(NF1):c.6147+1G>T	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000851432	17	29663492	17	31336474	851432	852868	rs1060500296	NC_000017.11:31336473:G:T
NM_001042492.3(NF1):c.6147+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404489	17	29663492	17	31336474	404489	401837	rs1060500296	NC_000017.11:31336473:G:A
NM_001042492.3(NF1):c.6147+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547673	17	29663493	17	31336475	547673	538210	rs1555534621	NC_000017.11:31336474:T:C
NM_001042492.3(NF1):c.6148-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996440	17	29663651	17	31336633	996440	984213	rs2069681259	NC_000017.11:31336632:A:G
NM_001042492.3(NF1):c.6148-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000527537	17	29663652	17	31336634	527537	531021	rs1555534661	NC_000017.11:31336633:G:C
NM_001042492.3(NF1):c.6355A>T (p.Arg2119Ter)	NF1	R2098*, R2119*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001333425	17	29663860	17	31336842	1333425	1324197		NC_000017.11:31336841:A:T
NM_001042492.3(NF1):c.6410C>G (p.Ser2137Ter)	NF1	S2137*, S2116*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001459448	17	29663915	17	31336897	1459448	1484639		NC_000017.11:31336896:C:G
NM_001042492.3(NF1):c.6412C>T (p.Gln2138Ter)	NF1	Q2117*, Q2138*	Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000946672	17	29663917	17	31336899	946672	928192	rs2069691114	NC_000017.11:31336898:C:T
NM_001042492.3(NF1):c.6427+1G>A	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV001068190	17	29663933	17	31336915	1068190	1056404		NC_000017.11:31336914:G:A
NM_001042492.3(NF1):c.6428-3C>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816775	17	29664383	17	31337365	816775	804967	rs374014162	NC_000017.11:31337364:C:G
NM_001042492.3(NF1):c.6428-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404510	17	29664384	17	31337366	404510	402492	rs1060500312	NC_000017.11:31337365:A:G
NM_001042492.3(NF1):c.6488T>A (p.Leu2163Ter)	NF1	L2163*, L2142*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000836119	17	29664446	17	31337428	836119	845107	rs1353492847	NC_000017.11:31337427:T:A
NM_001042492.3(NF1):c.6546C>G (p.Tyr2182Ter)	NF1	Y2182*, Y2161*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803373	17	29664504	17	31337486	803373	791726	rs876659768	NC_000017.11:31337485:C:G
NM_001042492.3(NF1):c.6557C>G (p.Ser2186Ter)	NF1	S2165*, S2186*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428969	17	29664515	17	31337497	428969	420819	rs1131691091	NC_000017.11:31337496:C:G
NM_001042492.3(NF1):c.6642+1G>A	NF1		not provided|Neurofibromatosis, type 1|Cafe-au-lait spot	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000523343	17	29664601	17	31337583	523343	514080	rs1060500345	NC_000017.11:31337582:G:A
NM_001042492.3(NF1):c.6642+1G>T	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404558	17	29664601	17	31337583	404558	402348	rs1060500345	NC_000017.11:31337582:G:T
NM_001042492.3(NF1):c.6643-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV000652474	17	29664835	17	31337817	652474	653262	rs1597844547	NC_000017.11:31337816:A:G
NM_001042492.3(NF1):c.6669C>A (p.Cys2223Ter)	NF1	C2202*, C2223*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547678	17	29664863	17	31337845	547678	538215	rs1555534918	NC_000017.11:31337844:C:A
NM_001042492.3(NF1):c.6674G>A (p.Trp2225Ter)	NF1	W2204*, W2225*	not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000488819	17	29664868	17	31337850	488819	482131	rs1193716348	NC_000017.11:31337849:G:A
NM_001042492.3(NF1):c.6675G>A (p.Trp2225Ter)	NF1	W2225*, W2204*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000872184	17	29664869	17	31337851	872184	860371	rs2069717916	NC_000017.11:31337850:G:A
NM_001042492.3(NF1):c.6682C>T (p.Gln2228Ter)	NF1	Q2207*, Q2228*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996507	17	29664876	17	31337858	996507	984220	rs2069718249	NC_000017.11:31337857:C:T
NM_001042492.3(NF1):c.6686G>A (p.Trp2229Ter)	NF1	W2229*, W2208*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV001451873	17	29664880	17	31337862	1451873	1438635		NC_000017.11:31337861:G:A
NM_001042492.3(NF1):c.6687G>A (p.Trp2229Ter)	NF1	W2229*, W2208*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000826516	17	29664881	17	31337863	826516	813432	rs1597844653	NC_000017.11:31337862:G:A
NM_001042492.3(NF1):c.6700C>T (p.Gln2234Ter)	NF1	Q2213*, Q2234*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000583019	17	29664894	17	31337876	583019	571179	rs1567617727	NC_000017.11:31337875:C:T
NM_001042492.3(NF1):c.6704+1G>C	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000856149	17	29664899	17	31337881	856149	852730	rs1060500376	NC_000017.11:31337880:G:C
NM_001042492.3(NF1):c.6704+1G>T	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: Jul 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547680	17	29664899	17	31337881	547680	538217	rs1060500376	NC_000017.11:31337880:G:T
NM_001042492.3(NF1):c.6704+1G>A	NF1		not provided|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404599	17	29664899	17	31337881	404599	402353	rs1060500376	NC_000017.11:31337880:G:A
NM_001042492.3(NF1):c.6705-3C>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000481981	17	29665040	17	31338022	481981	478971	rs1131691079	NC_000017.11:31338021:C:A
NM_001042492.3(NF1):c.6733C>T (p.Gln2245Ter)	NF1	Q2224*, Q2245*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000657256	17	29665071	17	31338053	657256	645718	rs1597845013	NC_000017.11:31338052:C:T
NM_001042492.3(NF1):c.6772C>T (p.Arg2258Ter)	NF1	R2237*, R2258*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230389	17	29665110	17	31338092	230389	235788	rs876658541	NC_000017.11:31338091:C:T
NM_001042492.3(NF1):c.6819+1G>T	NF1		Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV001329856	17	29665158	17	31338140	1329856	1320540		NC_000017.11:31338139:G:T
NM_001042492.3(NF1):c.6819+1G>A	NF1		not provided|Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000457804	17	29665158	17	31338140	457804	467523	rs1555534964	NC_000017.11:31338139:G:A
NM_001042492.3(NF1):c.6819+2T>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431680	17	29665159	17	31338141	431680	425185	rs1135402894	NC_000017.11:31338140:T:C
NM_001042492.3(NF1):c.6820-2A>C	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV001048727	17	29665720	17	31338702	1048727	1036831		NC_000017.11:31338701:A:C
NM_001042492.3(NF1):c.6855C>G (p.Tyr2285Ter)	NF1	Y2264*, Y2285*	not provided|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439973	17	29665757	17	31338739	439973	433262	rs772295894	NC_000017.11:31338738:C:G
NM_001042492.3(NF1):c.6855C>A (p.Tyr2285Ter)	NF1	Y2264*, Y2285*	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000185082	17	29665757	17	31338739	185082	184734	rs772295894	NC_000017.11:31338738:C:A
NM_001042492.3(NF1):c.6902T>G (p.Leu2301Ter)	NF1	L2301*, L2280*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000844773	17	29665804	17	31338786	844773	845126	rs2069745354	NC_000017.11:31338785:T:G
NM_001042492.3(NF1):c.6904C>T (p.Gln2302Ter)	NF1	Q2281*, Q2302*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Jul 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373973	17	29665806	17	31338788	373973	361014	rs1057518807	NC_000017.11:31338787:C:T
NM_001042492.3(NF1):c.6921+1G>A	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404571	17	29665824	17	31338806	404571	401871	rs1060500355	NC_000017.11:31338805:G:A
NM_001042492.3(NF1):c.6921+2T>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV001397776	17	29665825	17	31338807	1397776	1352976		NC_000017.11:31338806:T:C
NM_001042492.3(NF1):c.6970C>T (p.Gln2324Ter)	NF1	Q2303*, Q2324*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428948	17	29667571	17	31340553	428948	420826	rs1131691073	NC_000017.11:31340552:C:T
NM_001042492.3(NF1):c.7018C>T (p.Gln2340Ter)	NF1	Q2340*, Q2319*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 30, 2022)	criteria provided, multiple submitters, no conflicts	VCV000847696	17	29667619	17	31340601	847696	845131	rs2069793099	NC_000017.11:31340600:C:T
NM_001042492.3(NF1):c.7062+1G>A	NF1		Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216066	17	29667664	17	31340646	216066	213294	rs863224492	NC_000017.11:31340645:G:A
NM_001042492.3(NF1):c.7063-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000635820	17	29670025	17	31343007	635820	623637	rs1597851255	NC_000017.11:31343006:A:G
NM_001042492.3(NF1):c.7063-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV001070419	17	29670026	17	31343008	1070419	1064098		NC_000017.11:31343007:G:A
NM_001042492.3(NF1):c.7063-1G>T	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428994	17	29670026	17	31343008	428994	420828	rs1131691114	NC_000017.11:31343007:G:T
NM_001042492.3(NF1):c.7106G>A (p.Trp2369Ter)	NF1	W2348*, W2369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996432	17	29670070	17	31343052	996432	984232	rs2069867116	NC_000017.11:31343051:G:A
NM_001042492.3(NF1):c.7107G>A (p.Trp2369Ter)	NF1	W2348*, W2369*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404475	17	29670071	17	31343053	404475	401885	rs1060500286	NC_000017.11:31343052:G:A
NM_001042492.3(NF1):c.7113C>A (p.Cys2371Ter)	NF1	C2350*, C2371*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000849556	17	29670077	17	31343059	849556	845134	rs2069867490	NC_000017.11:31343058:C:A
NM_001042492.3(NF1):c.7117C>T (p.Gln2373Ter)	NF1	Q2352*, Q2373*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000440001	17	29670081	17	31343063	440001	433263	rs1555535417	NC_000017.11:31343062:C:T
NM_001042492.3(NF1):c.7189G>A (p.Gly2397Arg)	NF1	G2376R, G2397R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000431686	17	29670153	17	31343135	431686	425191	rs1135402900	NC_000017.11:31343134:G:A
NM_001042492.3(NF1):c.7189+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000951449	17	29670154	17	31343136	951449	941176	rs1555535455	NC_000017.11:31343135:G:C
NM_001042492.3(NF1):c.7190-1G>A	NF1		Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000939750	17	29676137	17	31349119	939750	940406	rs2070073417	NC_000017.11:31349118:G:A
NM_001042492.3(NF1):c.7314C>G (p.Tyr2438Ter)	NF1	Y2438*, Y2417*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404615	17	29676262	17	31349244	404615	401832	rs1060500385	NC_000017.11:31349243:C:G
NM_001042492.3(NF1):c.7348C>T (p.Arg2450Ter)	NF1	R2429*, R2450*	Hereditary cancer-predisposing syndrome|Lisch nodules|Subcutaneous neurofibromas|Neurofibromatosis, type 1|not provided|not specified	Pathogenic(Last reviewed: Nov 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000185789	17	29677227	17	31350209	185789	184747	rs786202457	NC_000017.11:31350208:C:T
NM_001042492.3(NF1):c.7359C>A (p.Cys2453Ter)	NF1	C2432*, C2453*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV001072587	17	29677238	17	31350220	1072587	1064107		NC_000017.11:31350219:C:A
NM_001042492.3(NF1):c.7458-1G>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000635818	17	29679274	17	31352256	635818	623638	rs1597862012	NC_000017.11:31352255:G:C
NM_001042492.3(NF1):c.7474C>T (p.Gln2492Ter)	NF1	Q2471*, Q2492*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439998	17	29679291	17	31352273	439998	433265	rs1555536340	NC_000017.11:31352272:C:T
NM_001042492.3(NF1):c.7482G>A (p.Trp2494Ter)	NF1	W2473*, W2494*	Axillary freckling|Cafe-au-lait spot|Inguinal freckling|Familial predisposition|Specific learning disability|Inguinal hernia|Delayed speech and language development|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000216067	17	29679299	17	31352281	216067	213298	rs863224493	NC_000017.11:31352280:G:A
NM_001042492.3(NF1):c.7549C>T (p.Arg2517Ter)	NF1	R2496*, R2517*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|not specified|Abnormality of the skin	Pathogenic(Last reviewed: Nov 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000230467	17	29679366	17	31352348	230467	235823	rs866445127	NC_000017.11:31352347:C:T
NM_001042492.3(NF1):c.7615+1G>T	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000489226	17	29679433	17	31352415	489226	482132	rs1555536380	NC_000017.11:31352414:G:T
NM_001042492.3(NF1):c.7760C>G (p.Ser2587Ter)	NF1	S2566*, S2587*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000428968	17	29683999	17	31356981	428968	420834	rs1131691090	NC_000017.11:31356980:C:G
NM_001042492.3(NF1):c.7762C>T (p.Gln2588Ter)	NF1	Q2588*, Q2567*	Neurofibromatosis, type 1|Cardiovascular phenotype|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000484056	17	29684001	17	31356983	484056	479071	rs1555536687	NC_000017.11:31356982:C:T
NM_001042492.3(NF1):c.7869+1G>A	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000480091	17	29684109	17	31357091	480091	478383	rs1329683225	NC_000017.11:31357090:G:A
NM_001042492.3(NF1):c.7906C>T (p.Gln2636Ter)	NF1	Q2615*, Q2636*	Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000547698	17	29684323	17	31357305	547698	538235	rs567988442	NC_000017.11:31357304:C:T
NM_001042492.3(NF1):c.7909C>T (p.Arg2637Ter)	NF1	R2616*, R2637*	not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Tibial pseudarthrosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000184261	17	29684326	17	31357308	184261	184776	rs786201367	NC_000017.11:31357307:C:T
NM_001042492.3(NF1):c.7920T>G (p.Tyr2640Ter)	NF1	Y2619*, Y2640*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404544	17	29684337	17	31357319	404544	401910	rs1060500333	NC_000017.11:31357318:T:G
NM_001042492.3(NF1):c.7970+1G>A	NF1		not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439967	17	29684388	17	31357370	439967	433268	rs1555536773	NC_000017.11:31357369:G:A
NM_001042492.3(NF1):c.7971-2A>G	NF1		Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001366028	17	29685496	17	31358478	1366028	1399018		NC_000017.11:31358477:A:G
NM_001042492.3(NF1):c.8113+2T>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000827420	17	29685642	17	31358624	827420	815668	rs1597868312	NC_000017.11:31358623:T:G
NM_138387.4(G6PC3):c.130C>T (p.Pro44Ser)	G6PC3	P44S	Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency|not provided	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189781	17	42148463	17	44071095	189781	187650	rs775224457	NC_000017.11:44071094:C:T
NM_138387.4(G6PC3):c.565C>T (p.Arg189Ter)	G6PC3	P149L, R189*, R74*	not provided|Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency	Pathogenic(Last reviewed: Nov 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000653016	17	42152707	17	44075339	653016	646075	rs745582203	NC_000017.11:44075338:C:T
NM_017777.4(MKS1):c.1208C>T (p.Ser403Leu)	MKS1	S403L, S200L	Meckel-Gruber syndrome|Joubert syndrome|not provided|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217672	17	56285320	17	58207959	217672	214363	rs773684291	NC_000017.11:58207958:G:A
NM_017777.4(MKS1):c.1025-2A>C	MKS1		Joubert syndrome 28|Bardet-Biedl syndrome 13|Meckel syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194102	17	56285946	17	58208585	194102	191265	rs794727070	NC_000017.11:58208584:T:G
NM_017777.4(MKS1):c.1024+1G>A	MKS1		Meckel syndrome, type 1|Bardet-Biedl syndrome 13|Joubert syndrome 28|Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001391	17	56288019	17	58210658	1391	16430	rs199874059	NC_000017.11:58210657:C:T
NM_017777.4(MKS1):c.844C>T (p.Arg282Ter)	MKS1	R282*, R79*	Meckel syndrome, type 1|Joubert syndrome 28|Bardet-Biedl syndrome 13|Meckel syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211503	17	56290357	17	58212996	211503	208405	rs797045706	NC_000017.11:58212995:G:A
NM_017777.4(MKS1):c.829G>T (p.Glu277Ter)	MKS1	E277*, E74*	Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome, type 1|Joubert syndrome 28|Bardet-Biedl syndrome 13	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554581	17	56290372	17	58213011	554581	548273	rs1555599412	NC_000017.11:58213010:C:A
NM_017777.4(MKS1):c.658A>T (p.Lys220Ter)	MKS1	K17*, K220*	Meckel-Gruber syndrome|Joubert syndrome|Bardet-Biedl syndrome 13|Joubert syndrome 28|Meckel syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV001379652	17	56291217	17	58213856	1379652	1483031		NC_000017.11:58213855:T:A
NM_017777.4(MKS1):c.515+1G>A	MKS1		Joubert syndrome|Meckel-Gruber syndrome|Bardet-Biedl syndrome 13|Meckel syndrome, type 1|Joubert syndrome 28|Meckel syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056624	17	56292101	17	58214740	56624	71263	rs201933838	NC_000017.11:58214739:C:T
NM_017777.4(MKS1):c.508C>T (p.Arg170Ter)	MKS1	R170*	Meckel syndrome, type 1|Joubert syndrome 28|Bardet-Biedl syndrome 13|not provided|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000235405	17	56292109	17	58214748	235405	237090	rs756853299	NC_000017.11:58214747:G:A
NM_017777.4(MKS1):c.472C>T (p.Arg158Ter)	MKS1	R158*	Joubert syndrome|Meckel-Gruber syndrome|not provided	Pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056623	17	56292145	17	58214784	56623	71262	rs386834050	NC_000017.11:58214783:G:A
NM_017777.4(MKS1):c.55G>T (p.Asp19Tyr)	MKS1	D19Y	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217675	17	56296537	17	58219176	217675	214370	rs863225205	NC_000017.11:58219175:C:A
NM_005994.4(TBX2):c.59G>A (p.Arg20Gln)	TBX2	R20Q	Vertebral anomalies and variable endocrine and T-cell dysfunction|TBX2-related condition	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000522826	17	59477596	17	61400235	522826	513470	rs1364709483	NC_000017.11:61400234:G:A
NM_002734.5(PRKAR1A):c.46C>T (p.Arg16Ter)	PRKAR1A	R16*	Carney complex, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279877	17	66511586	17	68515445	279877	264800	rs886041228	NC_000017.11:68515444:C:T
NM_002734.5(PRKAR1A):c.124C>T (p.Arg42Ter)	PRKAR1A	R42*	not provided|Carney complex, type 1	Pathogenic(Last reviewed: Aug 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000041382	17	66511664	17	68515523	41382	49806	rs281864782	NC_000017.11:68515522:C:T
NM_002734.5(PRKAR1A):c.289C>T (p.Arg97Ter)	PRKAR1A	R97*	not provided|Carney complex, type 1	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523771	17	66519008	17	68522867	523771	514732	rs1555813217	NC_000017.11:68522866:C:T
NM_002734.5(PRKAR1A):c.502+1G>A	PRKAR1A		Carney complex, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000469066	17	66520219	17	68524078	469066	468302	rs1555813578	NC_000017.11:68524077:G:A
NM_002734.5(PRKAR1A):c.535C>T (p.Gln179Ter)	PRKAR1A	Q179*	Carney complex, type 1|not provided	Pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000379923	17	66521085	17	68524944	379923	376530	rs141913727	NC_000017.11:68524943:C:T
NM_002734.5(PRKAR1A):c.682C>T (p.Arg228Ter)	PRKAR1A	R228*	not provided|Carney complex, type 1|Carney complex	Pathogenic(Last reviewed: Oct 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000041391	17	66522027	17	68525886	41391	49815	rs281864784	NC_000017.11:68525885:C:T
NM_002734.5(PRKAR1A):c.738T>G (p.Tyr246Ter)	PRKAR1A	Y246*	not provided|Carney complex, type 1	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280060	17	66524010	17	68527869	280060	265024	rs886041351	NC_000017.11:68527868:T:G
NM_002734.5(PRKAR1A):c.1102C>T (p.Arg368Ter)	PRKAR1A	R368*	not provided|Carney complex, type 1|Acrodysostosis 1 with or without hormone resistance	Pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029907	17	66526546	17	68530405	29907	38862	rs387906692	NC_000017.11:68530404:C:T
NM_002067.5(GNA11):c.547C>T (p.Arg183Cys)	GNA11	R183C	not provided|CLOVES syndrome|Capillary malformation|Segmental undergrowth associated with capillary malformation	Pathogenic(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000548668	19	3115012	19	3115014	548668	539160	rs1555702147	NC_000019.10:3115013:C:T
NM_000527.5(LDLR):c.2043C>A (p.Cys681Ter)	LDLR	C681*, C513*, C640*	Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Familial hypercholesterolemia|not provided|Hypercholesterolemia, familial, 1|Hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000003699	19	11231101	19	11120425	3699	18738		NC_000019.10:11120424:C:A
NM_030578.4(B9D2):c.463G>A (p.Gly155Ser)	B9D2	G155S	Joubert syndrome and related disorders|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217556	19	41860670	19	41354765	217556	214371	rs750436680	NC_000019.10:41354764:C:T
NM_030578.4(B9D2):c.220C>T (p.Pro74Ser)	B9D2	P74S	Joubert syndrome and related disorders|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV000217558	19	41860913	19	41355008	217558	214372	rs863225150	NC_000019.10:41355007:G:A
NM_001282531.3(ADNP):c.2213C>G (p.Ser738Ter)	ADNP	S738*	not provided|ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000391218	20	49509038	20	50892501	391218	378330	rs779340209	NC_000020.11:50892500:G:C
NM_001282531.3(ADNP):c.2188C>T (p.Arg730Ter)	ADNP	R730*	ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000279598	20	49509063	20	50892526	279598	263863	rs886041116	NC_000020.11:50892525:G:A
NM_001282531.3(ADNP):c.2157C>A (p.Tyr719Ter)	ADNP	Y719*	ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder|not provided	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000280623	20	49509094	20	50892557	280623	265101	rs587777526	NC_000020.11:50892556:G:T
NM_001282531.3(ADNP):c.2157C>G (p.Tyr719Ter)	ADNP	Y719*	ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000139635	20	49509094	20	50892557	139635	143258	rs587777526	NC_000020.11:50892556:G:C
NM_001282531.3(ADNP):c.517C>T (p.Arg173Ter)	ADNP	R173*	ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder|not provided	Pathogenic(Last reviewed: Mar 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431117	20	49510734	20	50894197	431117	424673	rs1135401791	NC_000020.11:50894196:G:A
NM_000516.7(GNAS):c.1A>G (p.Met1Val)	GNAS	M1V	not provided|Progressive osseous heteroplasia|Pituitary adenoma 3, multiple types|Cushing syndrome|McCune-Albright syndrome|Pseudohypoparathyroidism type 1B|Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism|Pseudohypoparathyroidism type 1C	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015927	20	57466782	20	58891727	15927	30966	rs137854530	NC_000020.11:58891726:A:G
NM_000516.7(GNAS):c.34C>T (p.Gln12Ter)	GNAS	Q12*	Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism|Pseudopseudohypoparathyroidism|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000209158	20	57466815	20	58891760	209158	205793	rs797045046	NC_000020.11:58891759:C:T
NM_000516.7(GNAS):c.85C>T (p.Gln29Ter)	GNAS	Q29*	Pseudohypoparathyroidism|Pseudohypoparathyroidism type 1C|McCune-Albright syndrome|Pseudohypoparathyroidism type 1B|Pseudopseudohypoparathyroidism|Progressive osseous heteroplasia|Pituitary adenoma 3, multiple types|Cushing syndrome|not provided|Pseudohypoparathyroidism type 1B|Short stature|Tetany|Subcutaneous nodule|Obesity|Hypocalcemia|Round face|Brachydactyly|Cognitive impairment	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000374113	20	57466866	20	58891811	374113	361065	rs1057518907	NC_000020.11:58891810:C:T
NM_000516.7(GNAS):c.432+1G>A	GNAS		Inborn genetic diseases|Pseudopseudohypoparathyroidism|not provided	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000446491	20	57478847	20	58903792	446491	440007	rs1555889131	NC_000020.11:58903791:G:A
NM_000516.7(GNAS):c.493C>T (p.Arg165Cys)	GNAS	R150C, R151C, R165C, R166C, R808C, R106C	Pseudohypoparathyroidism type I A|not provided|Hereditary spastic paraplegia 4	Pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015932	20	57480498	20	58905443	15932	30971	rs137854532	NC_000020.11:58905442:C:T
NM_000516.7(GNAS):c.602G>A (p.Arg201His)	GNAS	R201H, R186H, R187H, R202H, R844H, R142H	Pseudohypoparathyroidism type I A|not provided	Pathogenic(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015934	20	57484421	20	58909366	15934	30973	rs121913495	NC_000020.11:58909365:G:A
NM_000516.7(GNAS):c.682C>T (p.Arg228Cys)	GNAS	R228C, R169C, R213C, R214C, R229C, R871C	Pseudohypoparathyroidism type I A|not provided	Pathogenic(Last reviewed: Jun 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV001065886	20	57484598	20	58909543	1065886	1054223		NC_000020.11:58909542:C:T
NM_000516.7(GNAS):c.691C>T (p.Arg231Cys)	GNAS	R172C, R216C, R217C, R231C, R232C, R874C	Pseudohypoparathyroidism type I A|not provided|Pseudohypoparathyroidism	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000816910	20	57484607	20	58909552	816910	805116	rs1601162438	NC_000020.11:58909551:C:T
NM_000516.7(GNAS):c.1174G>A (p.Glu392Lys)	GNAS	E392K, E393K, E378K, E1035K, E333K, E377K	not provided	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029747	20	57485873	20	58910818	29747	38702	rs397514456	NC_000020.11:58910817:G:A
NM_000216.4(ANOS1):c.1891C>T (p.Arg631Ter)	ANOS1	R631*	Hypogonadotropic hypogonadism 1 with or without anosmia|Martsolf syndrome 1|not provided	Pathogenic(Last reviewed: Sep 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000265206	X	8502453	X	8534412	265206	260344	rs886039395	NC_000023.11:8534411:G:A
NM_003611.3(OFD1):c.2668C>T (p.Arg890Ter)	OFD1	R890*, R850*, R750*	Orofaciodigital syndrome I|Joubert syndrome|not provided|Joubert syndrome 10	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217686	X	13785314	X	13767195	217686	214376	rs863225212	NC_000023.11:13767194:C:T
NM_003611.3(OFD1):c.2725C>T (p.Arg909Ter)	OFD1	R909*, R769*, R869*	OFD1-related disorder|Joubert syndrome|Orofaciodigital syndrome I	Pathogenic(Last reviewed: May 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000404165	X	13785371	X	13767252	404165	404499	rs1060500123	NC_000023.11:13767251:C:T
NM_000044.6(AR):c.1823G>A (p.Arg608Gln)	AR	R608Q, R76Q	Kennedy disease|Androgen resistance syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009820	X	66905906	X	67686064	9820	24859	rs137852573	NC_000023.11:67686063:G:A
NM_000489.6(ATRX):c.7156C>T (p.Arg2386Ter)	ATRX	R2348*, R2386*	Microcephaly|Intellectual disability, severe|Ambiguous genitalia|Cryptorchidism|Bone osteosarcoma|not provided|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000011728	X	76776310	X	77520832	11728	26767	rs122445099	NC_000023.11:77520831:G:A
NM_001015877.2(PHF6):c.2T>C (p.Met1Thr)	PHF6	M1T	Hereditary spastic paraplegia 4|Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011068	X	133511649	X	134377619	11068	26107	rs132630300	NC_000023.11:134377618:T:C
NM_001015877.2(PHF6):c.1024C>T (p.Arg342Ter)	PHF6	R342*	not provided|Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000011063	X	133559286	X	134425256	11063	26102	rs132630297	NC_000023.11:134425255:C:T
